Product Name | CAS | MF | MW | Synonyms |
---|---|---|---|---|
Lucidenic acid C | 95311-96-9 | C27H40O7 | 476.6023 | Lucidenic acid C; (3beta,5alpha,7beta,12beta)-3,7,12-Trihydroxy-4,4,14-trimethyl-11,15-dioxo-chol-8-en-24-oic acid |
Lucidenic acid B | 95311-95-8 | C27H38O7 | 474.58642 | Lucidenic acid B; (5alpha,7beta,12beta)-7,12-Dihydroxy-4,4,14-trimethyl-3,11,15-trioxo-chol-8-en-24-oic acid |
Lucidenic acid A | 95311-94-7 | C27H38O6 | 458.59 | |
Lucidal | 252351-96-5 | C30H46O3 | 454.695 | Lucialdehyde C |
Lucidadiol | 252351-95-4 | C30H48O3 | 456.711 | |
Medicago sativaL. Extract | 84082-36-0 | 0 | Alfalfa, ext.; MEDICAGO SATIVA (ALFALFA) EXTRACT; ALFALFASPROUTEXTRACT; ALFALFA EXTRACT, SOLID (MEDICAGO SATIVA L.)Botanical Division | |
Lucanthone | 479-50-5 | C20H24N2OS | 340.485 | Lucanthone monohydrochloride; NCIMech_000830; CCRIS 1106; AIDS013879; AIDS-013879; Thiaxanthenone; miracil D. |
L-Tyrosine,L-tyrosyl-L-tyrosyl- | 7390-78-5 | C27H29 N3 O7 | 507.54 | L-TYR-TYR-TYR; H-TYR-TYR-TYR-OH; TYR-TYR-TYR; (S)-2-((S)-2-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-3-(4-hydroxyphenyl)propanamido)-3-(4-hydroxyphenyl)propanoic acid; REF DUPL: H-Tyr-Tyr-Tyr-OH |
L-Tyrosine, O-(2-tosyloxyethyl)-N-trityl, tert-butyl ester | 478037-15-9 | C41H43NO6S | 0 | L-Tyrosine, O-[2-[[(4-methylphenyl)sulfonyl]oxy]ethyl]-N-(triphenylmethyl)-, 1,1-dimethylethyl ester |
L-Tyrosine, O-(2-fluoroethyl)-, trifluoroacetate | 854750-33-7 | C11H14FNO3C2HF3O2 | 0 | |
L-Tyrosine disodium salt 2-hydrate | 122666-87-9 | C9H9NNa2O3 | 261.18 | DISODIUM TYROSINE; L-3-[4-HYDROXYPHENYL]ALANINE DISODIUM SALT; L-TYROSINE DISODIUM SALT; L-TYROSINE DISODIUM SALT, DIHYDRATE; (S)-2-AMINO-3-(4-HYDROXYPHENYL)PROPIONIC ACID, DISODIUM SALT; L-TYROSINE DISODIUM SALT 95+% |
L-threo-Sphingosine (d18:1) | 25695-95-8 | C18H37NO2 | 299.5 | L-threo-Sphingosine C18; L-threo-Sphingosine; (E,2S,3S)-2-aminooctadec-4-ene-1,3-diol |
L-Threose | 95-44-3 | C4H8O4 | 120.1 | |
L-threo-PPMP hydrochloride | 207278-87-3 | C29H50N2O3·HCl | 511.18 | L-threo-PPMP HCl; L-threo-1-phenyl-2-Palmitoylamino-3-morpholino-1-propanol hydrochloride; N-[(1R,2R)-1-hydroxy-3-morpholin-4-yl-1-phenylpropan-2-yl]hexadecanamide hydrochloride |
Methyl 2-deoxy-L-threo-pentofuranoside | 302349-32-2 | C6H12O4 | 148.16 | L-threo-Pentofuranoside,methyl 2-deoxy-(9CI); methyl 2-deoxy-L-riboside; Methyl-2-deoxy-L-erythro pentofuranoside; 1-O-methyl-2-deoxy-L-ribofuranoside; methyl 2-deoxy-L-xylofuranoside; (2S,3S)-2-(hydroxymethyl)-5-methoxyoxolan-3-ol |
L-Threoninol hydrochloride;(2R,3R)-2-Amino-3-hydroxy-1-butanol hydrochloride | 79474-65-0 | 141.6 | ||
L-Serine-15N-N-FMOC, O-tert-butyl ether | 387867-79-0 | C22H25[15N]O5 | 384.44 | |
L-Serine | 56-45-1 | C3H7NO3 | H-Ser-OH; (S)-2-Amino-3-hydroxypropanoic acid; | |
L-Selenomethionine-(methyl-13C) | 1217470-45-5 | [13C]H3SeCH2CH2CH(NH2)CO2H | 197.1 | |
L-Selectridesolution | 38721-52-7 | C12H27BLi | 190.10 | Lithium tri-sec-butylborohydride solution |
LSD Inhibitor I | 1234494-75-7 | C15H36N8·4HCl | 474.34 | Lysine-specific Demethylase Inhibitor (1C) hydrochloride; KDM1 Inhibitor I |
L-Scoulerine | 605-34-5 | C19H21NO4 | 327.38 | 3,10-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline-2,9-diol |
LQB-118 | 1219104-20-7 | C19H12O4 | 304.296 | LQB-118; LQB 118; LQB118 |
LPYFD-NH2 | 700361-48-4 | C33H44N6O8 | 652.75 | H-Leu-Pro-Tyr-Phe-Asp-NH2; (3S)-4-amino-3-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoic acid; ZINC98052568; AKOS024457970 |
LpxC inhibitor 1a | 1289620-49-0 | C18H21NO4S | 347.43 | (2R)-N-hydroxy-2-methyl-2-methylsulfonyl-4-(4-phenylphenyl)butanamide |
L-Psicose | 16354-64-6 | C6H12O6 | 180.16 | |
L-Propargylglycine | 198774-27-5 | C5H7NO2 | 113.12 | L-Propargylglycine |
L-Prolyl-L-leucylglycinamide | 2002-44-0 | C13H24N4O3 | 284.36 | N-[1-[(Carbamoylmethyl)carbamoyl]-3-methylbutyl]-2-pyrrolidinecarboxamide; 26: PN: US6093797 PAGE: 15 claimed protein; 27: PN: US6093797 PAGE: 15 claimed protein; 2: PN: WO2009039992 PAGE: 107 claimed protein; 7-9-Oxytocin; H-Pro-Leu-Gly-NH2; L-Proline-L- |
L-Proline,1-(dithiocarboxy)- | 7250-31-9 | C6H9 N O2 S2 | 208.30200 | |
L-Proline, 4-bromo-,(4S)- | 16257-69-5 | C5H8 Br N O2 | 0 | (2S,4S)-4-bromopyrrolidine-2-carboxylic acid |
L-Proline | 147-85-3 | C5H9NO2 | 115.13 | (-)-2-Pyrrolidinecarboxylic Acid; (-)-Proline; (S)-(-)-Proline; (S)-2-Carboxypyrrolidine; (S)-2-Pyrrolidinecarboxylic Acid |
L-Polylactide(PLLA) | 33135-50-1 | C6H8O4 | 144.12532;g/mol | 4511-42-6;(3S,6S)-3,6-dimethyl-1,4-dioxane-2,5-dione;L-(-)-Lactide;L-Lactide;(3S)-cis-3,6-Dimethyl-1,4-dioxane-2,5-dione;(3S,6S)-(-)-3,6-Dimethyl-1,4-dioxane-2,5-dione |
L-Phenylephrine | 59-42-7 | C9H13NO2 | 167.2 | (R)-(-)-Phenylephrine; phenylephrine; Metasympatol; Mezaton; 3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol |
L-Phenyl-d5-alanine-N-t-BOC | 121695-40-7 | C6D5CH2CH(NH-t-BOC)COOH | 270.34 | BOC-L-Phenylalanine-d5; BOC-L-Phe-OH-d5; N-Boc-L-phenyl-d5-alanine; (2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid |
L-Phenyl-d5-alanine-N-FMOC | 225918-67-2 | C6D5CH2CH(NH-FMOC)COOH | 392.46 | FMOC-L-Phenylalanine-d5; FMOC-L-Phe-OH-d5 |
L-Phenyl-d5-alanine-2,3,3-d3-N-t-BOC | 106881-07-6 | C6D5CD2CD(NH-t-BOC)COOH | 273.36 | BOC-L-Phenylalanine-d5; BOC-L-Phe-OH-d5; Boc-Phe-OH-phenyl-d5-2,3,3-d3; N-(tert-Butoxycarbonyl)-L-phenyl-d5-alanine-2,3,3-d3; (2S)-2,3,3-trideuterio-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid |
L-Phenyl-d5-alanine-2,3,3-d3 | 17942-32-4 | C6D5CD2CD(NH2)COOH | 173.24 | (S)-2-Amino-3-phenylpropionic Acid-d8; H-L-Phe-OH-d8; (2S)-2-amino-2,3,3-trideuterio-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid |
L-Phenyl-d5-alanine | 56253-90-8 | C6D5CH2CH(NH2)COOH | 170.22 | (S)-2-Amino-3-phenylpropionic Acid-d5; H-L-Phe-OH-d5; (2S)-2-amino-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid |
L-Phenylalanine-3-13C | 136056-02-5 | C9H11NO2 | 166.184 | L-Phenylalanine-|A-13C; L-(beta-~13~C)Phenylalanine; DTXSID80514736 |
L-Phenylalanine-3,3-d2 | 221346-31-2 | C6H5CD2CH(NH2)COOH | 167.2 | (S)-2-Amino-3-phenylpropionic Acid-d2; H-L-Phe-OH-d2; (2S)-2-amino-3,3-dideuterio-3-phenylpropanoic acid |
L-Phenylalanine-2-d1 | 54793-54-3 | C6H5CH2CD(NH2)CO2H | 166.2 | (2S)-2-amino-2-deuterio-3-phenylpropanoic acid |
L-Phenylalanine (RING-13C6) | 180268-82-0 | C9H11NO2 | 171.146 | L-Phenylalanine-13C6; L-Phenyl-13C6-alanine; (S)-(-)-Phenylalanine-13C6; (S)-|A-Aminohydrocinmic Acid-13C6; (S)-|A-Amino-benzenepropanoic Acid-13C6 |
LP-935509 | 1454555-29-3 | C20H24N6O3 | 396.44 | Isopropyl 4-(3-(2-methoxypyridin-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl)piperazine-1-carboxylate; 4-[3-(2-Methoxy-pyridin-3-yl)-pyrazolo[1,5-a]pyrimidin-5-yl]-piperazine-1-carboxylic acid isopropyl ester |
LP-922761 | 1454808-95-7 | C21H26N6O3 | 410.47 | tert-Butyl (2-((3-(4-carbamoylphenyl)imidazo[1,2-b]pyridazin-6-yl)amino)ethyl)(methyl)carbamate |
LP-533401 | 945976-43-2 | C27H22F4N4O3 | 526.5 | (2S)-2-Amino-3-[4-[2-amino-6-[2,2,2-trifluoro-1-[4-(3-fluorophenyl)phenyl]ethoxy]pyrimidin-4-yl]phenyl]propanoic acid |
LP-261 | 915412-67-8 | C22H19N3O4S | 421.471 | LP-261 |
LP 44 | 824958-12-5 | C27H37N3OS.HCl | 488.13 | 4-[2-(Methylthio)phenyl]-N-(1,2,3,4-tetrahydro-1-naphthalenyl)-1-piperazinehexanamide hydrochloride |
LP 20 hydrochloride | 1386928-34-2 | C17H20N2O.HCl | 304.81 | 1-(4'-Methoxy[1,1-biphenyl]-2-yl)piperazine hydrochloride |
LP 12 hydrochloride | 1185136-22-4 | C32H39N3O.HCl | 518.13 | 4-(2-Diphenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide hydrochloride |
Loxoribine | 121288-39-9 | C13H17N5O6 | 339.3 | 7-Allyl-8-oxoguanosine; Loxoribine; Loxoribina; Loxoribinum; RWJ-21757; RWJ 21757; RWJ21757; 7a8oGuo |
Lovastatin-d3 | 1002345-93-8 | C24H33O5D3 | 407.56 | (2S)-2-(Methyl-d3)butanoic Acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro- 3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester; MK-803-d3; Lovalip-d3; Lovastatin Lactone-d3; Mevacor-d3; Mevinacor-d3 |
Lovastatin Hydroxy Acid, Sodium Salt | 75225-50-2 | C24H37O6Na | 444.54 | Lovastatin Sodium Salt; MB 530B; Mevinolinic Acid |
Lovastatin Hydroxy Acid | 75225-51-3 | C24H38O6 | 422.562 | Lovastatin acid; Mevinolinic acid; Monacolinic K acid; MSD 803 acid; MSD 803 free acid; UNII-5CLV35Y90C; (3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-dimethyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid |
Dihydromevinolin | 77517-29-4 | C24H38O5 | 406.56 | 4a,5-Dihydro Lovastatin; (2S)-2-Methylbutanoic Acid (1S,3S,4aR,7S,8S,8aS)-1,2,3,4,4a,7,8,8a-Octahydro- 3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester; (+)-Dihydromevinolin; Dihydrolovastatin; Dihydromevinol |
Loureirin D | 119425-91-1 | C16H16O5 | 288.29 | |
Loureirin C | 116384-24-8 | C16H16O4 | 272.3 | 3-(4-hydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)propan-1-one |
Loureirin B | 119425-90-0 | C18H20O5 | 316.35 | 1-Propanone,1-(4-hydroxyphenyl)-3-(2,4,6-triMethoxyphenyl) |
Loureirin A | 119425-89-7 | C17H18O4 | 286.32 | 3-(2,4-dimethoxyphenyl)-1-(4-hydroxyphenyl)propan-1-one; 3-(2,4-Dimethoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone |
Lotusine | 6871-67-6 | C19H24NO3+ | 314.4 | |
Lotrafiban hydrochloride | 179599-82-7 | C23H33ClN4O4 | 464.99 | Lotrafiban hydrochloride; Lotrafiban HCl; Lotrafiban hydrochloride; 2-[(2S)-4-methyl-3-oxo-7-(4-piperidin-4-ylpiperidine-1-carbonyl)-2,5-dihydro-1H-1,4-benzodiazepin-2-yl]acetic acid;hydrochloride |
Lotilaner | 1369852-71-0 | C20H14Cl3F6N3O3S | 569.75 | UNII-HEH4938D7K;(S)-3-methyl-N-(2-oxo-2-((2,2,2-trifluoroethyl)amino)ethyl)-5-(5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)thiophene-2-carboxamide |
Lotaustralin | 534-67-8 | C11H19NO6 | 261.27 | 2-(b-D-Glucopyranosyloxy)-2-methylbutyronitrile |
Losoxantrone | 88303-60-0 | C22H27N5O4 | 425.489 | Losoxantrone; Biantrazole; CI-941; DuP-941. |
Losmapimod | 585543-15-3 | C22H26FN3O2 | 383.467 | GSK-AHAB; GW856553; GW856553X; 6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide |
Losartan Impurity 4 | 141949-90-8 | C22H21ClN6O | 420.91 | |
Losartan Impurity 2 | 1407521-00-9 | C22H20ClN3O | 377.88 | |
Losartan Impurity 1 | 79047-41-9 | C8H13ClN2O | 188.65 | 2-Butyl-5-chloroimidazole-4-methanol; 2-Butyl-4-chloro-5-(hydroxymethyl)imidazole; 2-n-Butyl-4-chloro-5-(hydroxymethyl)imidazole; 5-Chloro-2-butyl-imidazole-4-methanol |
Losartan d4 | 1030937-27-9 | C22H19ClD4N6O | 426.91 | |
Losartan Cum-Alcohol | 852357-69-8 | C31H33ClN6O | 541.10 | |
Lorglumide sodium | 1021868-76-7 | C22H31Cl2N2O4·Na | 481.4 | Lorglumide sodium salt; 4-[(3,4-dichlorobenzoyl)amino]-5-(dipentylamino)-5-oxopentanoate sodium |
Lorediplon | 917393-39-6 | C20H15FN4O2S | 394.42 | Acetamide, N-(2-fluoro-5-(3-(2-thienylcarbonyl)pyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-methyl-;N-(2-Fluoro-5-(3-(thiophene-2-carbonyl)pyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-methylacetamide |
Loreclezole hydrochloride | 117857-45-1 | C10H6Cl3N3.HCl | 311 | (Z)-1-[2-Chloro-2-(2,4-dichlorophenyl)ethenyl]-1H-1,2,4-triazole hydrochloride |
Lorcaserin N-Oxide | 1421747-19-4 | C11H14ClNO | 211.69 | N-Hydroxy Lorcaserin; (1R)-8-Chloro-2,3,4,5-tetrahydro-3-hydroxy-1-methyl-1H-3-benzazepine |
Lorcaserin Impurity D | 1030624-36-2 | C11H14ClNO2 | 227.69 | 4-Chloro-N-(2-hydroxypropyl)benzeneacetamide; 2-(4-Chlorophenyl)-N-(2-hydroxypropyl)acetamide |
Lorcaserin Impurity B | 953789-37-2 | C11H16Cl3N | 268.61 | 4-Chloro-N-(2-chloropropyl)benzeneethanamine Hydrochloride; 2-Chloro-N-(4-chlorophenethyl)propan-1-amine Hydrochloride |
Lorcaserin hydrochloride hemihydrate | 856681-05-5 | C11H15Cl2N·0.5H2O | 241.16 | |
Lorcaserin Hydrochloride | 846589-98-8 | APD-356; APD 356; APD356 | ||
Lorcaserin 5-Methyl Isomer | 616201-89-9 | C11H14ClN | 195.69 | 7-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine; 7-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine |
Lorcainide | 59729-31-6 | C22H28Cl2N2O | 407.3760 | |
Lorazepam | 846-49-1 | C15H10Cl2N2O2 | 321.16 | Ativan; Temesta; o-Chloroxazepam; 7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepine-2-one |
Loratadine-d5(ethyl-d5) | 1398065-63-8 | C22H13D5ClN2O2 | 387.92 | Ethyl 4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta-[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylate |
Loratadine-d5 | 1020719-57-6 | C22H18D5ClN2O2 | 387.91 | 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene-2,3,4,5,5-d5)-1-piperidinecarboxylic Acid Ethyl Ester; Claritin-d5; Sch-29851-d5 |
Loratadine-d4 | 381727-27-1 | C22H19D4ClN2O2 | 386.91 | 4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylic Acid-d5, Ethyl Ester |
Loratadine Side Chain Impurity | 133345-21-8 | C14H18N2O3 | 262.31 | |
Loratadine Impurity F | 125743-80-8 | C22H24ClFN2O2 | 402.89 | 4-(8-Chloro-11-fluoro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-Piperidinecarboxylic Acid Ethyl Ester; 5H-Benzo[5,6]cyclohepta[1,2-b]pyridine, 1-piperidinecarboxylic Acid Derivative |
Loratadine Impurity E | 133330-60-6 | C14H9Cl2NO | 278.13 | 4,8-Dichloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one |
Loratadine Impurity D | 38089-93-9 | C20H23ClN2O | 342.86 | 11-Hydroxy-N-methyl Dihydro Loratadine; 8-Chloro-6,11-dihydro-11-(1-methyl-4-piperidinyl)-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ol |
Loratadine Impurity (Ethyl 4-{[3-[2-(3-Chlorophenyl]-2-Pyridinyl]carbonyl}-1-Piperidinecarboxylayte) | 107256-32-6 | C22H25ClN2O3 | 400.9 | 4-[[3-[2-(3-Chlorophenyl)ethyl]-2-pyridinyl]carbonyl]-1-piperidinecarboxylic Acid Ethyl Ester |
Loratadine Impurity ((1-Methyl-4-piperidinyl)[3-[2-(3-chlorophenyl)ethyl]pyridinyl]methanone) | 119770-60-4 | C20H24Cl2N2O | 379.32 | (3-(3-Chlorophenethyl)pyridin-2-yl)(1-methylpiperidin-4-yl)methanone hydrochloride |
Loratadine EP Impurity G | 38092-89-6 | C20H21ClN2 | 324.85 | N-Methyl Desloratadine; 8-Chloro-6,11-dihydro-11-(1-methyl-4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; 8-Chloro-6,11-dihydro-11-(N-methyl-4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
Loratadine EP Impurity D (Desloratadine) | 100643-71-8 | C19H19ClN2 | 310.82 | SCH-34117, SCH 34117; SCH34117; NSC 675447; NSC675447; NSC-675447 |
Loratadine EP Impurity C | 165739-83-3 | C22H22Cl2N2O2 | 417.33 | 4-Chloro Loratadine; 4-(4,8-Dichloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylic Acid Ethyl Ester |
Loratadine EP Impurity B | 31251-41-9 | C14H10ClNO | 243.69 | 8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one; USP Loratadine Related Compound C |
Loratadine EP Impurity A | 133284-74-9 | C22H25ClN2O3 | 400.9 | 11-Hydroxy Dihydro Loratadine; 4-(8-Chloro-6,11-dihydro-11-hydroxy-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidinecarboxylic Acid Ethyl Ester |
Loratadine (Desloratadine Impurity E) | 79794-75-5 | C22H23ClN2O2 | 382.88 | Loratadine; Claritin; Loratidine; Clarityn; Alavert; Loratadine Wyeth Brand; Sch 29851; Sch-29851; Sch29851; Wyeth Brand of Loratadine; |
Lorapride | 68677-06-5 | C14H22ClN3O3S | 347.861 g/mol | |
Loracarbef | 76470-66-1 | C16H16ClN3O4 | 349.77 | (6R,7S)-7-[[(2R)-2-Amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; Lorabid; |
Lopinavir Impurity S | 943250-65-5 | C47H58N4O7 | 790.99 | Lopinavir O-Phenoxyacetyl |
Lopinavir (4R) Epimer | 1798014-18-2 | C37H48N4O5 | 628.8 | (2S,4R,5S)-Lopinavir; (S)-N-((2S,4R,5S)-5-(2-(2,6-Dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide |
Lopinavir (2R) Epimer | 1217628-64-2 | C37H48N4O5 | 628.8 | (2R,4S,5S)-Lopinavir; (S)-N-((2R,4S,5S)-5-(2-(2,6-Dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide |
Lopinavir | 192725-17-0 | C37H48N4O5 | 628.81 | ABT 378; ABT-378; ABT378; Aluviran; Kaletra |
Lombazole | 60628-98-0 | C22H17ClN2 | 344.84 | 1-[[1,1'-Biphenyl]-4-yl(2-chlorophenyl)methyl]-1H-imidazole;BAY-h-6020;1H-Imidazole,1-[[1,1'-biphenyl]-4-yl(2-chlorophenyl)methyl]-;Lombazolum |
LOLITREM B | 81771-19-9 | C42H55NO7 | 685.89 | |
Loliolide | 5989-02-6 | C11H16O3 | 196.246 | (6S,7aR)-6-hydroxy-4,4,7a-trimethyl-6,7-dihydro-5H-1-benzofuran-2-one |
Logwood extract | 8005-33-2 | |||
Loganin | 18524-94-2 | C17H26O10 | 390.39 | 7-Hydroxy-6-desoxyverbenalin; Loganoside |
Loganic acid | 22255-40-9 | C16H24O10 | 376.4 | LOGANIC ACID; [1S-(1alpha,4aalpha,6alpha,7alpha,7aalpha)]-1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-6-hydroxy-7-methylcyclopenta[c]pyran-4-carboxylic acid; (1S-(1alpha,4aalpha,6alpha,7alpha,7aalpha))-1-(beta-D-Glucopyranosylox y)-1,4a,5,6,7,7a- |
Loganetin | 29748-10-5 | C11H16O5 | 228.2 | Methyl (1R,4aS,6S,7R,7aS)-1,6-dihydroxy-7-methyl-1,4a,5,6,7,7a-he xahydrocyclopenta[c]pyran-4-carboxylate |
Loflucarban | 790-69-2 | C13H9Cl2FN2S | 315.187 | Fluonilid; Fluonilide; 3,5-Dichloro-4'-fluorothiocarbanilide; 1-(3,5-dichlorophenyl)-3-(4-fluorophenyl)thiourea |
Lofexidine hydrochloride | 21498-08-8 | C11H13Cl3N2O | 295.59 | 2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole;hydrochloride 2-(alpha-(2,6-dichlorophenoxy)ethyl) delta-2-imidazoline BritLofex lofexidine lofexidine hydrochloride Lofexidine mono-hydrochloride lofexidine monohydrochloride lofexidine, (+ |
Lofexidine | 31036-80-3 | C11H12Cl2N2O | 259.13 | 2-[1-(2,6-dichlorophenoxy)ethyl]-2-imidazoline; LOFEXIDINE; 2-(1-(2,6-dichlorophenoxy)ethyl)-4,5-dihydro-1h-imidazol; 2-(1-(2,6-dichlorophenoxy)ethyl)-4,5-dihydro-1h-imidazole; 2-(alpha-(2,6-dichlorophenoxy)ethyl)2-imidazoline; 6-dichlorophenoxy)ethyl)-2- |
lofepramine hydrochloride | 26786-32-3 | C26H28Cl2N2O | 455.426 | N-(4-CHLOROBENZOYLMETHYL)-3-(10,11-DIHYDRO-5H-DIBENZ[B,F]AZEPIN-5-YL)-N-METHYLPROPYLAMINE HYDROCHLORIDE; LOFEPRAMINE HCL; LOFEPRAMINE HYDROCHLORIDE; 4'-chloro-2-((3-(10,11-dihydro-5h-dibenz(b,f)azepin-5-yl)propyl)methylamino); acetophenone,4'-chloro-2-((3 |
Lofepramine | 23047-25-8 | C26H27N2OCl | 418.97 | 1-(4-Chlorophenyl)-2-[[3-(10,11-dihydro-5H-dibenz(Z)[b,f]azepin-5-yl)propyl]methylamino]ethanone |
Lofendazam | 29176-29-2 | C15H13ClN2O | 272.72952;g/mol | Lofendazam; UNII-V7O53S50SN; 29176-29-2; 8-Chloro-1,3,4,5-tetrahydro-1-phenyl-2H-1,5-benzodiazepin-2-one; 8-Chloro-1-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-2-one; Lofendazamum |
Lodoxamide tromethamine | 63610-09-3 | C19H28ClN5O12 | 553.9 | Alomide; Lodoxamidetromethamine |
Lodoxamide | 53882-12-5 | C11H6ClN3O6 | 311.6 | 2-[2-chloro-5-cyano-3-(oxaloamino)anilino]-2-oxoacetic acid |
LNT 1 | 824983-91-7 | C15H12N2O5S | 332.33 | FEN1-IN-1; FEN1 Inhibitor C1; 1-[(2,3-Dihydro-1,4-benzodioxin-2-yl)methyl]-3-hydroxythieno[3,2-d]pyrimidine-2,4(1H,3H)-dione |
L-Noviose | 107739-83-3 | |||
L-N,N-Dimethyl aspartic acid dimethyl ester | 7545-54-2 | C8H15NO4 | 189.2 | L-N,N-Dimethyl aspartic acid dimethyl ester |
L-N(W)-NITROARGININE-2 4-DIAMINOBUTRYIC | 244185-39-5 | C14F6H24N8O8 | 546.38 | (2S)-2-amino-5-[[amino(nitramido)methylidene]amino]-N-[(2S)-1,4-diamino-1-oxobutan-2-yl]pentanamide; 2,2,2-trifluoroaceticacid; CHEMBL1204421; L-N|O-Nitroarginine-2,4-L-diaminobutyricamidedi(trifluoroacetate)salt; (2S)-2-amino-N-[(1S)-3-amino-1-(aminocarb |
L-N-(4-N-Cbz-piperidino)proline | 289677-06-1 | C18H24N2O4 | 332.39 | (S)-4-(2-CARBOXY-PYRROLIDIN-1-YL)-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER; L-N-(4'-N-CBZ-PIPERIDINO)PROLINE; L-N-(4-N-CBZ-PIPERIDINO)PROLINE; 4-(2-CARBOXY-PYRROLIDIN-1-YL)-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER; L-N-(4'-N-Cbz-piperidino)proline |
LMPTP inhibitor compound 23 | 1908414-82-3 | C28H36N4O | 444.6 | LMPTP inhibitor 1; N,N-diethyl-4-(4-((3-(piperidin-1-yl)propyl)amino)quinolin-2-yl)benzamide |
LMP744 | 308246-52-8 | C24H24N2O7 | 452.46 | 6-(3-(2-hydroxyethyl)amino-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno(1,2-)isoquinoline; MJ-III-65; NSC 706744; NSC-706744; NSC706744; uglysy8 cpd |
L-Moses | 15713-67-4 | C24H72Cl2N12O17P6Zn | 1123.03 | Zinc(2+), tris(octamethylpyrophosphoramide)-, diperchlorate; Zinc perchlorate compd. with octamethylpyrophosphoramide (1:3); Pyrophosphoramide, octamethyl-, compd. with zinc perchlorate (3:1); Perchloric acid, zinc salt, compd. with 3 moles of octamethyl |
LMK-235 | 1418033-25-6 | C15H22N2O4 | 294.351 | LMK-235; LMK 235; LMK235 |
L-Mimosine | 500-44-7 | C8H10N2O4 | 198.18 | Leucenol |
L-Methionine S-methylsulfonium chloride | 1115-84-0 | C6H14ClNO2S | 199.6989 | L-Methionine S-methylsulfonium chloride; S-Methylmethioninium chloride; Vitamin U |
L-Methionine [R,S]-Sulfoximine | 15985-39-4 | C5H12N2O3S | 180.23 | |
L-Magnesium Aspartate | 2068-80-6 | C8H12MgN2O8·2H2O | 324.5 | |
LM985 | 87626-56-0 | C23H25NO4 | 379.45 | 2-(diethylamino)ethyl 2-(4-oxo-2-phenylchromen-8-yl)acetate; flavone acetic acid diethanolamine ester; LM 985; LM 985 hydrochloride; LM-985; LM985; NSC 293015; oxo-4-phenyl-2,4,H-1-benzopyran-8-yl 2-diethylaminoethyl acetate HCl |
LM22B-10 | 342777-54-2 | C27H33ClN2O4 | 485.01 | 2-[4-[[4-[bis(2-hydroxyethyl)amino]phenyl]-(4-chlorophenyl)methyl]-N-(2-hydroxyethyl)anilino]ethanol |
LM11A 31 dihydrochloride | 1243259-19-9 | C12H25N3O2.2HCl | 316.27 | (2S,3S)-2-Amino-3-methyl-N-[2-(4-morpholinyl)ethyl]pentanamide dihydrochloride |
LM 22A4 | 37988-18-4 | C15H21N3O6 | 339.34 | N,N',N''Tris(2-hydroxyethyl)-1,3,5-benzenetricarboxamide |
LM 10 | 1316695-35-8 | C11H8FN5 | 229.21 | 6-Fluoro-3-[(1E)-2-(2H-tetrazol-5-yl)ethenyl]-1H-indole |
L-Lyxose | 1949-78-6 | C5H10O5 | 150.13 | |
L-Lysine hydrochloride | 10098-89-2 | C6H15ClN2O2 | 182.648 | L-Lysine monohydrochloride; H-Lys-OH.HCl; L-Lysine, monohydrochloride; Lyamine; (2S)-2,6-diaminohexanoic acid hydrochloride |
LLY-507 | 1793053-37-8 | C36H42N6O | 574.77 | 5-cyano-2'-(4-(2-(3-methyl-1H-indol-1-yl)ethyl)piperazin-1-yl)-N-(3-(pyrrolidin-1-yl)propyl)-[1,1'-biphenyl]-3-carboxamide; LLY-507; LLY 507; LLY507. |
LLY-283 | 2040291-27-6 | C17H18N4O4 | 342.4 | 2-(4-Aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-[hydroxy(phenyl)methyl]oxolane-3,4-diol |
LLL12 | 1260247-42-4 | C14H9NO5S | 303.290 | LLL12; LLL-12; LLL 12 |
L-Leucine-d3-N-t-BOC H2O (methyl-d3) | 203645-42-5 | 252.32 | BOC-L-Leucine-d3 H2O; BOC-L-Leu-OH-d3 H2O; Boc-Leu-OH-5,5,5-d3 monohydrate; L-Leucine-5,5,5-d3, N-t-Boc derivative monohydrate; N-(tert-Butoxycarbonyl)-L-leucine-5,5,5-d3 monohydrate; (2S)-5,5,5-trideuterio-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamin | |
L-Leucine-1-13C,15N | 80134-83-4 | (CH3)2CHCH2CH(15NH2)[13C]OOH | 133.16 | |
L-Leucine-1-13C | 74292-94-7 | (CH3)2CHCH2CH(NH2)[13C]OOH | 132.17 | (2S)-2-amino-4-methylpentanoic acid-13C |
Lithium trifluoromethanesulfonate | 33454-82-9 | CF3LiO3S | 156 | Methanesulfonicacid,trifluoro-,lithiumsalt; trifluoro-methanesulfonicacilithiumsalt; PFM-LI; TRIFLUOROMETHANESULFONIC ACID LITHIUM SALT; LITHIUM TRIFLATE; LITHIUM TRIFLUOROMETHANESULPHONATE |
Lithium thiocyanate hydrate | 123333-85-7 | CLiNS | 65.02 | LITHIUM THIOCYANATE; LITHIUM THIOCYANATE HYDRATE; LITHIUM THIOCYANATE N-HYDRATE; LITHIUM RHODANIDE; LITHIUM RHODANIDE HYDRATE; Lithium thiocyanate hdrate |
Lithium tetrafluoroborate | 14283-07-9 | LiBF4 | 93.74 | LITHIUM TETRAFLUOROBORATE; LITHIUM BOROFLUORIDE; Borate(1-),tetrafluoro-,lithium; lithiumfluoborate; Lithiumfluoborate,monohydrate; lithiumtetrafluoroborate,anhydrous |
LITHIUM TETRACHLOROALUMINATE | 14024-11-4 | AlCl4Li | 175.73 | lithium,(beta-4)-aluminate(1-tetrachloro-; LITHIUM TETRACHLOROALUMINATE; Lithium aluminate chloride; LITHIUM TETRACHLOROALUMINATE, ANHYDROUS, POWDER, 99.99%; LITHIUM TETRACHLOROALUMINATE, ANHYDROUS, BEADS, -10 MESH, 99.99%; lithium aluminium chloride |
LITHIUM TETRA(PERFLUORO-T-BUTOXY)ALUMINATE | 274933-96-9 | C16AlF36LiO4 | 974.03 | LITHIUM TETRA(PERFLUORO-T-BUTOXY)ALUMINATE; Lithiumtetra(perfluoro-t-butoxy)aluminate,min.98%; Lithium tetra(perfluoro-t-butoxy)aluminate, min. 98% |
Lithium tetra(8-hydroxyquinolinato)boron | 322727-85-5 | C36H24BN4O4Li | 594.35 | lithium; tetra(quinolin-8-yloxy)boranuide; 322727-85-5; LITHIUMTETRABORO&; Lithiumtetra(8-hydroxyquinolinato)boron |
Lithium tert-Butoxide (LTB), typ. 20 % solution in THF (typ. 2.2 M) | 1907-33-1 | 4H9LiO | 80.05466;g/mol | lithium;2-methylpropan-2-olate;Lithiumtert-butoxide;1907-33-1;Lithium2-methylpropan-2-olate;tert-Butoxylithium |
Lithium tert-Amoxide (LTA), typ. 40% solution in Heptane (typ. 3.1 M) | 53535-81-2 | 5H11LiO | 94.08124;g/mol | lithium; 2-methylbutan-2-olate; Lithiumtert-amoxidesolution; 53535-81-2; tert-Amyloxylithium; Lithiumtert-amylate |
Lithium sulfite | 13453-87-7 | H2O3 S . 2 Li | 93.9452 | dilithium sulphite; Lithiumsulfite; Sulfurous acid, dilithium salt |
LITHIUM SULFIDE | 12136-58-2 | Li2S | 45.95 | dilithiummonosulfide; dilithiumsulfide; lithiumsulfide(li2s); lithiumsulphide,anhydrous; LITHIUM SULFIDE; Lithiumsulfide,98%(99.9%-Li); LITHIUMSULPHIDE; LITHIUM SULFIDE (99.9% LI) |
Lithium stearate | 4485-12-5 | C18H35LiO2 | 290.41 | LITHIUM STEARATE; STEARIC ACID LITHIUM SALT; lithalure; lithiumoctadecanoate; litholite; Octadecanoicacid,lithiumsalt |
Lithium selenide | 12136-60-6 | Li2Se | 92.84 | LITHIUM SELENIDE; dilithium selenide; Lithium selenate, 99.5% (metals basis); Lithium selenide, 99.5% (metals basis); Selenobislithium; Einecs 235-230-2 |
Lithium periodate | 21111-84-2 | LiO4I | 197.85 | LITHIUM PERIODATE; reagentgrade; LITHIUM PERIODATE REAGENT; lithium periodate dihydrate, reagent grade |
Lithium oxalate | 30903-87-8 | C2HLiO4 | 101.90 | LITHIUM OXALATE; LITHIUM ACID OXALATE; DI-LITHIUM OXALATE; ETHANEDIOIC ACID DILITHIUM SALT; OXALIC ACID DILITHIUM SALT; Lithium oxalate, 99+%; Lithiumoxalate,min.95%; Lithium oxalate, min. 95% |
Lithium orotate | 5266-20-6 | C5H3LiN2O4 | 162.1 | 2,4-dioxo-1H-pyrimidine-6-carboxylate lithium salt |
Lithium nitrite | 13568-33-7 | HN O2 . Li | 0 | Nitrous acid lithium salt |
Lithium nitrate 3-hydrate | 13453-76-4 | LiNO3.3H2O | 122.99200 | |
Lithium manganese nickel oxide | 12031-75-3 | |||
Lithium manganate | 12057-17-9 | LiMn2O4 | 180.81 | LITHIUM MANGANESE(III,IV) OXIDE; LITHIUM MANGANESE OXIDE; LITHIUM MANGANESE(III,IV) OXIDE, ELECTRO -CHEMICAL GRADE; Lithium manganese oxide (LiMn2O4); Lithium manganese(III,IV) oxide, 99.5% (metals basis); Lithium manganate |
Lithium laurate | 14622-13-0 | LiC12H23O2 | 206.25 | |
Lithium Hydroxide Monohydrate, free flowing typ. 57 % LiOH | 1310-66-3 | INECS-No.: 215-183-4 | 41.96362;g/mol | lithium; hydroxide; hydrate; Lithiumhydroxidemonohydrate; lithiumhydroxidehydrate; 1310-66-3 |
Lithium hydride (LiD) | 13587-16-1 | DLi | 8.96 | LITHIUM DEUTERIDE; LITHIUM DEUTERIDE (D); LiD; lithium (2H)hydride; LITHIUM DEUTERIDE, 98 ATOM % D; LITHIUM DEUTERIDE DEUTERATION DEGREE MIN . 99 ATOM % D; Isotopic; Lithium deuteride, for NMR, 99 atom% D |
lithium hexafluorophosphate | 21324-40-3 | LiPF6 | 151.9 | LITHIUM HEXAFLUOROPHOSPHATE; hexafluoro-phosphate(1-lithium; Phosphate(1-),hexafluoro-,lithium; lithium hexafluorophosphate(1-); LITHIUM HEXAFLUOROPHOSPHATE, 99.99+%; Lithium hexafluorophosphate, pure, 98% |
LITHIUM FORMATE | 556-63-8 | CHLiO2 | 51.96 | LITHIUM FORMATE; FORMIC ACID LITHIUM SALT; Lithiumformiat; Lithiummethanoat; lithiummethanoate; Lithiumformiate-1-hydrate; Lithiumformiatemonohydrate; Formic acid lithium |
Lithium bromide | 7550-35-8 | LiBr | 86.84 | LITHIUM HALIDE; Hydrobromic acid lithium salt; LiBr; Lithium bromide (LiBr); lithiumbromide(libr); Lithiumbromide,dihydrate; lithiummonobromide; Lithiumbromidewhitepowder |
Lithium bis(trimethylsilyl)amide | 4039-32-1 | C6H18LiNSi2 | 167.32 | 1,1,1,3,3,3-HEXAMETHYLDISILAZAN LITHIUMSALZ; 1,1,1,3,3,3-HEXAMETHYLDISILAZANE LITHIUM SALT; HEXAMETHYLDISILAZANE LITHIUM SALT; LHMDS; LIHMDS; LITHIUM HEXAMETHYLDISILAZANE; LITHIUM HEXAMETHYLDISILAZIDE; LITHIUM-BIS-(TRIMETHYLSILYL)-AMID |
Lithium bis-(oxalato)borate - LiBOB (sbg), standard battery grade | 244761-29-3 | 4BO8Li | 193.79;g/mol | lithium; 1,4,6,9-tetraoxa-5-boranuidaspiro[4.4]nonane-2,3,7,8-tetrone; Lithiumbis(oxalate)borate; 244761-29-3; Lithium2,3,7,8-tetraoxo-1,4,6,9-tetraoxa-5-boraspiro[4.4]nonan-5-uide; LiBOB |
LITHIUM BIS(1,1,2,2,3,3,3-HEPTAFLUORO-1-PROPANESULFONYL)IMIDE | 189217-59-2 | C6F14LiNO4S2 | 487.12 | LITHIUM BIS(1,1,2,2,3,3,3-HEPTAFLUORO-1-PROPANESULFONYL)IMIDE; Lithium Bis(1,2,2,3,3,3-heptafluoro-propanesulfony)imide |
Lithium azide solution | 19597-69-4 | LiN3 | 48.96 | Lthium triazide |
lithium azide | 157302-05-1 | LiN3 | 48.9611 g/mol | |
LITHIUM ALUMINUM HEXAHYDRIDE | 16941-14-3 | AlH6Li3 | 53.852178 | LITHIUM ALUMINUM HEXAHYDRIDE; LITHIUM HEXAHYDRIDOALUMINATE |
Lithium Aluminium Deuteride | 14128-54-2 | AlD4Li | 41.99 | LiAlD4; LAD (D4); LITHIUM ALUMINIUM DEUTERIDE; LITHIUM ALUMINUM DEUTERIDE; LITHIUM ALUMINUM DEUTERIDE (D4); aluminium lithium deuteride; lithium tetradeuteridoaluminate; LITHIUM ALUMINUM DEUTERIDE, 96 ATOM % D, 1.0M SOLUTION IN DIETHYL ETHER; LITHIUM ALUM |
Lithium Acetylide - Ethylene Diamine complex (LAEDA) | 6867-30-7 | 4H9LiN2 | 92.06870 | |
Lithium acetate dihydrate | 6108-17-4 | 102.01 | LITHIUM ACETATE HYDRATE; LITHIUM ACETATE DIHYDRATE; ACETIC ACID LITHIUM SALT DIHYDRATE; Quilonum; Lithium Acetate Anhydrous; MONOCLONAL ANTI-LEF-1/TCF*(TRANSACTIVATI; LITHIUM ACETATE DIHYDRATE, CRYSTALLIZED; LITHIUM ACETATE DIHYDRATE SIGMAULTRA | |
Lithium 9-BBN hydride solution | 76448-08-3 | C8H15BLi | 129.96 | |
Lithium 12-hydroxystearate | 7620-77-1 | C18H36 O3 . Li | 306.42 | LITHIUM 12-HYDROXYSTEARATE; 12-hydroxy-octadecanoicacimonolithiumsalt; lithiumhydroxy-12stearate; Octadecanoicacid,12-hydroxy-,monolithiumsalt; 12-HYDROXYSTEARICACID,LITHIUMSALT; Lithium-12-hydroxystearat; 12-hydroxy-octadecanoic acid monolithium salt; 12 |
Lithium (±)-2,4-dihydroxy-3,3-dimethylbutyrate | 55289-50-4 | C6H11LiO4 | 154.09014;g/mol | lithium; 2,4-dihydroxy-3,3-dimethylbutanoate; LithiumDL-pantoate; Butanoicacid,2,4-dihydroxy-3,3-dimethyl-,monolithiumsalt; lithium2,4-dihydroxy-3,3-dimethylbutanoate; 55289-50-4 |
LIT-927 | 2172879-52-4 | C17H13ClN2O3 | 328.75 | 4-(4-Chlorophenyl)-6-(4-hydroxy-3-methoxyphenyl)pyrimidin-2(1H)-one |
Lisuride maleate | 19875-60-6 | C25H31N3O5 | 454.58 | 3-[(6aR,9S)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-yl]-1,1-diethylurea;(Z)-but-2-enedioic acid; Lisuride Maleate ; Cuvalit; Lysenyl; Lysenyl bimaleate; Lysenyl hydrogen maleate; Lisuride hydrogen maleate; Mesylate, Lisuride; Methylergol |
Lintopride | 107429-63-0 | C14H19ClN4O2 | 310.78 | 4-amino-5-chloro-N-[(1-ethyl-4,5-dihydroimidazol-2-yl)methyl]-2-methoxybenzamide; 4-amino-5-chloro-N-((1-ethylimidazolin-2-yl)methyl); 2-methoxybenzamide; ACEMM; lintopride |
Linsitinib | 867160-71-2 | C26H23N5O | 421.504 | OSI-906; OSI906; OSI 906. |
Linseed Oil | 8001-26-1 | 0 | OIL OF LINSEED; aceitedelinaza; Flaxoil; groco; huiledelin; l-310; leinol; linseedoil,bleached | |
L-Inosine | 21138-24-9 | C10H12N4O5 | 268.23 | 9-((2S,3S,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one |
Linopirdine dihydrochloride | 113168-57-3 | C26H21N3O.2HCl | 464.39 | 1,3-Dihydro-1-phenyl-3,3-bis(4-pyridinylmethyl)-2H-indol-2-one dihydrochloride |
Linezolid Dimer | 908143-04-4 | C30H35F2N5O7 | 615.62 | N,N-bis[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; Bis(linezolid); Bis-Linezolid; Linezolid Impurity D |
Linezolid Desacetamide Phthalimide | 168828-89-5 | C22H20FN3O5 | 425.41 | (S)-N-[[3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]phthalimide; (S)-2-[[3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione; 2-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl] |
Linezolid D8 | 1032182-14-1 | C16H12D3FN3O4 | 345.39 | |
Linezolid | 165800-03-3 | C16H20FN3O4 | 337.35 | Linezolid; Zyvox; Zyvoxid; Zyvoxam; PNU 100766; PNU-100766; PNU100766; U 100766; U-100766; U100766. |
Linear B-2 trisaccharide | 101627-01-4 | C20H35NO16 | 545.49 | Gal-a-1,3-Gal-b-1,4-GlcNAc; Galili antigen triaose; Blood Group B type II linear trisaccharide; Xeno antigen type 2; Gala1-3 epitope |
Linaroside | 53452-12-3 | C23H24O11 | 476.44 | |
Linaprazan mesylate | 855998-67-3 | C22H30N4O5S | 462.57 | AR-h044277AW; AZD-0865 mesilate; AZD-0865 mesylate; Linaprazan mesilate; 8-((2,6-dimethylbenzyl)amino)-N-(2-hydroxyethyl)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamide methanesulfonate;248919-64-4(base) |
Linaprazan | 847574-05-4 | C21H26N4O2 | 366.47 | AZD0865; UNII-E0OU4SC8DP; CHEMBL497011;8-[(2,6-dimethylphenyl)methylamino]-N-(2-hydroxyethyl)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamide |
Linamarin | 554-35-8 | C10H17NO6 | 247.25 | 2-(b-D-Glucopyranosyloxy)-2-methyl-propanenitrile; Phaseolunatin; a-Hydroxyisobutyronitrile b-D-glucose |
Linagliptin-d4 | 2140263-92-7 | C25H24D4N8O2 | 476.58 | 8-[(3S)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione |
Linagliptin-d3 | 1398044-48-8 | C25H25N8O2D3 | 475.57 | 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione-d3 |
Linagliptin-13C, d3 | 1398044-43-3 | C25H25N8O2D3 | 476.56 | |
Linagliptin N-Boc Impurity | 668273-75-4 | C30H36N8O4 | 572.67 | Linagliptin Related Compound B, N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-carbamic Acid 1,1-Dimethylethyl Ester |
Linagliptin N-Acetyl Impurity | 1803079-49-3 | C27H30N8O3 | 514.58 | (R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide |
Linagliptin Metabolite CD1790 | 1620278-39-8 | C25H27N7O3 | 473.54 | 3-Deamino 3-Hydroxy Linagliptin; (S)-7-(But-2-yn-1-yl)-8-(3-hydroxypiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity S | 1446263-39-3 | C25H29BrN8O2 | 553.47 | N-Des-(2-butyn-1-yl)-N-(3-bromo-2-buten-1-yl) Linagliptin (E/Z Mixture); 8-[(3R)-3-Amino-1-piperidinyl]-7-[(2E/Z)-3-bromo-2-buten-1-yl]-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione; |
Linagliptin Impurity N | 13535-91-6 | C10H10N2O | 174.20 | 2-QuinazolineMethanol, 4-Methyl-; (4-Methylquinazolin-2-yl)Methanol; |
Linagliptin Impurity M | 216854-24-9 | C17H26N2O2 | 290.4 | (R)-1-BENZYL-3-N-BOC-AMINOPIPERIDINE; |
Linagliptin Impurity D | 666816-91-7 | C20H18N6O3 | 390.40 | |
Linagliptin Impurity 10 (S-Isomer) | 668270-11-9 | C25H28N8O2 | 472.55 | (S)-Linagliptin; 8-[(3S)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione |
Linagliptin Dimer Impurity 2 | 1418133-47-7 | C50H56N16O4 | 945.08 | Linagliptin Methyldimer; 8-[(3R)-3-Amino-1-piperidinyl]-1-[[4-[[2-[[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]methyl]-1,4-dihydro-4-methyl-4-quinazolinyl]methyl]-2-quinazolinyl]methyl]-7-(2-butyn- |
Linagliptin | 668270-12-0 | C25H28N8O2 | 472.553 | Tradjenta; BI-1356; BI 1356; BI1356; Ondero; Trajenta |
Linaclotide acetate | 851199-60-5 | C61H83N15O23S6 | 1586.80 | MM416775; MD-1100 acetate; Linaclotide; Linaclotide acetate; Linzess; Constela; 2-(32-amino-40-(2-amino-2-oxoethyl)-26-(2-carboxyethyl)-23-(4-hydroxybenzyl)-9-(1-hydroxyethyl)-3-methyl-1,4,7,10,13,22,25,28,31,38,41,47-dodecaoxotetracontahydro-1H-37,20-(ep |
Linaclotide | 851199-59-2 | C59H79N15O21S6 | 1526.74 | Linzess; Constella; 11: PN: WO2008151257 SEQID: 55 claimed protein; 13: PN: WO2008151257 SEQID: 57 claimed protein; 18: PN: WO2015054500 SEQID: 72 claimed protein; 1: PN: WO2014131024 SEQID: 55 claimed protein; 1: PN: WO2015054500 SEQID: 55 claimed protei |
Lin28 1632 | 108825-65-6 | C15H15N5O | 281.31 | N-Methyl-N-[3-(3-methyl-1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]acetamide |
ligustroflavone | 260413-62-5 | C33H40O18 | 724.67 | ligustroflavone; 7-[(O-6-Deoxy-alpha-L-mannopyranosyl-(1->2)-O-[6-deoxy-alpha-L-mannopyranosyl-(1->6)]-beta-D-glucopyranosyl)oxy]-5-hydroxy-2-(4-hydroxyphenyl)- 4H-1-benzopyran-4-one; Nuezhenoside; Ligustroflavone(Nuezhenoside) |
Ligustrazine Phosphate | 848645-86-3 | C8H12N2·H3PO4·H2O | 252.2 | tetramethylpyrazine phosphate |
Ligustrazine Hydrochloride | 76494-51-4 | C8H12N2.HCl | 172.66 | 2,3,5,6-Tetramethylpyrazine hydrochloride;Chuanxiongzine Hydrochlorid;Tetramethylpyrazine hydrochloride;Ligustrazine HCl |
Ligustilide | 4431-01-0 | C12H14O2 | 190.24 | 3-BUTYLIDEN-4,5-DIHYDRO-3H-ISOBENZOFURAN-1-ONE; |
Ligurobustoside N | 583058-07-5 | C35H46O18 | 754.74 | |
Ligupurpuroside D | 1194056-35-3 | C35H46O18 | 754.74 | |
Ligupurpuroside C | 1194056-33-1 | C35H46O17 | 738.74 | |
Ligupurpuroside B | 147396-02-9 | C35H46O17 | 738.74 | |
Ligupurpuroside A | 147396-01-8 | C35H46O19 | 770.74 | |
Lignosulfonic acid sodium salt | 8061-51-6 | |||
Lignoceryl alcohol | 506-51-4 | C24H50O | 354.65 | 1-Tetracosanol |
Lignine | 9005-53-2 | MFCD00147441 | 0 | PHYLLANTIN; LIGNIN; LIGNIN,ALKALINE; LIGNIN,DEALKALINE; LIGNINE; LIGNINE ALKALINE; 3,4-DICHLOROANILINE-LIGNINMETABOLITE; LIGNINE, DEALKALINE |
LIGNIN, ORGANOSOLV, ACETATE | 86855-54-1 | 0 | LIGNIN, ORGANOSOLV, ACETATE | |
LIGNIN, ORGANOSOLV | 8068-03-9 | |||
Lignin, Kraft, dimethylamino-, methylated | 110152-58-4 | |||
LIGNIN, ALKALI, 2-HYDROXYPROPYL ETHER | 88402-77-1 | |||
Lignin Peroxidase | 42613-30-9 | LiP, Ligninase, Peroxidase, lignin | ||
lignin | 8068-05-1 | C30H25ClN6 | 505.01 | kraftlignin; LIGNIN, KRAFT; LIGNIN, ALKALI; CI NO 50400; CI 50400; INDULIN; ACETIN BLUE; SPIRIT INDULIN |
Light Green SF | 5141-20-8 | C37H34N2O9S3.2Na | 792.85 | ACID GREEN; ACID GREEN 5; ACID GREEN A; ACID GREEN F; ACID GREEN G; ACID GREEN GG; CI 42095; CI NO 42053 |
Light aromatic solvent naphtha | 64742-95-6 | 0 | Solvent naphtha (petroleum), light arom.; C9-10 AROMATIC HYDROCARBONS; aromatic naphtha, type I; LIGHTAROMATICSOLVENTNAPHTHA; HIGHFLASHAROMATICNAPHTHA; SHELLSOLA; Losungsmittelnaphtha (Erdol), leichte aromatische; Aromatic hydrocarbon solvents: (High flas | |
Light alkylate naphtha | 64741-66-8 | 0 | Naphtha (petroleum), light alkylate; LIGHTALKYLATENAPHTHA; LIGHTALKYLATENAPHTHADISTILLATE; Naphtha (petroleum), light alkylate Low boiling point modified naphtha | |
Lifitegrast | 1025967-78-5 | C29H24Cl2N2O7S | 615.48 | SAR1118;L-Phenylalanine,N-[[2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-;N-[[2-(6-Benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-L-phenylalanin |
Lifirafenib | 1446090-79-4 | C25H17F3N4O3 | 478.42 | BGB-283; Beigene-283 |
Lificiguat | 170632-47-0 | C19H16N2O2 | 304.34 | YC-1; YC 1; YC1. |
Liensinine perchlorate | 2385-63-9 | C37H42N2O6.ClHO4 | 4-[[(1R)-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]-2-[[(1R)-1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinyl]oxy]phenol perchlorate | |
Liensinine diperchlorate | 5088-90-4 | C37H42N2O6.(HClO4)2 | 811.67 | |
Liensinine | 2586-96-1 | C37H42N2O6 | Hiensinine; 2-methyl-1-isoquinolinyl]methyl]-2-[[(1R)-1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinyl]oxy]-; Phenol,4-[[(1R)-1,2,3,4-tetrahydro-6, 7-dimethoxy-; 4-[[(1R)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1 | |
L-Idaric acid 1,4-lactone | 80876-59-1 | C6H8O7 | 192.12 | L-Idaro-1,4-lactone |
L-Idaric acid | 80876-58-0 | C6H10O8 | 210.14 | |
Lidanserin | 73725-85-6 | C26H31FN2O4 | 454.539 | |
Licorisoflavan A | 129314-37-0 | C27H34O5 | 438.56 | (+)-7-O-Methyllicoricidin; 7-O-Methyllicoricidin; 7-O-Methyllicorisoflavan B |
Licoricone | 51847-92-8 | C22H22O6 | 382.41 | 7-Hydroxy-3-[6-hydroxy-2,4-dimethoxy-3-(3-methyl-2-butenyl)phenyl]-4H-1-benzopyran-4-one |
Licoricidin | 30508-27-1 | C26H32O5 | 424.53 | 7-O-Demethyllicorisoflavan A;Licorisoflavan B |
Licoricesaponin G2 | 118441-84-2 | C42H62O17 | 838.93 | 24-Hydroxyglycyrrhizin; Licorice-saponin G2 |
Licorice Extract | 68916-91-6 | Mixture | ||
Licorice | 84775-66-6 | |||
Licoisoflavone B | 66056-30-2 | C20H16O6 | 352.34 | 5,7-Dihydroxy-3-(5-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-4H-1-benzopyran-4-one |
Licoisoflavone A | 66056-19-7 | C20H18O6 | 354.35 | 2',4',5,7-Tetrahydroxy-3'-(3,3-dimethylallyl)isoflavone;3-[2,4-Dihydroxy-3-(3-methyl-2-butenyl)phenyl]-5,7-dihydroxy-4H-1-benzopyran-4-one |
Licoisoflavanone | 66067-26-3 | C20H18O6 | 354.36 | 5,7-dihydroxy-3-(5-hydroxy-2,2-dimethylchromen-6-yl)-2,3-dihydrochromen-4-one |
Licoflavonol | 60197-60-6 | C20H18O6 | 354.35 | 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)chromen-4-one |
Licoflavone C | 72357-31-4 | C20H18O5 | 338.4 | 8-Prenylapigenin; 4',5,7-Trihydroxy-8-prenylflavone |
Licoflavone B | 91433-17-9 | C25H26O4 | 390.47 | Prenyllicoflavone A |
Licoflavone A | 61153-77-3 | C20H18O4 | 322.36 | 4',7-dihydroxy-6-prenylflavone |
Licofelone-d6 | 1178549-81-9 | C23H16ClNO2D6 | 385.92 | |
Licarin A | 23518-30-1 | C20H22O4 | 326.4 | 2-Methoxy-4-{(2S,3S)-7-methoxy-3-methyl-5-[(1E)-1-propen-1-yl]-2, 3-dihydro-1-benzofuran-2-yl}phenol |
Licarin A | 51020-86-1 | C20H22O4 | 326.39 | 2-methoxy-4-[(2S,3S)-7-methoxy-3-methyl-5-[(E)-prop-1-enyl]-2,3-dihydro-1-benzofuran-2-yl]phenol |
Liarozole dihydrochloride | 1883548-96-6 | C17H13ClN4.2HCl | 381.69 | 5-[(3-Chlorophenyl)-1H-imidazol-1-ylmethyl]-1H-benzimidazole dihydrochloride |
Liarozole | 145858-50-0 | C17H14Cl2N4 | 345.227 | Liarozole; R 75251; R-75251; R75251 |
Liarozole | 115575-11-6 | C17H13ClN4 | 308.771 | 6-[(3-chlorophenyl)-imidazol-1-ylmethyl]-1H-benzimidazole, R 75251; R-75251; R75251 |
Liangshanin A | 122717-54-8 | C20H26O4 | 330.4 | Kaura-1,16-diene-3,15-dione,7,14-dihydroxy-, (7a,14R)- |
Liafensine | 1198790-53-2 | C24H22N4 | 366.47 | 6-[(4S)-2-methyl-4-naphthalen-2-yl-3,4-dihydro-1H-isoquinolin-7-yl]pyridazin-3-amine;BMS 820836 |
L-Hydroxyproline | 30724-02-8 | C5H9NO3 | 131.13 g/mol | L-4-hydroxy-proline;4-Hydroxy-L-proline;allo-4-Hydroxyproline;allo-hydroxy-L-Proline;4-hydroxyproline;L-Allohydroxyproline |
L-Hydroxyproline | 51-35-4 | C5H9NO3 | 131.13 | trans-4-Hydroxy-L-proline; trans-4-Hydroxyproline |
L-Homocysteine Thiolactone Hydrochloride | 31828-68-9 | C4H8ClNOS | 153.63 | (3S)-3-Aminodihydro-2(3H)-thiophenone Hydrochloride; (S)-3-Aminodihydro-2(3H)-thiophenone Hydrochloride; L-3-Aminodihydro-2(3H)-thiophenone Hydrochloride |
L-Glutamic acid-5-13C | 81202-00-8 | HOO[13C](CH2)2CH(NH2)COOH | 148.12 | (2S)-2-aminopentanedioic acid-13C |
L-Glutamic acid -monohydroxamate | 1955-67-5 | C5H10N2O4 | 162.14 | L--Glutamylhydroxamic acid, L-5-N-Hydroxyglutamine |
LG190155 | 233268-78-5 | C31H44O4 | 480.69 | 1,1'-((pentane-3,3-diylbis(2-methyl-4,1-phenylene))bis(oxy))bis(3,3-dimethylbutan-2-one); LG190155; LG-190155; LG 190155; CAS# 233268-78-5 |
LG 101506 | 331248-11-4 | C25H34F2O3 | 420.53 | (2E,4E,6Z)-7-[2-(2,2-Difluoroethoxy)-3,5-bis(1,1-dimethylethyl)phenyl]-3-methyl-2,4,6-octatrienoic acid |
LG 100754 | 180713-37-5 | C26H36O3 | 396.56 | (2E,4E,6Z)-3-Methyl-7-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-propoxy-3-naphthalenyl)-2,4,6-octatrienoic acid |
LG 100268 | 153559-76-3 | C24H29NO2 | 363.49 | 6-[1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)cyclopropyl]-3-pyridinecarboxylic acid |
L-Fuculose - Aqueous solution | 13074-08-3 | C6H12O5 | 164.16 | |
L-Fucose-1-phosphate disodium salt | 374726-44-0 | C6H11Na2O8P | 288.1 | 6-Deoxy-L-galactose-1-phosphate disodium salt |
L-Fucose (AS) | 2438-80-4 | |||
L-Fucose | 6696-41-9 | C6H12O5 | 164.16 | 6-Deoxy-L-galactose; L-(-)-Rhodeose |
6-Deoxy-L-galactitol | 13074-06-1 | C6H14O5 | 166.17 | 1-deoxy-d-galactitol; (2R,3S,4R,5S)-hexane-1,2,3,4,5-pentol |
L-Fucal | 80483-16-5 | |||
L-Fructose-1-13C | 117013-21-5 | C5[13C]H12O6 | 181.15 | |
L-Fructose | 7776-48-9 | C6H12O6 | 180.16 | L-(+)-Fructose |
LFM-A13 | 244240-24-2 | C11H8Br2N2O2 | 360 | N/A |
LFM-A13 | 62004-35-7 | C11H8Br2N2O2 | 360.005 | LFM-A13; |
L-Felinine | 471-09-0 | C8H17NO3S | 207.29 | felinine; L-2-AMINO-7-HYDROXY-5,5-DIMETHYL-4-THIAHEPTANOIC ACID; L-FELININE; S-(4-hydroxy-2-methylbutyl)cysteine; S-(3-Hydroxy-1,1-dimethylpropyl)-L-cysteine |
LF3 | 664969-54-4 | C20H24N4O2S2 | 416.56 | 4-[(E)-3-phenylprop-2-enyl]-N-(4-sulfamoylphenyl)piperazine-1-carbothioamide; 4-[(2E)-3-phenylprop-2-en-1-yl]-N-(4-sulfamoylphenyl)piperazine-1-carbothioamide |
LF 11 | 832729-13-2 | C69H112N26O14 | 1529.81 | L-phenylalanyl-L-glutaminyl-L-tryptophyl-L-glutaminyl-L-arginyl-L-asparagyl-L-isoleucyl-L-arginyl-L-lysyl-L-valyl-L-argininamide |
Lexithromycin | 53066-26-5 | C38H70N2O13 | 763.0 | Erythromycin A 9-methoxime, Wy 48314 |
Lexibulin dihydrochloride | 917111-49-0 | C24H32Cl2N6O2 | 507.46 | CYT-997 dihydrochloride |
Lexibulin | 917111-44-5 | C24H30N6O2 | 434.544 | CYT997; CYT-997; CYT 997. lexibulin. |
Lexatumumab | 845816-02-6 | 0 | LEXATUMUMAB | |
Lexanopadol | 1357348-09-4 | C23H25FN2O | 364.46 | (1r,4r)-6'-fluoro-N-methyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4-b]indol]-4-amine;trans-6'-Fluoro-N-methyl-4-phenyl-4',9'-dihydro-3'H-spiro(cyclohexane-1,1'-pyrano(3,4-b)indol)-4-amine;GRT6006 |
Lexacalcitol | 131875-08-6 | C28H46O4 | 446.66 | KH 106; KH 1060; KH-1060; KH1060 |
Levomefolate | 31690-09-2 | C20H25N7O6 | 459.46 | 5-MTHF |
Levomedetomidine HCl | 190000-46-5 | C13H16N2 · HCl | 236.74 | (R)-4-[1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole monohydrochloride |
Levomedetomidine | 119717-21-4 | C13H16N2 | 200.28 | 4-[(1R)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole; (-)-Medetomidine; (R)-Medetomidine; MPV 1441; l-Medetomidine |
Levoglucosenone | 37112-31-5 | C6H6O3 | 126.11 | (1s)-8-dioxabicyclo(3.2.1)oct-2-en-4-one; 1,6-ANHYDRO-3,4-DIDEOXY-ALPHA-D-GLYCERO-HEX-3-ENOPYRANOSE-2-ULOSE; 6,8-DIOXA-BICYCLO[3.2.1]OCT-2-EN-4-ONE; LEVOGLUCOSENONE; 1,6-Anhydro-3,4-dideoxy-a-D-glycero-hex-3-enopyranose-2-ulose; 6,8-Dioxabicyclo3.2.1oct-2 |
Levoglucosan | 498-07-7 | C6H10O5 | 162.14 | 1,6-Anhydro-b-D-glucopyranose |
Levofloxacin-d8 | 1217716-71-6 | C18H12FN3O4D8 | 369.42 | (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl-d8)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Hemihydrate |
Levofloxacin-Acyl-D-Glucuronide | 160962-46-9 | C24H28FN3O10 | 537.49 | 1-[(3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate]-b-D-glucopyranuronic acid; Levofloxacin glucuronide |
Levofloxacin-13C-d3 | 1261398-33-7 | C17H17FN3O413CD3 | 365.38 | (3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid-13C-d3 |
Levofloxacin Tetrafluoro Impurity 2 | 103995-33-1 | C14H12F4O4 | 320.24 | 3-(2,3,4,5-tetrafluorophenyl)-3-oxo-2-(ethoxymethylene)-propanoic acid ethyl ester; |
Levofloxacin Tetrafluoro Impurity 1 | 110548-02-2 | C15H15F4NO4 | 349.28 | (+)-ethyl 2-[[[(S)-1-hydroxyprop-2-yl]amino]methylene]-3-oxo-3-(2,3,4,5-tetrafluorophenyl)propionate; |
Levofloxacin Related Compound C | 177472-30-9 | C20H24FN3O4 | 389.43 | Levofloxacin Ethyl Ester; (3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Ethyl Ester; USP Levofloxacin Related Compound C; |
Levofloxacin Related Compound A | 117707-40-1 | C17H18FN3O4 | 347.35 | N-Desmethyl Levofloxacin ; (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid ; |
Levofloxacin N-oxide | 117678-38-3 | C18H20FN3O5 | 377.38 | (S)-4-(6-carboxy-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-10-yl)-1-methylpiperazine 1-oxide; |
Levofloxacin Impurity 9 | 110548-06-6 | C15H13F2NO4 | 309.27 | Ethyl (R)-(+)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylate; |
Levofloxacin Impurity 8 | 110548-07-7 | C13H9F2NO4 | 281.22 | (R)-Ofloxacin Carboxylic Acid (Dextrofloxacin Difluoro Impurity); (3R)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid; |
Levofloxacin Impurity 7 | 1607796-83-7 | C15H14FNO5 | 307.28 | (S)-10-ethoxy-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; |
Levofloxacin Impurity 6 | 1329833-82-0 | C23H31N5O4 | 441.53 | 9-Defluoro-9-(4-methyl-1-piperazinyl) Levofloxacin; -)-(S)-10-(4-Methyl-1-piperazinyl)-2,3-Dihydro-3-methyl-9-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid; |
Levofloxacin Hydrochloride | 177325-13-2 | C18H20FN3O4·HCl | 397.83 | |
Levofloxacin Hemihydrate | 138199-71-0 | 370.38 | UNII-6GNT3Y5LMF; Levofloxacin [USAN]; RWJ 25213; 6GNT3Y5LMF; Levofloxacin (USAN) | |
Levofloxacin Diformyl Impurity | 151377-74-1 | C18H18FN3O6 | 391.36 | N,N'-Desethylene-N,N'-diformyl Levofloxacin; (S)-9-Fluoro-10-[formyl[2-(formylmethylamino)ethyl]amino]-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid; |
Levofloxacin Diamine | 1797099-76-3 | C15H16FN3O4 | 321.31 | N,N-Didesethylene Levofloxacin |
Levofloxacin Diamine | 1797510-34-9 | C15H16FN3O4 | 321.31 | N,N-Didesethylene Levofloxacin Hydrochloride; |
LEVOFLOXACIN ACID ESTER | 106939-34-8 | C15H13F2NO4 | 309.26 | 106939-34-8; (S)-Ethyl9,10-difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate; LEVOFLOXACINACIDESTER; (S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicAcidEthylEster; Ethyl(S)-9 |
Levofloxacin | 100986-85-4 | C18H20FN3O4 | 361.37 | Fluoroquinolone |
Levodropropizine (S-Dropropizine) | 99291-25-5 | C13H20N2O2 | 236.31 | Levodropropizine; DF 526; DF-526; DF526; Levotuss; |
Levocetirizine Impurity 9 | 83881-37-2 | C21H26ClN3O2 | 387.91 | (RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetamide; 2-[2-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-acetamide; |
Levocetirizine Impurity 7 | 58023-19-1 | C10H13ClNO2S | 282.19 | NSC 240403 |
Levocetirizine Impurity 6 | 109806-71-5 | C19H23ClN2O | 330.86 | 2-[4-[(RS)-(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethanol |
Levocetirizine Impurity 5 | 682323-77-9 | C23H29ClN2O4 | 432.94 | Hydroxyzine Acetic Acid Dihydrochloride; Cetirizine impurity E; Ethoxycetirizine |
Levocetirizine Impurity 3 | 113740-61-7 | C19H21ClN2O2 | 344.84 | 4-[(4-Chlorophenyl)phenylmethyl]-1-piperazineacetic Acid |
Levocetirizine Impurity 2 | 300543-56-0 | C17H19ClN2 | 286.81 | (-)-1-[(4-Chlorophenyl)phenylmethyl]piperazine; (R)-1-(p-Chlorobenzhydryl)piperazine; |
Levocarnitine Related Impurity A | 6538-82-5 | C7H14ClNO2 | 179.64 | 3-Carboxy-N,N,N-trimethyl-2-propen-1-aminium Chloride; Crotonobetaine Hydrochloride |
Levocarnitine Impurity C | 6490-20-6 | C7H17N2O2. Cl | 161.23 35.45 | |
Levocarnitine Impurity B | 124-83-4 | C10H16O4 | 200.24 | (1R,3S)-1,2,2-Trimethyl-1,3-cyclopentanedicarboxylic Acid; (1R-cis)-1,2,2-Trimethyl-1,3-cyclopentanedicarboxylic Acid; (1R,3S)-(+)-Camphoric Acid; |
Levocabastine | 79516-68-0 | C26H29FN2O2 | 420.52 | Levocabastine, Livostin, Bilina;(3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid |
Levobupivacaine free base | 27262-47-1 | C18H28N2O | 288.44 | (S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide; Levobupivacaine free base; (S)-1-Butyl-2',6'-pipecoloxylidide; L(-)-Bupivacaine |
Levobunolol hydrochloride | 27912-14-7 | C17H26ClNO3 | 327.85 | 5-[(2R)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one;hydrochloride AKBeta Akorn Brand of Levobunolol Hydrochloride Allergan Brand of Levobunolol Hydrochloride Apo Levobunolol Apo-Levobunolol ApoLevobunolol Apotex Brand of L |
Levobunolol | 47141-42-4 | C17H25NO3 | 291.388 | (S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone; |
Levobetaxolol HCl | 116209-55-3 | C18H29NO3.HCl | 343.89 | AL 1577A |
Levetiracetam Impurity C | 72762-00-6 | C5H5NO | 95.10 | 2(1H)-Pyridone; 2-pyridone; 2-Pyridinol; Pyridin-2-ol; 2-Hydroxy Pyridine; pyridin-2(1H)-one |
Levetiracetam Impurity B | 358629-47-7 | C8H12N2O2 | 168.19 | (Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide |
Levetiracetam Impurity 3 | 102767-31-7 | C8H15ClN2O2 | 206.67 | (S)-N-(1-Amino-1-oxobutan-2-yl)-4-chlorobutanamide; N-[(1S)-1-(Aminocarbonyl)propyl]-4-chlorobutanamide; (S)-N-[1-(Aminocarbonyl)propyl]-4-chlorobutanamide; USP Levetiracetam Related Compound A; |
Levetiracetam Acid | 103833-72-3 | C8H13NO3 | 171.19 | 103833-72-3; UNII-5GFJ8QXZ6J; 5GFJ8QXZ6J; Levetiracetamacid; (2R)-2-(2-oxopyrrolidin-1-yl)butanoicacid; 1-Pyrrolidineaceticacid,alpha-ethyl-2-oxo-,(alphaR)- |
Levetiracetam | 102767-28-2 | C8H14N2O2 | 170.21 | UCB-L059, SIB-S1; UCB L059, SIB S1; UCBL059, SIBS1 |
Levcromakalim | 94535-50-9 | C16H18N2O3 | 286.33 | (3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxopyrrolidin-1-yl)-3,4-dihydrochromene-6-carbonitrile; BRL 38226; BRL 38227; BRL-34915; BRL-38226; BRL-38227; BRL38226; BRL38227; Cromakalim; Cromakalim, (3R-cis)-Isomer; Cromakalim, (3R-trans)-Isomer; Cromakalim, (3S- |
Levatin | 140670-84-4 | C19H20O5 | 328.36 | |
Levan - from Jerusalem artichoke | 9013-95-0 | (C6H10O5)n | ||
Levamisole-d5 Hydrochloride | 1246819-64-6 | C11H8ClN2SD5 | 245.78 | (6S)-2,3,5,6-Tetrahydro-6-(phenyl-d5)imidazo[2,1-b]thiazole Hydrochloride; (-)-Levamisole-d5 Hydrochloride |
Levamisole Phosphate | 32093-35-9 | C11H15N2O4PS | 302.29 | LEVAMISOLE PHOSPHATE; (S)-2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazoletriylium phosphate; Imidazo2,1-bthiazole, 2,3,5,6-tetrahydro-6-phenyl-, (6S)-, phosphate (1:1); (6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole; (6S)-6-phenyl-2,3,5,6-t |
Levamisole Impurity D (HCl salt form) | 4335-29-9 | C11H11ClN2S | 238.733 | 6-phenyl-2,3-dihydroimidazo[2,1-b]thiazole hydrochloride; AC1MD4BJ; CTK8I7338; MolPort-000-653-456 |
Levamisole Impurity D | 4335-28-8 | C11H10N2S | 202.28 | 6-Phenyl-2,3-dihydro1midazo[2,1-b][1,3]thiazole |
Levamisole Impurity B | 20406-02-4 | C11H12N2S | 204.30 | 3-Styryl-thiazolidin-2-ylideneamine |
Levamisole hydrochloride | 16595-80-5 | C11H13ClN2S | 240.75 | (6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole;hydrochloride Decaris Dekaris Hydrochloride, Levamisole L-Tetramisole Levamisole Levamisole Hydrochloride Levotetramisole Solaskil |
Levamisole | 14769-73-4 | C11H12N2S | 204.29 | (s)-2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole;L-6-PHENYL-2,3,5,6-TETRAHYDROIMIDAZOL(2,1-B) THIAZOLE;IMMUNOPURE(R) PHOSPHATASE SUPPRESSOR;LEVAMISOLE;LEVAMISOLE BASE;Imidazo2,1-bthiazole, 2,3,5,6-tetrahydro-6-phenyl-, (6S)-;lepuron;levomysol |
Levalbuterol tartrate | 661464-94-4 | C17H27NO9 | 389.40 | (Levosalbutamol tartrate; 4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol;(2R,3R)-2,3-dihydroxybutanedioic acid |
Levalbuterol Related Compound E HCl | 69716-64-9 | C15H25NO3. HCl | 303.83 | |
Levalbuterol | 34391-04-3 | C13H21NO3 | 239.315 | Levosalbutamol; (-)-Salbutamol; (-)-Albuterol; R-Salbutamol; 4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol |
Leuprorelin | 53714-56-0 | C59H84N16O12 | 1209.41 | Leuprolide; Eligard; H-Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt; |
Leucomycin complex | 1392-21-8 | - | Kitasamycin A1, Turimycin H5, Leucomycin V 4-isovalerate | |
Leucomycin A5 | 18361-45-0 | C39H65NO14 | 771.9 | Kitasamycin A5, Turimycin H4 |
Leucomycin A4 | 18361-46-1 | C41H67NO | 814.0 | Kitasamycin A4 |
Leucomycin A13 | 78897-52-6 | C41H69NO14 | 800.0 | Kitasamycin A13 |
Leucomycin A1 | 16846-34-7 | C40H67NO14 | 786.0 | Kitasamycin A1, Turimycin H5, Leucomycin V 4-isovalerate |
Leucomalachite green-D6 | 1173021-13-0 | Bis-(4-dimethylamino- phenyl)-phenyl-D5- methane-D1; LMG-D6 | ||
Leucomalachite green-D5 | 947601-82-3 | Bis-(4-dimethylamino- phenyl)-phenyl-D5- methane; LMG-D5 | ||
Leucogen;Asparaginase;Colaspase | 9015-68-3 | |||
LEUCOCYANIDIN POLYMER | 480-17-1 | C15H14 O7 | 306.2675 | LEUCOCYANIDIN POLYMER; 3,3',4,4',5,7-HEXAHYDROXYFLAVANE (POLYMER); leucocianidol; LEUCOCYANIDOL; 2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,4,5,7-tetrol; 2-(3,4-Dihydroxyphenyl)-3,4,5,7-chromantetrol; 2H-1-Benzopyran-3,4,5,7-tetrol, 2-(3,4-dihy |
Leucocyanidin | 69256-15-1 | C15H14O7 | 306.27 | (+)-Leucocyanidin; 2,3-trans-3,4-trans-leucocyanidin; Trans,trans-Leucocyanidin |
Leuco-1,4,5,8-tetrahydroxyanthraquinone | 81-59-4 | C14H10O6 | 274.2256 | 2,3-dihydro-1,4,5,8-tetrahydroxyanthraquinone; 1,4,5,8-Tetrahydroxyanthraquinone, leuco derivative; Leucotetrahydroxyanthraquinone; 2,3-Dihydro-1,4,5,8-tetrahydroxy-9,10-anthracenedione; 5,8,9,10-tetrahydroxy-2,3-dihydroanthracene-1,4-dione; 5,8,9,10-tetr |
Leuco patent blue violet | 133978-89-9 | C27H32N2O6S2Na2 | 590.66 | |
Leuco crystal violet-D6 | 1173023-92-1 | Bis-(4-dimethylamino- phenyl)-4-dimethyl- amino-D6-phenyl- methane | ||
Leucinostatin A | 76600-38-9 | C62H111N11O13 | 1218.6 | Tryanocidin, CC 1014, M 13959, ML 1014, P 168, SF 1907VIII, U 53496 |
Leucanicidin | 91021-66-8 | C42H70O13 | 783.0 | |
Leu-AMS | 288591-93-5 | C16H25N7O7S | 459.48 | 5'-[[(2S)-2-Amino-4-methyl-1-oxopentyl]sulfamate]adenosine |
Letrozole-d4 | 1133712-96-5 | C17H7N5D4 | 289.33 | 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)bisbenzonitrile-d4; 4-[1-(4-Cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile-d4; |
Letrozole Related Compound A | 112809-52-6 | C17H11N5 | 285.31 | 4,4'-(4H-1,2,4-Triazol-4-ylmethylene)bisbenzonitrile; Iso Letrozole |
Letrozole Impurity E | 143030-54-0 | C16H11BrN4 | 339.20 | 4-Descyano-4-bromo-letrozole; 4-[(4-Bromophenyl)-1H-1,2,4-triazol-1-ylmethyl]benzonitrile |
Letrozole Impurity C | 112809-25-3 | C10H8N4 | 184.20 | 4-(1H-1,2,4-Triazol-1-ylmethyl)benzonitrile; 1-(4-Cyanobenzyl)-1,2,4-triazole; |
Letrozole Impurity B | 113402-31-6 | C22H13N3 | 319.39 | 4,4',4''-Methylidynetrisbenzonitrile (Letrozole Impurity) |
Lethedioside A | 221289-31-2 | C29H34O15 | 622.6 | 2-(3,4-Dimethoxyphenyl)-7-methoxy-5-[(6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy]-4H-1-benzopyran-4-one |
Letermovir | 917389-32-3 | C29H28F4N4O4 | 572.56 | AIC246; AIC-246; AIC 246; MK-8828; MK 8828; MK8828 |
Leteprinim potassium salt | 192564-13-9 | C15H12N5O4·K | 365.4 | AIT 082; Neotrofin; Leteprinim potassium |
Letaxaban | 870262-90-1 | C22H26ClN3O5S | 479.976 | Letaxaban, TAK-442; TAK 442; TAK442. |
Lesogaberan | 344413-67-8 | C3H9FNO2P | 141.03 | ARH 061746; AZD 3355; [(2R)-3-amino-2-fluoropropyl]-hydroxy-oxophosphanium; |
Lesinurad sodium | 1151516-14-1 | C17H13BrN3NaO2S | 426.26 | sodium 2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate; Lesinurad; RDEA594; RDEA 594; RDEA-594, brand name: Zurampic |
Lesinurad Impurity C | 1038366-57-2 | C14H11N3O2S | 285.33 | [[4-(1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid; |
Lesinurad Impurity 9 (Lesinurad Impurity E) | 1210330-64-5 | C14H10BrN3O2S | 364.22 | [[5-bromo-4-(1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid; |
Lesinurad Impurity 8 | 1158970-49-0 | C15H12BrN3O2S | 378.25 | [[5-bromo-4-(4-methyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid; |
Lesinurad Impurity 7 | 1533519-98-0 | C17H14N3O2S | 359.84 | [[5-chlorine-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid; |
Lesinurad Impurity 6 Di-Lithium Salt | 1533519-99-1 | C21H18N4O5SLi2 | 452.35 | |
Lesinurad Impurity 5 Sodium Salt (Lesinurad Impurity F Sodium Salt) | 1384208-36-9 | C17H14N3O3SNa | 363.37 | [[5-hydroxy-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic sodium salt; |
Lesinurad Impurity 4 | 1533519-97-9 | C17H14BrN3O2S | 404.29 | [[5-bromo-4-(5-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid; |
Lesinurad Impurity 3 | 1533519-96-8 | C17H16BrN3O2S | 406.30 | [[5-bromo-4-(4-propyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid; |
Lesinurad Impurity 2 | 1158970-37-6 | C17H16N4O2S | 340.41 | 2-((5-amino-4-(4-Cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid |
Lesinurad Impurity 16 | 878671-99-9 | C18H16BrN3O2S | 418.32 | Methyl 2-(5-broMo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetate |
Lesinurad Impurity 15 | 25033-19-6 | C13H12 | 168.24 | 1-cyclopropylnaphthalen |
Lesinurad Impurity 11 | 1533519-85-5 | C18H17N3O2S | 339.42 | [[4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid methyl ester; Methyl 2-[[4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetate |
Lesinurad Impurity 10 | 1533519-94-6 | C17H14BrN3O2S | 404.29 | [[5-bromo-4-(2-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid; |
Lesinurad Impurity 1 (Lesinurad Impurity B) | 1533519-93-5 | C17H15N3O2S | 325.39 | 2-((4-(4-Cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid |
Lesinurad | 878672-00-5 | C17H14BrN3O2S | 404.282 | RDEA594; Zurampic; 2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid |
L-Erythrulose | 533-50-6 | C4H8O4 | 120.1 | |
L-Erythrose | 533-49-3 | C4H8O4 | 120.1 | |
L-Erythrono-1,4-lactone | 23732-40-3 | C4H6O4 | 118.09 | L-Erythronic acid gamma-lactone |
L-erythro Sphingosine | 6036-75-5 | C18H37NO2 | 299.49 | L-erythro-C18-Sphingosine; (E,2R,3S)-2-aminooctadec-4-ene-1,3-diol |
Lersivirine | 473921-12-9 | C17H18N4O2 | 310.35 | UK-453061 |
Lerociclib | 1628256-23-4 | C26H34N8O | 474.60 | G1T38 |
Lerisetron | 143257-98-1 | C18H20N4 | 292.386 | Lerisetron; F-0930-RS. |
Lerimazoline | 54765-26-3 | C13H18N2 | 202.30 | 4,5-Dihydro-2-[(2,4,6-trimethylphenyl)methyl]-1H-imidazole;Trimazoline;2-[(2,4,6-Trimethylphenyl)methyl]-4,5-dihydro-1H-imidazole;ST-71;ST71 |
Lercanidipine-13C-d3 HCl | 1261397-71-0 | C36H42ClN3O6 | 652.2 | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-[(3,3-Diphenylpropyl)methylamino]-1,1-dimethylethyl Methyl Ester-13C-d3 Hydrochloride |
Dehydro Lercanidipine | 887769-34-8 | C36H39N3O6 | 609.71 | 2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-[2-[(3,3-Diphenylpropyl)methylamino]-1,1-dimethylethyl] 5-Methyl Ester; 2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-[(3,3-Diphenylpropyl)methylamino]-1,1-dimethylethyl Methy |
Lercanidipine Impurity C | 1797124-83-4 | C38H45N3O6 | 639.78 | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-[(3,3-Diphenylpropyl)methylamino]-1,1-dimethylethyl Propyl Ester; Lercanidipine 5-Desmethyl-5-Propyl Ester |
Lercanidipine Impurity B | 1119226-97-9 | C35H37N3O6 | 595.70 | |
Lercanidipine Impurity A | 74936-74-6 | C19H22N2O6 | 374.40 | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 1-methylpropyl ester |
Lercanidipine hydrochloride (1:x) | 100427-27-8 | C36H41N3O6.xHCl | 611.738 (free base) | Lercanidipine hydrochloride |
Lercanidipine Hydrochloride | 132866-11-6 | C36H41N3O6·HCl | 648.19 | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-[(3,3-Diphenylpropyl)methylamino]-1,1-dimethylethyl Methyl Ester Hydrochloride; |
Lercanidipine Ethyl Impurity (Lercanidipine Impurity 4) HCl | 210579-71-8 | C37H44ClN3O6 | 662.21 | 5-Ethyl-demethyl Lercanidipine Hydrochloride; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-[2-[(3,3-Diphenylpropyl)methylamino]-1,1-dimethylethyl] 5-ethyl Ester Hydrochloride; |
Lercanidipine Dipropyl Ester Impurity | 77888-05-2 | C21H26N2O6 | 402.45 | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3,5-Dipropyl Ester; |
Lanolin acetate | 61788-48-5 | Lanolin acetate; Lanolin acetylated, low pesticide | ||
Lanolin | 8006-54-0 | |||
Laniquidar | 197509-46-9 | C37H36N4O3 | 584.72 | Laniquidar; R101933; R 101933; R-101933. |
Laninamivir octanoate | 203120-46-1 | C21H36N4O8 | 472.53 | 5-(Acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-7-O-methyl-D-glycero-D-galacto-non-2-enonic acid 9-octanoate; (2R,3R,4S)-3-Acetamido-4-guanidino-2-[(1R,2R)-2-hydroxy-1-methoxy-3-(octanoyloxy)propyl]-3,4-dihydro-2H-pyran-6-carboxylic |
Laninamivir | 203120-17-6 | C13H22N4O7 | 346.34 | 5-(Acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-7-O-methyl-D-glycero-D-galacto-non-2-enonic acid; R 125489; (4S,5R,6R)-5-Acetamido-4-guanidino-6-((1R,2R)-2,3-dihydroxy-1-methoxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid |
Lanifibranor | 927961-18-0 | C19H15ClN2O4S2 | 434.909 | IVA-337; CPD1537; 5-Chloro-1-((6-benzothiazolyl)sulfonyl)-1H-indole-2-butanoic acid |
L-168,049 | 191034-25-0 | C24H20BrClN2O | 467.79 | 2-(4-Pyridyl)-5-(4-chlorophenyl)-3-(5-bromo-2-propyloxyphenyl)pyrrole; 4-[3-(5-Bromo-2-propoxyphenyl)-5-(4-chlorophenyl)-1H-pyrrol-2-yl]pyridine |
L-165041 | 79558-09-1 | C22H26O7 | 402.44 | |
L162441 | 154512-46-6 | C34H43N5O5S | 633.8 | butyl N-[2-[4-[[2-butyl-5-methyl-6-(pentanoylamino)imidazo[4,5-b]pyridin-3-yl]methyl]phenyl]phenyl]sulfonylcarbamate |
L-161,982 | 147776-06-5 | C32H29F3N4O4S2 | 654.72 | N-[[4'-[[3-Butyl-1,5-dihydro-5-oxo-1-[2-(trifluoromethyl)phenyl]-4H-1,2,4-triazol-4-yl]methyl][1,1'-biphenyl]-2-yl]sulfonyl]-3-methyl-2-thiophenecarboxamide |
L-156,602 | 125228-51-5 | C38H64N8O13 | 841 | PD 124966; GNF-Pf-75 |
L-152,804 | 6508-43-6 | C23H26O4 | 366.46 | 5,5-Dimethyl-2-(2,3,4,9-tetrahydro-3,3-dimethyl-1oxo-1H-xanthen-9-yl)-1,3-cyclohexanedione; 9-(4,4-Dimethyl-2,6-dioxocyclohexyl)-1,2,3,4-tetrahydro-3,3-dimethyl-1-xanthenone; 9-(2-Hydroxy-4,4-dimethyl-6-oxo-1-cyclohexenyl)-3,3-dimethyl-4,9-dihydro-2H-xant |
L-10-Camphorsulfonic acid ammonium salt | 13867-85-1 | C10H19NO4S | 249.33 | L-10-CAMPHORSULFONIC ACID AMMONIUM SALT; ammonium l-6-oxobornane-10-sulphonate; L-10-Camphorsulphonic Acid |
L-1,2,3,4-Tetrahydro-quinoline-2-carboxylic acid HCl | 63430-98-8 | C10H12ClNO2 | 213.66 | |
L-1,2,3,4-Tetrahydro-quinoline-2-carboxylic acid | 92976-98-2 | C10H11NO2 | 177.20000 | |
L006235 | 294623-49-7 | C24H30N6O2S | 466.604 | L-006235; L 006235; L006235. |
L002 | 321695-57-2 | C15H15NO5S | 321.35 | 2,6-Dimethyl-2,5-cyclohexadiene-1,4-dione 4-[O-[(4-methoxyphenyl)sulfonyl]oxime]; 4-[O-[(4-Methoxyphenyl)sulfonyl]oxime]-2,6-dimethyl-2,5-cyclohexadiene-1,4-dione; NSC764414 |
L-[5-13C]sorbose | 478506-36-4 | 13CC5H12O6 | 181.15 | |
KYP-2047 | 796874-99-2 | C20H25N3O2 | 339.43 | (2S)-1-[[(2S)-1-(1-Oxo-4-phenylbutyl)-2-pyrrolidinyl]carbonyl]-2-pyrrolidinecarbonitrile |
JTE522 | 180200-68-4 | C16H19FN2O3S | 338.4 | 4-(4-cyclohexyl-2-methyl-1,3-oxazol-5-yl)-2-fluorobenzenesulfonamide; 4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide; JTE 522; JTE-522 |
JTE-013 | 383150-41-2 | C17H19Cl2N7O | 408.287 | 1-(2,6-dichloropyridin-4-yl)-3-[(1,3-dimethyl-4-propan-2-ylpyrazolo[3,4-b]pyridin-6-yl)amino]urea; JTE 013 |
JTE 907 | 282089-49-0 | C24H26N2O6 | 438.48 | N-(1,3-Benzodioxol-5-ylmethyl)-1,2-dihydro-7-methoxy-2-oxo-8-(pentyloxy)-3-quinolinecarboxamide |
JTE 607 dihydrochloride | 188791-09-5 | C25H31Cl2N3O5.2HCl | 597.36 | N-[3,5-Dichloro-2-hydroxy-4-[2-(4-methyl-1-piperazinyl)ethoxy]benzoyl]-L-phenylalanine ethyl ester dihydrochloride |
JTE 013 | 547756-93-4 | C17H19N7OCl2 | 408.29 | 1-[1,3-Dimethyl-4-(2-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]-4-(3,5-dichloro-4-pyridinyl)-semicarbazide; N-(2,6-Dichloro-4-pyridinyl)-2-[1,3-dimethyl-4-(1-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]hydrazinecarboxamide |
JTC-801 | 244218-51-7 | C26H25N3O2.HCl | 447.96 | JTC-801 |
JT010 | 917562-33-5 | C16H19ClN2O3S | 354.85 | 2-Chloro-N-[4-(4-methoxyphenyl)-2-thiazolyl]-N-(3-methoxypropyl)acetamide |
JNJ 42396302 | 1298030-18-8 | C19H23N5O2 | 352.43 | UNII-P5M4972608;3-(6-(2-methoxyethyl)-3-pyridinyl)-2-methyl-8-(4-morpholinyl)-Imidazo(1,2-b)pyridazine |
JNJ 26481585 dihydrochloride | 875320-31-3 | C21H26N6O2.2HCl | 467.39 | Quisinostat HCl; N-hydroxy-2-(4-((((1-methyl-1H-indol-3-yl)methyl)amino)methyl)piperidin-1-yl)pyrimidine-5-carboxamide dihydrochloride |
JNJ 20788560 | 825649-28-3 | C25H28N2O2 | 388.51 | 9-(8-Azabicyclo(3.2.1)oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide |
JNJ 17029259 | 314267-57-7 | C26H30N6O | 442.56 | 4-[4-(2-aminopropan-2-yl)phenyl]-2-[4-(2-morpholin-4-ylethyl)anilino]pyrimidine-5-carbonitrile; |
JNJ 16259685 | 409345-29-5 | C20H23NO3 | 325.41 | (3,4-Dihydro-2H-pyrano[2,3-b]quinolin-7-yl)-(cis-4-methoxycyclohexyl)-methanone |
JNJ 10191584 maleate | 869497-75-6 | C13H15ClN4O.C4H4O4 | 394.81 | 1-[(5-Chloro-1H-benzimidazol-2-yl)carbonyl]-4-methylpiperazine maleate |
JNJ 10181457 dihydrochloride | 544707-20-2 | C20H28N2O.2HCl | 385.37 | 4-[3-[4-[Piperidinyl]but-1-ynyl]benzyl]morpholine dihydrochloride |
Isoliquiritigenin | 961-29-5 | C15H12O4 | 256.25 | |
Isolinderalactone | 957-66-4 | C15H16O3 | 244.29 | |
Isolinamarin | 14605-42-6 | |||
Isolimonexic acid | 73904-93-5 | C26H30O10 | 502.51 | Limonexylic acid;Rutaevinexic acid |
Isoliensinine | 6817-41-0 | C37H42N2O6 | (+)-Isoliensinin; (1R)-1,2,3,4-Tetrahydro-1-[[4-hydroxy-3-[[(1R)-1,2,3,4-tetrahydro-6-methoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-7-isoquinolinyl]oxy]phenyl]methyl]-6-methoxy-2-methyl-7-isoquinolinol | |
Isolicoflavonol | 94805-83-1 | C20H18O6 | 354.36 | 3,5,7-trihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]chromen-4-one |
Isolichenan | 53025-03-9 | (1-3)&(1-4) a-D-glucan | ||
Isobutyl stearate | 646-13-9 | C22H44O2 | 340.59 | ISOBUTYL STEARATE; Octadecanoic acid, 2-methylpropyl ester; ISOBUTYLOCTADECANOATE; OCTADECANOICACID,2-METHYL-; stearic acid, isobutyl ester; 2-Methylpropyl octadecanoate; Octadecanoic acid isobutyl ester; Stearic acid 2-methylpropyl ester |
ISOBUTYL NITRATE | 543-29-3 | C4H9NO3 | 119.12 | ISOBUTYL NITRATE; Nitric acid, 2-methylpropyl ester; Nitric acid, isobutyl ester; 2-methylpropyl nitrate |
Lercanidipine Dimethyl Ester Impurity | 21881-77-6 | C17H18N2O6 | 346.34 | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3,5-Dimethyl Ester; Nitrendipine EP Impurity B |
Lercanadipine | 100427-26-7 | C36H41N3O6 | 611.73 | Lercanidipine; Lercanidipine; masnidipine; Lercanil; Lercanidipine |
LEQ-506 | 1204975-42-7 | C25H32N6O | 432.57 | (R)-2-(5-(4-(6-benzyl-4,5-dimethylpyridazin-3-yl)-2-methylpiperazin-1-yl)pyrazin-2-yl)propan-2-ol |
Lercanidipine Impurity D HCl (Dehydro Lercanidipine HCl) | 887769-34-8 | C36H40ClN3O6 | 646.19 | 2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-[2-[(3,3-Diphenylpropyl)methylamino]-1,1-dimethylethyl] 5-Methyl Ester HCl |
Leptomerine | 22048-97-1 | C13H15NO | 201.3 | N-methyl-2-propyl-4-quinolone |
Lepirudin | 138068-37-8 | C287H440N80O111S6 | 6979.486 | |
Lepidocrocite | 12022-37-6 | FeHO2 | 88.85174;g/mol | Lepidocrocite;Goethite;hydroxy(oxo)iron;Ferrichydroxideoxide;Ironhydroxideoxide(Fe(OH)O);Goethite(Fe(OH)O) |
L-Epicatechin | 490-46-0 | C15H14O6 | 290.27 | Epicatechin; (-)-Epicatechin; epi-Catechin; epi-Catechol; NSC 81161; NSC-81161; NSC81161; |
LEP(116-130)(mouse) | 258276-95-8 | C64H109N19O24S | 1560.73 | H-Ser-Cys-Ser-Leu-Pro-Gln-Thr-Ser-Gly-Leu-Gln-Lys-Pro-Glu-Ser-NH2; SCSLPQTSGLQKPES; L-seryl-L-cysteinyl-L-seryl-L-leucyl-L-prolyl-L-glutaminyl-L-threonyl-L-seryl-glycyl-L-leucyl-L-glutaminyl-L-lysyl-L-prolyl-L-alpha-glutamyl-L-serinamide; (4S)-4-[[(2S)-1- |
Leonurine hydrochloride | 24697-74-3 | C14H22O5N3Cl | 4-(Diaminomethylideneamino)butyl 4-hydroxy-3,5-dimethoxybenzoate hydrochloride; 4-Hydroxy-3,5-dimethoxybenzoic acid 4-guanidinobutyl ester; 3,5-Dimethoxy-4-hydroxy-benzoic acid (4-guanidino)-1-butyl ester Hydrochloride; 4-Guanidinobutyl syringate; 4-Guani | |
Leonloside D | 20830-84-6 | C59H96O27 | 1237.37 | |
Leojaponin | 864817-63-0 | C20H26O3 | 314.42 | (4aR)-4-[2-(furan-3-yl)ethyl]-1-hydroxy-3,4a,8,8-tetramethyl-6,7-dihydro-5H-naphthalen-2-one |
LEO29102 | 1035572-38-3 | C20H22Cl2N2O5 | 441.31 | LEO-29102;2-(6-(2-(3,5-dichloropyridin-4-yl)acetyl)-2,3-dimethoxyphenoxy)-N-propylacetamide |
lenvatinib mesylate | 857890-39-2 | C21H19ClN4O4·CH4O3S | 522.96 | Lenvima; 4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide mesylate |
Lenvatinib | 417716-92-8 | C21H19ClN4O4 | 426.85 | 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide; E-7080; ER-203492-00 |
Lentinan | 37339-90-5 | (C42H72O36)n | A823605; Bromoduline | |
Lensiprazine | 327026-93-7 | C24H27FN4O2 | 422.50 | SLV-314; (2R)-8-[4-[3-(5-Fluoro-1H-indol-3-yl)propyl]-1-piperazinyl]-2-methyl-2H-1,4-benzoxazin-3(4H)-one |
Leniolisib | 1354690-24-6 | C21H25F3N6O2 | 450.46 | (S)-1-(3-((6-(6-methoxy-5-(trifluoromethyl)pyridin-3-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)amino)pyrrolidin-1-yl)propan-1-one;UNII-L22772Z9CP |
Lenalidomide-d5 | 1227162-34-6 | C13H8N3O3D5 | 264.35 | 3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione-d5 |
Lenalidomide Impurity B | 827026-45-9 | C13H11N3O5 | 289.25 | 3-(1,3-Dihydro-4-nitro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione; 3-(4-Nitro-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione; 4-Nitro Lenalidomide |
Lenalidomide hydrochloride | 1243329-97-6 | C13H14ClN3O3 | 295.72 | Revlimid hydrochloride; CC-5013 hydrochloride; CC5013 hydrochloride; CC 5013 hydrochloride |
Lenalidomide hemihydrate | 847871-99-2 | C13H13N3O3 | 259.26 | Revlimid hemihydrate; CC-5013 hemihydrate |
Lenacil | 2164-08-1 | 234.29 | 3-Cyclohexyl-6,7-dihydro-1H-cyclopentapyrimidine-2,4-(3H,5H)-dione | |
Lemuteporfin | 215808-49-4 | C44H48N4O10 | 792.886 | QLT-0074; QLT 0074; QLT0074; EA 6; Lemuteporfin. |
Lemongrass oil | 8007-02-1 | Mixture | Lemongrass essential oil | |
Lemon Oil | 8008-56-8 | |||
Lemon extract | 84929-31-7 | Lemon,extract; LEMON OIL; LEMON OIL AND EXTRACT; LEMON OIL, CALIFORNIA; LEMON OIL, CALIFORNIA TYPE; LEMON OIL SPANISH; LEMON PEEL TINCTURE; LEMON TERPENES | ||
Lemon bioflavonoid extract | 61788-55-4 | |||
Lemidosul | 88041-40-1 | C12H19NO3S | 257.34900 | |
Lemborexant | 1369764-02-2 | C22H20F2N4O2 | 410.42 | Lemborexant; UNII-0K5743G68X; Lemborexant [INN]; SCHEMBL2116558; CHEMBL3545367; 0K5743G68X |
Leinamycin | 120500-15-4 | C22H26N2O6S3 | 510.653 | |
LEI-106 | 1620582-23-1 | C26H27NO6S | 481.6 | 2-[(2,2-dimethyl-3,4-dihydrochromen-6-yl)sulfonyl-[(4-phenoxyphenyl)methyl]amino]acetic acid |
Leflunomide | 75706-12-6 | C12H9F3N2O2 | 270.21 | Leflunomide, Arava, Leflunomidum, HWA-486; HWA486; HWA 486 |
Leelamine hydrochloride | 16496-99-4 | C20H31N·HCl | 321.9 | Lylamine hydrochloride; Dehydroabiethylamine hydrochloride; [(1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methanamine hydrochloride |
Leelamine | 1446-61-3 | C20H31N | 285.5 | [(1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methanamine; dehydroabietylamine; DEHYDROABIETYLAMINE; (+)-Dehydroabietylamine; Dehydroabiethylamine; 16496-99-4 Leelamine (hydrochloride) |
Leeaoside | 1015063-56-5 | C24H40O11 | 504.575 | |
LEE011 succinate hydrate | 1374639-79-8 | C27H38N8O6X | 570.64 | Ribociclib succinate hydrate; LEE 011 succinate hydrate; LEE-011 succinate hydrate |
LEE011 succinate | 1374639-75-4 | C27H36N8O5 | 552.63 | Ribociclib succinate; LEE 011 succinate; LEE-011 succinate |
LEE011 hydrochloride | 1211443-80-9 | C23H31ClN8O | 471.0 | 7-cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide hydrochloride; Ribociclib hydrochloride; LEE011; LEE-011 LEE 011 |
Ledoxantrone | 113457-05-9 | C21H27N5OS | 397.541 | Ledoxantrone; sedoxantrone; CI-958. |
L-cystine diethyl ester dihydrochloride | 583-89-1 | C10H20N2O4S2.2HCl | 369.32 | |
L-Cysteinesulfinic acid | 1115-65-7 | C3H7NO4S | 153.15 | 3-Sulfino-L-alanine; Cysteinesulfinic Acid; L-2-Amino-3-sulfinopropionic Acid |
L-Cysteine-3-13C | 201612-57-9 | HS[13C]H2CH(NH2)COOH | 122.15 | |
L-Cysteine-3,3-d2 | 130633-02-2 | HSCD2CH(NH2)COOH | 123.17 | |
L-Azetidine-2-carboxylic acid HCl | 2133-35-9 | C4H8ClNO2 | 137.56 | |
Lazertinib | 1903008-80-9 | C30H34N8O3 | 554.64 | 2-Propenamide, N-(5-((4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)-; N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl)acrylami |
Lazabemide hydrochloride | 103878-83-7 | C8H10ClN3O.HCl | 236.1 | N-(2-Aminoethyl)-5-chloro-2-pyridinecarboxamide hydrochloride |
Lazabemide hydrate | 103878-84-8 | C8H10ClN3O | 199.64 (anhydrous basis) | N-(2-Aminoethyl)-5-chloro-2-pyridinecarboxamide hydrate, Ro 19-6327 hydrate |
Laxiracemosin H | 1241871-28-2 | C26H35NO3 | 409.6 | 3-[(5alpha,13alpha,14beta,17alpha)-4,4,14-Trimethyl-3-oxoandrost-7-en-17-yl]-1H-pyrrole-2,5-dione;Laxiracemosine H |
Interleukin1 receptor antagonist (human isoform x reduced),N2-L-methionyl- (9CI) | 143090-92-0 | |||
Ki16425 | 355025-24-0 | C23H23ClN2O5S | 474.96 | |
Ki16198 | 355025-13-7 | C24H25ClN2O5S | 488.98 | |
KHS 101 hydrochloride | 1784282-12-7 | C18H22ClN5S | 375.92 | KHS 101 HCl; 4-N-(2-methylpropyl)-2-N-[(2-phenyl-1,3-thiazol-4-yl)methyl]pyrimidine-2,4-diamine hydrochloride |
KHK-IN-1 hydrochloride | 1303470-48-5 | C21H27ClN8S | 459.01 | ketohexokinase inhibitor |
KHK-IN-1 | 1303469-70-6 | C21H26N8S | 422.55 | ketohexokinase inhibitor |
Khelloside | 17226-75-4 | C19H20O10 | 408.356 g/mol | |
Khellin | 82-02-0 | C14H12O5 | 260.2 | 4,9-dimethoxy-7-methylfuro[3,2-g]chromen-5-one |
KAT681 | 373641-87-3 | C24H22FNNaO6 | 462.42 | |
Kasugamycin hydrochloride hydrate | 200132-83-8 | C14H28ClN3O10 | 433.84 | 2-amino-2-[(2R,3S,5S,6R)-5-amino-2-methyl-6-[(2S,3S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyoxan-3-yl]iminoacetic acid;hydrate;hydrochloride UNII-5A9BN7V7QL 5A9BN7V7QL SCHEMBL69506 200132-83-8 |
Kasugamycin hydrochloride | 19408-46-9 | C14H25N3O9.HCl | 415.82 | |
Kassinin | 63968-82-1 | C59H95N15O18S | 1334.54 | 3-amino-4-[[1-[2-[[6-amino-1-[[1-[[1-[[5-amino-1-[[1-[[1-[[2-[[1-[(1-amino-4-methylsulfanyl-1-oxobutan-2-yl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]ami |
Kartogenin | 4727-31-5 | C20H15NO3 | 317.344 | KGN; 2-([1,1'-Biphenyl]-4-ylcarbamoyl)benzoic acid; 2-[(4-phenylphenyl)carbamoyl]benzoic acid |
Jangomolide | 93767-25-0 | C26H28O8 | 468.5 | (3R,3aS,5aR,5bS,9aR,11aR,13aR,13bR,14aS)-3-(3-Furyl)-3a,11,11,13a -tetramethyl-3,3a,4,5,5a,11a,12,13a-octahydro-8H-oxireno[d]pyrano [2',3':3,3a][2]benzofuro[5,4-f]isochromene-1,8,13(11H,14aH)-trion e |
JANEX-1 | 202475-60-3 | C16H15N3O3 | 297.31 | WHI-P131; JAK3 Inhibitor I; 4-(6,7-dimethoxyquinazolin-4-ylamino)phenol |
Janelia Fluor 669, SE | 2127150-20-1 | C34H30F3N3O6SSi | 693.77 | 1-[7-(1-Azetidinyl)-10-[2-Carboxy-5-[(2-(2,5-dioxopyrrolidin-1-yl)oxy)-2-oxoethyl]thio-3,4,6-trifluorophenyl]-9,9-dimethyl-9-silaanthracen-2(9H)-ylidene]azetidinium, inner salt |
Janelia Fluor 646, SE | 1811539-59-9 | C33H31N3O6Si | 593.71 | 1-[7-(1-Azetidinyl)-10-[2-carboxy-5-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]phenyl]-9,9-dimethyl-9-silaanthracen-2(9H)-ylidene]azetidinium, inner salt |
Jaboticabin Ethyl Impurity | 1404192-74-0 | C17H16O8 | 348.31 | Desmethyl Jaboticabin Ethyl Carboxylate; 2-[(3,4-Dihydroxybenzoyl)oxy]-4,6-dihydroxy-benzeneacetic Acid Ethyl Ester |
Isoanhydroicaritin | 28610-30-2 | C21H20O6 | 368.4 | 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-methoxy-8-(3-methylbut-2-enyl)chromen-4-one |
Isoangustone A | 129280-34-8 | C25H26O6 | 422.47 | 3-[3,4-Dihydroxy-5-(3-methyl-2-buten-1-yl)phenyl]-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one |
ISOAMYLASE | 9067-73-6 | 0 | EC 3.2.1.68; ISOAMYLASE; GLYCOGEN 5 GLUCANOHYDROLASE; isoamylase F. pseudomonas amyloderamosa; isoamylase from pseudomonas*amyloderamosa; Amylase, iso-; ISOAMYLASE FROM PSEUDOMONAS AMYLODERAMOS; frompseudomonasamyloderamosa | |
Holmium oxide | 12055-62-8 | HO2O3 | 377.86 | oxo(oxoholmiooxy)holmium; Holmium(III)oxide; Rareearth; Holmia; AC1N6BNI; Ho2O3 |
Irinotecan Related Compound(RPR 121056) | 181467-56-1 | C33H38N4O8 | 618.69 | 7-Ethyl-10-(4-N-aminopentanoic acid)-1-piperidino)carbonyloxycamptothecin |
Irinotecan Impurity 2 | 143490-53-3 | C32H36N4O5 | 556.67 | [1,4'-Bipiperidine]-1'-carboxylic Acid 3,10-Diethyl-11,13-dihydro-1,13-dioxo-1H,3H- furo[3',4':6,7]indolizino[1,2-b]quinolin-8-yl Ester |
Irinotecan Hydrochloride Trihydrate | 136572-09-3 | C33H38N4O6.HCl.3H2O | 677.18 | CPT-11 HCl Trihydrate; Irinotecan Hcl Trihydrate; UNII-042LAQ1IIS |
Irinotecan HCl | 100286-90-6 | C33H39ClN4O6 | 623.14 | CPT-11 hydrochloride; CPT 11 hydrochloride; CPT11 hydrochloride; Camptothecin 11 hydrochloride |
Irinotecan 8-Ethyl Impurity | 947687-02-7 | C35H42N4O6 | 614.75 | (S)-4,8,11-Triethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-9-yl (1,4'-bipiperidine)-1'-carboxylate ; |
Irinotecan 11-Desethyl Impurity | 103816-16-6 | C31H34N4O6 | 558.64 | (S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-9-yl (1,4'-bipiperidine)-1'-carboxylate ; [1,4'-Bipiperidine]-1'-carboxylic acid (4S)-4-ethyl-3,4,12,14- tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino |
Irinotecan | 97682-44-5 | C33H38N4O6 | 586.68 | Camptosar; Irinotecanum; CPT-11; CPT 11; CPT11 |
Lawsonia inermis, ext. | 84988-66-9 | |||
Lavoltidine | 76956-02-0 | C19H29N5O2 | 359.471 | |
Lavendustin C | 125697-93-0 | C14H13NO5 | 275.26 | 5-[[(2,5-dihydroxyphenyl)methyl]amino]-2-hydroxy-benzoic acid; Lavendustin C; HDBA, NSC 666251. |
Lavendustin B | 125697-91-8 | C21H19NO5 | 365.38 | 5-[bis[(2-hydroxyphenyl)methyl]amino]-2-hydroxybenzoic acid |
Lavendustin A | 125697-92-9 | C21H19NO6 | 381.38 | 5-[[(2,5-Dihydroxyphenyl)methyl][(2-hydroxyphenyl)methyl]amino]-2-hydroxybenzoic acid |
Lavender oil | 8000-28-0 | Mixture | Lavender Essential Oil | |
Iron phosphide (Fe2P) | 1310-43-6 | Fe2P | 142.66 | diironmonophosphide; di-ironphosphide; ironphosphide(fe2p); FERROUS PHOSPHIDE; IRON (II) PHOSPHIDE; IRON PHOSPHIDE; ironphosphide99.5%(metalsbasis)-40meshpowder; Ferrous phosphide, Iron diphosphide |
Iron oxide brown | 52357-70-7 | |||
Iron oxide black | 12227-89-3 | Fe3O4 | 231.54 | c.i. 77499; C.I. Pigment Black 11; IRON OXIDE BLACK |
Iron oxide (Fe2O3),hydrate | 12259-21-1 | Fe2O3 . x H2 O | 177.7035 | IRON(III) OXIDE HYDRATE; IRON(III) OXIDE MONOHYDRATE; IRON OXIDE YELLOW; diirontrioxidehydrate; Ironoxide,hydrate; Iron oxide (Fe2O3), hydrate |
Iron oxide | 1332-37-2 | FeO | 71.8444 | AM 125; Ancor FR; Ancor FY; Auvico AX 1000; AX 1000; BUS; EP-A 0014382; Ferroxon 422 |
Iron oxide | 11115-92-7 | ClH | 36.46094;g/mol | hydrochloricacid; hydrogenchloride; Muriaticacid; 7647-01-0; Chlorohydricacid; Acidechlorhydrique |
Iron nitride | 37245-77-5 | Fe6N2 | 363.08 | IRON NITRIDE; Iron nitrogen; Nitriloiron(III) |
Imidazo[1,2-b]pyridazine,6-chloro-2-methyl- | 14793-00-1 | C7H6 Cl N3 | 167.6 | IMIDAZO[1,2-B]PYRIDAZINE, 6-CHLORO-2-METHYL-; 6-CHLORO-2-METHYLIMIDAZO[1,2-B]PYRIDAZINE |
IMIDAZO[1,2-B]PYRIDAZINE | 766-55-2 | C6H5N3 | 119.12 | |
Hydrogenated Soybean Oil | 8016-70-4 | |||
Hydrogenated palm kernel-oil mono- and di- glycerides | 93334-20-4 | |||
Hydrogenated palm glycerides | 91744-66-0 | |||
Hydrogenated Castor Oil | 8001-78-3 | |||
Hydrogen trifluorohydroxyborate(1-) | 16903-52-9 | BF3 H O . H | 103.84 | BORON TRIFLUORIDE DIHYDRATE COMPLEX; Trifluoroboron dihydrate; hydrogen trifluorohydroxyborate(1-); Borate(1-), trifluorohydroxy-, hydrogen, (T-4)- |
Hydrastine hydrochloride | 5936-28-7 | C21H21NO6.HCl | 419.86 | (+)-B-HYDRASTINE HCL; (+)-BETA-HYDRASTINE HCL; ISOCORYNE HYDROCHLORIDE; HYDRASTINE HCL, (+)-B-; HYDRASTINE HYDROCHLORIDE; beta-hydrastinehydrochloride |
Hydrangetin | 485-90-5 | C10H8O4 | 192.17 | 7-Hydroxy-8-methoxycoumarin; 7-hydroxy-8-methoxychromen-2-one |
Hydrangenoside A dimethyl acetal | 952485-00-6 | C33H46O14 | 666.72 | Methyl 1H-indazole-7-carboxylate |
Hydrangenol | 480-47-7 | C15H12O4 | 256.3 | 3-(4-Hydroxyphenyl)-8-hydroxy-3,4-dihydro-1H-2-benzopyran-1-one; |
Hydramicromelin D | 1623437-86-4 | C15H14O7 | 306.27 | 6-[(2R,3S,4S)-3,4-dihydroxy-4-methyl-5-oxooxolan-2-yl]-7-methoxychromen-2-one |
Hydramicromelin B | 369391-55-9 | C15H14O7 | 306.27 | 6-[(2R,3R,4S)-3,4-dihydroxy-4-methyl-5-oxooxolan-2-yl]-7-methoxychromen-2-one |
Holmium vanadium tetraoxide | 13977-63-4 | HoO4V | 279.86942;g/mol | holmium(3+);oxygen(2-);vanadium;Holmiumvanadiumtetraoxide;13977-63-4;EINECS237-759-4 |
Hexasiloxane,1,1,1,3,3,5,5,7,7,9,9,11,11,11-tetradecamethyl- | 107-52-8 | C14H42 O5 Si6 | 458.99 | tetradecamethyl-hexasiloxan; TETRADECAMETHYLHEXASILOXANE; Hexasiloxane, tetradecamethyl-; Tetradecamethylundecanehexasiloxane; [dimethyl(trimethylsilyloxy)silyl]oxy-[[dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-silyl]oxy-dimethyl-silane; [dimethyl(trime |
Hexanoic acid,2,6-diisocyanato-, 2-isocyanatoethyl ester | 69878-18-8 | C11H13N3O5 | 267.24 | 2,6-Diisocyanatohexanoic acid 2-isocyanatoethyl ester; 2-Isocyanatoethyl 2,6-diisocyanatohexanoate |
Hexanoic acid, 6-chloro-3,5-dihydroxy-, 1,1-dimethylethyl ester, (3R,5S)- | 154026-93-4 | C10H19ClO4 | 238.70846;g/mol | tert-butyl(3R,5S)-6-chloro-3,5-dihydroxyhexanoate;154026-93-4;(3R,5S)-tert-Butyl6-chloro-3,5-dihydroxyhexanoate;Hexanoicacid,6-chloro-3,5-dihydroxy-,1,1-dimethylethylester,(3R,5S)-;C10H19ClO4;AMOT0166 |
LAVENDER ALDEHYDE | 35158-25-9 | C10H18O | 154.24 | 2-Hexenal, 5-methyl-2-(1-methylethyl)-, 2-ISOPROPYL-5-METHYL-2-HEXENAL, ISODIHYDRO LAVANDULAL FCC, ISOPROPYL METHYL HEXENAL, LAVENDER ALDEHYDE FCC |
Lavandulol | 498-16-8 | C10H18O | 154.25 | (-)-4-hexen-1-o; (r)-4-hexen-1-o; (r)-5-methyl-2-(1-methylethenyl)-4-hexen-1-ol; (R)-Lavandulol; (theta)-4-hexen-1-o; 4-Hexen-1-ol, 2-isopropenyl-5-methyl-, (-)-; 4-Hexen-1-ol, 5-methyl-2-(1-methylethenyl)-, (R)-; LAVANDULOL |
Lavamilast | 1218778-89-2 | C25H30Cl2N4O4 | 521.44 | 4-((3,5-dichloropyridin-4-yl)amino)-7-methoxy-8-((6-morpholinohexyl)oxy)quinolin-2(1H)-one |
Lauterine | 28200-65-9 | C18H11NO4 | 305.28 | 10-Methoxyliriodenine;Oxolaureline;Oxolaurenine |
Laurylpyridinum chloride | 139549-68-1 | C17H30ClN | 283.88 | 1-DODECYLPYRIDINIUM CHLORIDE HYDRATE 9&; Laurylpyridinum chloride; 1-Dodecylpyridinium chloride; PYRIDINIUM,1-DODECYL-,CHLORIDE,MONOHYDRATE |
Lauryl-LF 11 | 832729-14-3 | C81H134N26O15 | 1712.11 | |
LAURYL SULFATE TRIS SALT | 50996-85-5 | C16H37NO7S | 387.53 | LAURYL SULFATE TRIS SALT; TRIS(HYDROXYMETHYL)AMINOMETHANE LAURYL SULFATE; TRIS(HYDROXYMETHYL)AMINOMETHANE DODECYL SULFATE; TRIS LAURYL SULFATE; TRIS-SDS SAMPLE BUFFER; lauryl sulfate tris; tris(hydroxymethyl)methyl-ammonium*dodecyl sulfat; [2-hydroxy-1,1- |
LAURYL POLYGLUCOSE | 167817-58-5 | |||
Lauryl maltose neopentyl glycol | 1257852-96-2 | C47H88O22 | 1005.19 | 2,2-didecylpropane-1,3-bis b-D-maltopyranoside; Lauryl MNG |
Lauryl isoquinolinium bromide | 93-23-2 | 378.395 | ||
Lauryl glucoside | 110615-47-9 | |||
Lauryl glucose neopentyl glycol | 1423318-02-8 | C31H60O12 | 624.80 | 2,2-Didecylpropane-1,3-bis b-D-glucopyranoside |
Lauryl dimethylamine oxide | 70592-80-2 | C10H13Br2N | 0 | (c10-c16-alkyl)dimethylamines,n-oxides; amines,; Amines,C10-16-alkyldimethyl,N-oxides; C10-16ALKYLDIMETHYLAMINESN-OXIDES; 6-Bromonaphthalen-2-amine; 5-Amino-1-(4-bromophenyl)-4-cyano-3-methyl-1H-pyrazole; 5-Amino--4-cyano-1-(2,4-difluorophenyl)-3-methyl-1 |
Lauryl Chloroformate | 24460-74-0 | C13H25ClO2 | 248.79 | LAURYL CHLOROFORMATE; DODECYL CHLOROFORMATE; CHLOROFORMIC ACID LAURYL ESTER; CHLOROFORMIC ACID DODECYL ESTER; N-DODECYLCHLOROFORMATE; LAURYL CHLOROFORMATE 98%; LAURYLCHLOPOFORMATE; Chloridocarbonic acid dodecyl ester |
Lauryl betaine | 683-10-3 | C16H33NO2 | 271.44 | (dodecyldimethylammonio)acetate; 1-dodecanaminium,n-(carboxymethyl)-n,n-dimethyl-,hydroxide,innersalt; 1-dodecanaminium,n-(carboxymethyl)-n,n-dimethyl-,hyroxide,innersalt; 1-Dodecanaminium,N-(carboxymethyl)-N,N-dimethyl-,innersalt; ambitericd40; amipol6s; |
Latanoprostene Bunod | 860005-21-6 | C27H41NO8 | 507.62 | BOL-303259-X; NCX 116; PF-3187207; 4-nitrooxybutyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate |
Latanoprost lactone diol | 145667-75-0 | C18H24O4 | 304.38 | LATANOPROST LACTONE DIOL; (3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(3R)-3-HYDROXY-5-PHENYLPENTYL]-2H-CYCLOPENTA[B]FURAN-2-ONE; (3AR,4R,5R,6AS)-5-HYDROXY-4-((3R)-3-HYDROXY-5-PHENYLPENTYL)HEXAHYDROCYCLOPENTA[B]FURAN-2-ONE; LP-diol (LT-DI)(Latanprost) |
Latanoprost Acid | 41639-83-2 | C23H34O5 | 390.52 | (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic Acid; |
Latanoprost | 130209-82-4 | C26H40O5 | 432.59 | Xalatan |
Latamoxef sodium | 64953-12-4 | C20H18N6Na2O9S | 564.43 | Moxalactam sodium; disodium;7-[[2-carboxylato-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; |
Latamoxef | 64952-97-2 | C20H20N6O9S | 520.48 | 5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid,7-((carboxy(4-hydroxyphen; Moxalactam, Lamoxactam, Festamoxin |
L-Aspartic-2,3,3-d3 Acid | 3842-25-9 | C4H4D3NO4 | 136.12 | L-Asparagic Acid-d3; L-Asparaginic Acid-d3; L-Aminosuccinic Acid-d3 |
Lasiocarpin | 303-34-4 | C21H33NO7 | 411.492 | lasiocarpine; 2-Butenoic acid, 2-methyl-, 7[[(2,3-dihydroxy-2-(1-methoxyethyl)-3-methyl-1-oxobutoxy] methyl]-2,3,5,7a-tetrahydro-1H-prrolizin-1-yl ester, [1S-[1alpha(Z), 7(2S*, 3R*), 7aalpha)]-; (Z)-2-Methyl-2-butenoic acid (1S)-7-[[[(2R)-2,3-dihydroxy-2- |
Lascufloxacin | 848416-07-9 | C21H24F3N3O4 | 439.43 | KRP-AM1977; 7-{(3S,4S)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidin- 1-yl}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo- 1,4-dihydroquinoline-3-carboxylic acid |
L-Ascorbic acid-2-phosphate sodium | 109620-90-8 | C6H9O9P | 0 | L-Ascorbic acid-2-phosphate sodium; L-Ascorbyl-2-phosphate |
L-ASCORBIC ACID IRON(II) | 24808-52-4 | C12H14FeO12 | 406.08 | |
L-Ascorbic acid 2-phosphate magnesium ester | 113170-55-1 | Mg3.(C6H6O9P)2 | 579.08 | MERCARE MAP; MAGNESIUM-L-ASCORBYL-2-PHOSPHATE; ASCORBIC ACID 2-PHOSPHATE MAGNESIUM ESTER; Magnesium L-ascrobate-2-phosphate; L-ASCORBIC ACID 2-PHOSPHATE SESQUIMAGNESIUM SALT HYDRATE; MagnesiumL-AscorbylPhosphate; VitaminCMagnesiumPhosphate; Ascorbic acid |
Lasalocid sodium | 25999-20-6 | C34H53NaO8 | 612.8 | Avatec, Bovatec, Ro 2-2985, X 537A |
Lasalocid | 25999-31-9 | C34H53O8 | 590.80 | Lasalocid A; Lasalocide; Lasalocidum; Antibiotic X 537A; 6-(7-(5-Ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methylbenzoic acid, (2R-(2alpha(2S*(3R*,4S*,5S*,7R*) |
LAS191859 | 1420071-13-1 | C24H24F3N3O3 | 459.5 | 1-[2-[[(cyclopropylcarbonyl)ethylamino]methyl]-4-(trifluoromethyl)phenyl]-6-methyl-1H-pyrrolo[2,3-b]pyridine-3-aceticacid |
Larotaxel | 156294-36-9 | C45H53NO14 | 831.912 | RPR 109881; RPR 109881A. Code names: RPR 109881; RPR 109881A; XRP9881. Larotaxel; PNU 100940 |
Laropiprant-d4 | 1132664-22-2 | C21H15ClFNO4SD4 | 439.96 | N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine-d4 |
Laropiprant | 571170-77-9 | C21H19ClFNO4S | 435.91 | (3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)-cyclopent[b]indole-3-acetic acid |
Laronidase | 210589-09-6 | |||
LARIXOL ACETATE | 1438-66-0 | C24H38O4 | 390.56 | 1-Naphthalenepropanol, alpha-ethenyldecahydro-4-hydroxy-alpha,5,5,8a-tetramethyl-2-methylene-, [1S-[1alpha(R),4beta,4abeta,8aalpha]]-; 1-Naphthalenepropanol, alpha-ethenyldecahydro-4-hydroxy-alpha,5,5,8a-tetramethyl-2-methylene-, [1S-[1alpha(R*),4beta,4ab |
Larixinol | 101046-79-1 | C30H22O10 | 542.5 | 2''-epi-Abiesinol F;Abiesinol E;Listvenol |
Laricitrin | 53472-37-0 | C16H12O8 | 332.263 | Laricitrin; 3'-O-Methylmyricetin; CHEBI:31763; 53472-37-0; LARICYTRIN; AC1NQZKE |
Lariciresinol dimethyl ether | 67560-68-3 | C22H28O6 | 388.5 | [(2S,3R,4R)-2-(3,4-dimethoxyphenyl)-4-[(3,4-dimethoxyphenyl)methyl]oxolan-3-yl]methanol |
Lariciresinol acetate | 79114-77-5 | C22H26O7 | 402.44 | 3,4-Dimethyl-2,5,6-triphenyl-1-phosphabicyclo[2.2.1]hepta-2,5-die ne |
Lariatin A | 732286-09-8 | C94H143N27O25 | 2051.31 | Peptide K01-B0171-B |
Lapiriumchloride | 6272-74-8 | C21H35N2O3 | 363.52 | Lapirium chloride; Lapyrium chloride |
L-Apiose | 6477-44-7 | C5H10O5 | 150.13 | |
L-a-Phosphatidylinositol - from Soy bean | 97281-52-2 | C43H78NaO13P | 857.04 | 1,2-Diacyl-sn-glycero-3-phospho-(1-D-myo-inositol) |
L-a-Phosphatidyl-(1,2-dipalmitoyl)-D-myo-inositol | 62742-56-7 | C41H79O13P | 811.03 | |
Lanthanum acetylacetonate | 14284-88-9 | C15H21LaO6 | 436.23 | LANTHANUM(III) 2,4-PENTANEDIONATE; LANTHANUM ACETYLACETONATE; LANTHANUM 2,4-PENTANEDIONATE; ACETYLACETONE, LANTHANUM DERIVATIVE; tris(pentane-2,4-dionato-O,O')lanthanum; Tris-(2,4-pentanedionato)-lanthanum; Lanthanum tris(acetylacetonate); Lanthanum, tris |
Lanthanum acetate hydrate, | 2572-92-0 | |||
Lantanilic acid | 60657-41-2 | C35H52O6 | 568.795 | |
LANTADENE | 11111-47-0 | 0 | LANTADENE | |
Lansoprazole-D4 Sulfone N-Oxide | 1190009-70-1 | C18H10D4F3N3O4S | 405.38 | 2-[[[3-Methyl-1-oxido-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole-d4 |
Lansoprazole-d4 | 934294-22-1 | C18H10D4F3N3O2S | 373.39 | 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole-d4; A-65006-d4; AG-1749-d4; Agopton-d4; Lansox-d4; Lanzor-d4; Limpidex-d4; Ogast-d4; Prevacid-d4; |
Lansoprazole Thioxo Impurity | 1246819-06-6 | C14H9N3OS | 267.31 | 1-Methyl-12-thioxopyrido[1,2,3,4]imidazole-[1,2-a]benzimidazole-2(12H)-one |
Lansoprazole Sulfone-D4 | 1184999-77-6 | C18H10D4F3N3O3S | 389.38 | 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole-d4; AG-1813-d4 |
Lansoprazole Sulfone N-Oxide | 953787-54-7 | C16H14F3N3O4S | 401.37 | 2-[[[3-Methyl-1-oxido-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole |
Lansoprazole Sulfide-D4 | 1216682-38-0 | C18H10D4F3N3OS | 357.39 | 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]thio]-1H-benzimidazole-d4; AG 1777-d4; H 225/18-d4; K 1252-d4 |
Lansoprazole sodium | 226904-00-3 | C16H13F3N3NaO2S | 391.34 | 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]benzimidazol-1-ide 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole Abbot Brand of Lansoprazole AG 1749 AG-1749 AG1749 Agopton Almirall Brand of Lansop |
Lansoprazole Related Compound 3 | 1083100-27-9 | C25H22F6N4O2S | 556.53 | N-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl Lansoprazole Sulfide; 1-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]thio]-1H-benzimidazole; |
Lansoprazole Related Compound 2 (Des(trifluoroethyl) Lansoprazole Sulfide) | 131926-97-1 | C14H13N3OS | 271.34 | 2-[(1H-Benzimidazol-2-ylthio)methyl]-3-methyl-4-pyridinol; |
Lansoprazole Pyridine N-Oxide | 163119-30-0 | C16H14F3N3O2S | 369.37 | 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]thio]-1H-benzimidazole N-Oxide; |
Lansoprazole N-Trifuoroethyl Impurity | 1187926-84-6 | C18H15F6N3O2S | 451.39 | 1H-BenziMidazole, 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl]sulfinyl]-1-(2,2,2-trifluoroethyl)- |
Lansoprazole N-(3-Methyl-4-Trifuoroethoxyl-Pyridin-2-yl) Impurity | 1083100-26-8 | C25H22F6N4O3S | 572.53 | N-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl Lansoprazole; 1-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole; |
Lansoprazole Impurity I | 103577-66-8 | C9H10F3NO2 | 221.18 | (3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methanol; Lansoprazole Hydroxymethyl Impurity |
Lansoprazole Impurity H | 1346598-28-4 | C23H16F3N5OS | 467.48 | 10-(1H-Benzoimidazol-2-ylsulfanyl)-1-methyl-2-(2,2,2-trifluoro-ethoxy)-4a,5,9b-triaza-indeno[2,1-a]indene |
Lansoprazole EP Impurity E | 583-39-1 | C7H6N2S | 150.20 | 1,3-Dihydro-2H-benzimidazole-2-thione, 2-Benzimidazolethiol; 2-Mercaptobenzimidazole |
Lansoprazole EP Impurity D | 615-16-7 | C7H6N2O | 134.14 | 1,3-Dihydro-2H-benzimidazol-2-one; 2-Hydroxybenzimidazole |
Lansoprazole EP Impurity C | 103577-40-8 | C16H14F3N3OS | 353.37 | 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]thio]-1H-benzimidazole; Lansoprazole Sulfide |
Lansoprazole EP Impurity B (Lansoprazole Sulfone) | 131926-99-3 | C16H14F3N3O3S | 385.37 | 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole; AG 1813; |
Lansoprazole EP Impurity A | 213476-12-1 | C16H14F3N3O3S | 385.37 | 2-[[[3-Methyl-1-oxido-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole; Lansoprazole N-Oxide |
Lansoprazole | 103577-45-3 | C16H14F3N3O2S | 369.3615 | Lansoprazole |
Lansiumarin C | 205115-75-9 | C21H22O5 | 354.4 | 8-[(E)-6-Hydroxy-3,7-dimethylocta-2,7-dienyloxy]psoralen |
Lansiumarin A | 205115-73-7 | C21H20O5 | 352.386 | 9-{[(2E)-3,7-dimethyl-6-oxoocta-2,7-dien-1-yl]oxy}-2H-furo[3,2-g]chromen-2-one; 9-[(2E)-3,7-dimethyl-6-oxoocta-2,7-dienoxy]furo[3,2-g]chromen-7-one |
Lanreotide acetate | 127984-74-1 | C56H73N11O12S2 | 1096.32 | Somatuline |
Lanosterol | 79-63-0 | C30H50O | 426.729 | Lanosterin; Lanster; Botalan base 138; Lanosta-8,24-dienol; (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol |
Lanost-7-ene-3,23-diol,24,25-epoxy-, (3b,13a,14b,17a,20S,23R,24S)- | 115334-05-9 | C30H50O3 | 458.7 | |
Lanopepden | 1152107-25-9 | C22H34FN7O4 | 479.58 | N-[(2R)-2-(cyclopentylmethyl)-3-(2-{5-fluoro- 6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]- 2-methylpyrimidin-4-yl}hydrazin-1-yl)-3-oxopropyl]- N-hydroxyformamide,GSK-1322322,GSK-322 |
Lanolin,ethoxylated propoxylated | 68458-88-8 | |||
Lanolin liquid | 70321-63-0 | 0 | Lanolin liquid; Lanolin liquid, low pesticide; Lanolin oil | |
Lanolin ethoxylated | 61790-81-6 | 0 | Lanolin ethoxylated; Lanolin PEG-75; Lanolin PEG-75/50 | |
LaniceMine | 153322-05-5 | C13H14N2 | 198.27 | Lanicemine; UNII-9TMU325RK3; ARL 15896; 9TMU325RK3; AR-R15896AR; (1S)-1-phenyl-2-pyridin-2-ylethanamine |
Landiolol hydrochloride | 144481-98-1 | C25H40ClN3O8 | 546.06 | Landiolol Hydrochloride; 4-[(2S)-2-Hydroxy-3-[[2-[(4-morpholinylcarbonyl)amino]ethyl]amino]propoxy]benzenepropanoic Acid [(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]methyl Ester Hydrochloride; |
Landiolol | 133242-30-5 | C25H39N3O8 | 509.60 | (2,2-dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-((S)-2-hydroxy-3-((2-(morpholine-4-carboxamido)ethyl)amino)propoxy)phenyl)propanoate |
Lancifolin C | 74048-71-8 | C22H28O5 | 372.5 | (4S)-2-Allyl-4-[(2R)-1-(3,4-dimethoxyphenyl)-2-propanyl]-4,5-dime thoxy-2,5-cyclohexadien-1-one |
Lancerin | 81991-99-3 | C19H18O10 | 406.34 | 4-C-Glucosyl-1,3,7-trihydroxyxanthone |
Lanatoside D | 11030-31-2 | C49H76O21 | 1001.12 | lanatoside D |
Lanatoside C (Digoxin Impurity H) | 17575-22-3 | C49H76O20 | 985.12 | Isolanid; Digoxin impurity H |
Lanatoside B | 17575-21-2 | C49H76O20 | 985.12 | LANATOSIDE B; 20(22),5BETA-CARDENOLID-3BETA,14BETA,16BETA-TRIOL 3BETA-[O-BETA-D-GALACTOPYRANOSYL-(1->4)-O-BETA-D-[3-O-ACETYLDIGITOXOPYRANOSYL]-(1->4)-DIGITOXOPYRANOSYL-(1->4)-O-BETA-D-DIGITOXOPYRANOSIDE]; digilanidb; digilanideb; LANTOSIDEB |
Lanabecestat | 1383982-64-6 | C26H28N4O | 412.53 | (1r,4r)-4-methoxy-5''-methyl-6'-(5-(prop-1-yn-1-yl)pyridin-3-yl)-3'H-dispiro[cyclohexane-1,2'-indene-1',2''-imidazol]-4''-amine; 4-methoxy-5'-methyl-6'-(5-(prop-1-yn-1-yl)pyridin-3-yl)-3'H-dispiro(cyclohexane-1,2'-inden-1',2'-imidazol)-4'-amine; AZD3293 |
Lamotrigine-13C-d3 | 1246815-13-3 | C8[13C]H4Cl2N5D3 | 260.10 | 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine-13C3,d3; 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine-13C3,d3 |
Lamotrigine-13C3 | 1188265-38-4 | C613C3H7Cl2N5 | 259.07 | 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine-13C3; 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine-13C3 |
Lamotrigine Related Compound D | 252186-79-1 | C16H9Cl4N5O | 429.10 | 3-(2,3-Dichlorobenzamido) Lamotrigine; N-[5-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide; |
Lamotrigine Related Compound C | 252186-78-0 | C9H6Cl2N4O | 257.08 | 5-Desamino 5-Oxo-2,5-dihydro Lamotrigine; 3-Amino-6-(2,3-dichlorophenyl)-1,2,4-tryriazin-5(2H)-one; |
Lamotrigine N2-Oxide | 136565-76-9 | C9H7Cl2N5O | 272.10 | 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine 2-Oxide; |
Lamotrigine N2-Glucuronide | 133310-19-7 | C15H15Cl2N5O6 | 432.22 | 3,5-Diamino-6-(2,3-dichlorophenyl)-2-D-glucopyranuronosyl-1,2,4-triaziniu; |
Lamotrigine isethionate | 113170-86-8 | C9H7Cl2N5.C2H6O4S | 382.22 | 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine isethionate |
Lamotrigine Impurity D | 661463-79-2 | C9H5Cl2N3O2 | 258.07 | 3,5-Didesamino-3,5-dioxo Lamotrigine; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5(2H,4H)-dione; |
Lamotrigine Impurity C | 94213-23-7 | C9H7Cl2N5 | 256.10 | (Z)-[cyano(2,3-dichlorophenyl)methylene]carbazamidine; 2-(2,3-Dichlorophenyl)-2-(guanidinoimino) acetonitrile |
Lamotrigine Dimer Impurity 1 | 1797983-48-2 | C19H14Cl4N10 | 524.20 | 3-[[5-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazine-3-amino]methylamino]-5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazine; |
L-Alanine-N,N,O-d3 | 19470-97-4 | CH3CH(ND2)COOD | 92.11 | (S)-2-Aminopropanoic Acid-d3; H-L-Ala-OH-d3; L-alpha-Alanine-D3; deuterio (2S)-2-(dideuterioamino)propanoate |
L-Alanine-d7 | 74280-71-0 | CD3CD(ND2)COOD | 96.14 | (S)-2-Aminopropanoic Acid-d7; H-L-Ala-OH-d7; deuterio (2S)-2,3,3,3-tetradeuterio-2-(dideuterioamino)propanoate |
L-Alanine isopropyl ester hydroChloride | 39825-33-7 | C6H13NO2.HCl | 167.63 | H-ALA-OIPR HCL; H-Ala-OiPro.HCl; L-Alanine isopropyl ester hydrochloride; L-Alanine, 1-methylethyl ester (9CI); H-ALA-OIPHCL; 2-Aminopropionic acid isopropyl ester hydrochloride; (S)-isopropyl 2-aminopropanoate hydrochloride |
L-Alaninamide,L-alanyl-N-[(1a,5a,6a)-3-[6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5,8-dihydro-5-oxo-1,8-naphthyridin-2-yl]-3-azabicyclo[3.1.0]hex-6-yl]- | 146961-76-4 | C26H25 F3 N6 O5 | ||
Laidlomycin potassium salt | 56283-74-0 | C37H62O12 | 698.885 | (2S,3R,4R)-4-[(2S,7S,8R,9S)-7-hydroxy-2-[(2R,5S)-5-[(2R,3S,5R)-5-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]-5-methyloxolan-2-yl]-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-2-methyl-3-propanoyloxypentanoicacid; |
Lafutidine-d10 | 1795136-26-3 | C22H19D10N3O4S | 441.62 | 2-[(2-Furanylmethyl)sulfinyl]-N-[(2Z)-4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]-2-buten-1-yl]acetamide-d10; rac Lafutidine-d10 |
Lafutidine Impurity B | 174583-84-7 | C22H29N3O5S | 447.56 | 2-[(2-Furanylmethyl)sulfonyl]-N-[(2Z)-4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]-2-buten-1-yl]acetamide; Lafutidine Sulfone |
Lafutidine Dihydro Impurity | 118288-14-5 | C22H31N3O4S | 433.57 | 2-[(2-Furanylmethyl)sulfinyl]-N-[4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]butyl]acetamide; |
Lafutidine | 118288-08-7 | C22H29N3O4S | 431.55 | FRG-8813; FRG 8813; FRG8813 |
Laflunimus | 147076-36-6 | C15H13F3N2O2 | 310.274 | Laflunimus |
Laetanine | 72361-67-2 | C18H19NO4 | 313.35 | (6aS)-1,9-dimethoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,10-diol |
Ladostigil tartrate | 209394-46-7 | 2(C16H20N2O2).C4H6O6 | 694.78 | ethylmethyl-carbamic acid (3r)-2,3-dihydro-3-(2-propynylamino)-1h-inden-5-yl ester (2r,3r)-2,3-dihydroxybutanedioate (2:1); ladostigil tartrate; Ethylmethyl-carbamic acid (3R)-2,3-dihydro-3-(2-propynylamino)-1H-inden-5-yl ester (2R,3R)-2,3-dihydroxybutane |
Ladostigil | 209349-27-4 | C16H20N2O2 | 272.348 | [(3R)-3-(prop-2-ynylamino)-2,3-dihydro-1H-inden-5-yl] N-ethyl-N-methylcarbamate; (N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamate; Ladostigil; TV 3326; TV3326 |
Ladostigil | 209394-27-4 | C16H20N2O2 | 272.348 | [(3R)-3-(prop-2-ynylamino)-2,3-dihydro-1H-inden-5-yl] N-ethyl-N-methylcarbamate; (N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamate; Ladostigil; TV 3326; TV3326 |
L-2-Amino-3-(5-methoxyindolyl)propionic acid | 25197-96-0 | C12H14N2O3 | 234.25 | L-2-Amino-3-(5-methoxyindolyl)propionic acid; 5-Methoxy-L-tryptophan |
Jujuboside B | 55466-05-2 | C52H84O21 | 1045.21 | (3b,16b,23R)-16,23 |
Jujuboside A | 55466-04-1 | C58H94O26 | 1207.37 | (3b,16b,23R)-16,23 |
JTV 519 fumarate | 1883549-36-7 | C25H32N2O2.C4H4O4 | 540.67 | 1-(2,3-Dihydro-7-methoxy-1,4-benzothiazepin-4(5H)-yl)-3-[4-(phenylmethyl)-1-piperidinyl]-1-propanone fumarate |
JTP-4819 | 162203-65-8 | C19H25N3O4 | 359.43 | Jtp 4819; CHEMBL76578; (2S)-N-benzyl-2-[(2S)-2-(2-hydroxyacetyl)pyrrolidine-1-carbonyl]pyrrolidine-1-carboxamide; SCHEMBL194809; ICULFJDHZQTNRB-HOTGVXAUSA-N |
JNJ 5207787 | 683746-68-1 | C32H38N4O2 | 510.67 | (2E)-N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyanophenyl)-N-[1-(2-cyclopentylethyl)-4-piperidinyl]-2-propenamide; trans-N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyanophenyl)-N-[1-(2-cyclopentylethyl)piperidin-4-yl]acrylamide |
JNJ 47965567 | 1428327-31-4 | C28H32N4O2S | 488.64 | 2-(Phenylthio)-N-[[tetrahydro-4-(4-phenyl-1-piperazinyl)-2H-pyran-4-yl]methyl-3-pyridinecarboxamide |
JNJ 0966 | 315705-75-0 | C16H16N4O2S2 | 360.45 | N-[2-[(2-Methoxyphenyl)amino]-4'-methyl[4,5'-bithiazol]-2'-yl]acetamide; N-[5-[2-(2-Methoxyanilino)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]acetamide |
JMV3002 | 925239-03-8 | C35H34N6O3 | 586.7 | N-[1-[4-[(2,4-dimethoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide |
JMV 449 | 139026-66-7 | C38H66N8O7 | 746.96 | (S)-1-de-L-lysine-2-[N2-(2,6-diaminohexyl)-L-lysine]-neuromedin N (pig spinal cord); H-Lysy(CH2NH)Lys-Pro-Tyr-Ile-Leu-OH |
JMV 390-1 | 148473-36-3 | C23H35N3O6 | 449.54 | N-[(2R)-4-Hydroxyamino)-1,4-dioxo-2-(phenylmethyl)butyl]-L-isoleucyl-L-leucine |
JCP174 | 126062-19-9 | C12H12ClNO3 | 253.7 | 7-amino-4-chloro-3-Propoxyisocoumarin; 7-Amino-4-chloro-3-propoxy-1H-isochromen-1-one |
Jasminoid A | 1459784-57-6 | C15H20O2 | 232.323 | (5S)-3-(3-hydroxyprop-1-en-2-yl)-4,5-dimethyl-5,6,7,8-tetrahydronaphthalen-1-ol |
Isopentenyl pyrophosphate trilithium salt | 18687-43-9 | C5H9Li3O7P2 | 263.89 | 3-Methyl-3-butenyl pyrophosphate trilithium salt |
Isopentenyl Pyrophosphate Triammonium Salt | 116057-53-5 | C5H21N3O7P2 | 297.18 | Diphosphoric Acid Mono(3-methyl-3-butenyl) Ester Triammonium Salt; Triammonium 3-Methyl-3-butenyl Pyrophosphate; |
Isopedicin | 4431-42-9 | C18H18O6 | 330.33 | 6-Hydroxy-5,7,8-trimethoxyflavanone |
Isopanose | 32581-33-2 | C18H32O16 | 504.44 | 6-o-a-D-Glucosyl-maltose; 4,6-Di-a-D-glucosyl-D-glucose |
Isopalmitic chloride | 74918-57-3 | C16H31ClO | 274.86974 | |
Iso-H7 dihydrochloride | 140663-38-3 | C14H19Cl2N3O2S | 364.29 | 1-(5-Isoquinolinylsulfonyl)-3-methylpiperazine dihydrochloride |
Isoguvacine hydrochloride | 68547-97-7 | C6H10ClNO2 | 163.6 | 1,2,3,6-tetrahydropyridine-4-carboxylic acid;hydrochloride; isoguvacine; isoguvacine hydrobromide; isoguvacine hydrochloride |
Isoguvacine hydrochloride | 64603-90-3 | C6H10ClNO2 | 163.6 | Isoguvacine hydrochloride; 1,2,3,6-Tetrahydro-4-pyridinecarboxylic acid hydrochloride |
Isodecyl benzoate | 131298-44-7 | C17H26O2 | 262.39 | Isodecylbenzoate; 8-methylnonylbenzoate; Benzoicacid,isodecylester; Benzoicacid,isodecylester; 120657-54-7; AC1MIR95 |
Labetalone hydrochloride | 96441-14-4 | C19H22N2O3·HCl | 362.85 | Labetalone HCl; 2-hydroxy-5-[2-(4-phenylbutan-2-ylamino)acetyl]benzamide hydrochloride |
L-693,403 maleate | 207455-21-8 | C24H27NO4 | 393.48 | N-1'-Benzyl-3,4-dihydrospiro[1H-indene-1,4'-piperidine] Maleate; 2,3-Dihydro-1'-(phenylmethyl)-spiro[1H-indene-1,4'-piperidine] (Z)-2-Butenedioate |
L-692,585 | 145455-35-2 | C32H37N7O3 | 567.69 | 3-[[(2R)-2-Hydroxypropyl]amino]-3-methyl-N-[(3R)-2,3,4,5-tetrahydro-2-oxo-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-1-benzazepin-3-yl]-butanamide; [R-(R*,R*)]-3-[(2-hydroxypropyl)amino]-3-methyl-N-[2,3,4,5-tetrahydro-2-oxo-1-[[2'-(1H-tetraz |
L-690,488 | 142523-14-6 | C32H52O16P2 | 754.70 | 1-[(4-Hydroxyphenoxy)ethylidene]bis[phosphinylidynebis(oxymethylene)]-2,2-dimethylpropanoate |
L-690,330 | 142523-38-4 | C8H12O8P2 | 298.13 | [1-(4-Hydroxyphenoxy)ethylidene]bisphosphonic Acid; P,P'-[1-(4-Hydroxyphenoxy)ethylidene]bis[phosphonic acid]; L 690330 |
L-689502 | 138483-63-3 | C39H51N3O7 | 673.84 | tert-butyl N-[(2S,3S,5R)-3-hydroxy-6-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-[[4-(2-morpholin-4-ylethoxy)phenyl]methyl]-6-oxo-1-phenylhexan-2-yl]carbamate; L 689502; L-689,502 |
L-689,560 | 139051-78-8 | C17H15Cl2N3O3 | 380.23 | trans-(±)-5,7-Dichloro-1,2,3,4-tetrahydro-4-[[(phenylamino)carbonyl]amino]-2-quinolinecarboxylic Acid; rel-(2R,4S)-5,7-Dichloro-1,2,3,4-tetrahydro-4-[[(phenylamino)carbonyl]amino]-2-quinolinecarboxylic Acid; (2R,4S)-rel-5,7-Dichloro-1,2,3,4-tetrahydro-4-[ |
L-685,458 | 292632-98-5 | C39H52N4O6 | 672.85 | L-685458; tert-butyl N-[(2S,3R,5R)-6-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-benzyl-3-hydroxy-6-oxo-1-phenylhexan-2-yl]carbamate |
L-681217 | 93522-10-2 | C36H53NO10 | 659.8 | L 681217 |
L-670,596 | 121083-05-4 | C22H21F2NO4S | 433.47 | (-)-6-8-Difluoro-2,3,4,9-tetrahydro-9-[[4-(methylsulfonyl)phenyl]methyl]-1H-carbazole-1-acetic acid; 2-[6,8-Difluoro-9-[(4-methylsulfonylphenyl)methyl]-1,2,3,4-tetrahydrocarbazol-1-yl]acetic acid |
L67 | 325970-71-6 | C16H14Br2N4O4 | 486.12 | L67; L-67; L 67. |
L-655,708 | 130477-52-0 | C18H19N3O4 | 341.36 | ETHYL (S)-11,12,13,13A-TETRAHYDRO-7-METHOXY-9-OXO-9H-IMIDAZO[1,5-A]PYRROLO[2,1-C][1,4]BENZODIAZEPINE-1-CARBOXYLATE;L-655,708;11,12,13,13A-TETRAHYDRO-7-METHOXY-9-OXO-9H-IMIDAZO[1,5-A]PYRROLO[2,1-C][1,4]BENZODIAZEPINE-1-CARBOXYLIC ACID, ETHYL ESTER;11,12,1 |
L-655,240 | 103253-15-2 | C21H21ClFNO2 | 373.9 | 3-(1-(4-Chlorobenzyl)-5-fluoro-3-methylindol-2-yl)-2,2-dimethylpropanoic acid |
L-651,582 | 99519-84-3 | C17H12Cl3N5O2 | 424.67 | Carboxyamidotriazole; CAI; RFE-007; NSC-609974; L-651582; RFE007; NSC609974; L651582; 5-Amino-1-[[3,5-dichloro-4-(4-chlorobenzoyl)phenyl]methyl]-1H-1,2,3-triazole-4-carboxamide |
L-4'-Tetrahydropyranylglycine | 811842-25-8 | C7H13NO3 | 159.18 | (S)-2-Amino-2-(tetrahydro-2H-pyran-4-yl)acetic acid; (L)-4'-Tetrahydropyranylglycine |
L-4-Hydroxyphenyl-d4-alanine-2-d1 | 1226919-57-8 | HOC6D4CH2CD(NH2)COOH | 186.22 | L-Tyrosine-d5; p-Hydroxyphenyl-L-alanine-d5; H-L-Tyr-OH-d5; (2S)-2-amino-2-deuterio-3-(2,3,5,6-tetradeuterio-4-hydroxyphenyl)propanoic acid |
L-4-Hydroxyphenyl-d4-alanine-2,3,3-d3 | 130551-49-4 | HOC6D4CD2CD(NH2)COOH | 188.23 | L-Tyrosine-d7; p-Hydroxyphenyl-L-alanine-d7; H-L-Tyr-OH-d7; (2S)-2-amino-2,3,3-trideuterio-3-(2,3,5,6-tetradeuterio-4-hydroxyphenyl)propanoic acid |
L-4-Hydroxyphenyl-d4-alanine | 62595-14-6 | HOC6D4CH2CH(NH2)COOH | 185.22 | L-Tyrosine-d4; p-Hydroxyphenyl-L-alanine-d4; H-L-Tyr-OH-d4; L-4-Hydroxyphenyl-2,3,5,6-d4-alanine; L-Tyrosine-(phenyl-d4); (2S)-2-amino-3-(2,3,5,6-tetradeuterio-4-hydroxyphenyl)propanoic acid |
L-4-Hydroxyphenylalanine-3,3-d2 | 72963-27-0 | HOC6H4CD2CH(NH2)COOH | 183.2 | L-Tyrosine-d2; p-Hydroxyphenyl-L-alanine-d2; H-L-Tyr-OH-d2; (2S)-2-amino-3,3-dideuterio-3-(4-hydroxyphenyl)propanoic acid |
L-4-Hydroxyphenyl-3,5-d2-alanine | 30811-19-9 | HOC6H2D2CH2CH(NH2)COOH | 183.2 | L-Tyrosine-d2; p-Hydroxyphenyl-L-alanine-d2; H-L-Tyr-OH-d2; L-Tyrosine-(phenyl-3,5-d2); (2S)-2-amino-3-(3,5-dideuterio-4-hydroxyphenyl)propanoic acid |
L-4-Hydroxyphenyl-2,6-d2-alanine-2-d1 | 71939-39-4 | HOC6H2D2CH2CD(NH2)COOH | 184.2 | L-Tyrosine-d3; p-Hydroxyphenyl-L-alanine-d3; H-L-Tyr-OH-d3; (2S)-2-amino-2-deuterio-3-(2,6-dideuterio-4-hydroxyphenyl)propanoic acid |
L-4-Hydroxyphenyl-2,6-d2-alanine | 57746-15-3 | HOC6H2D2CH2CH(NH2)COOH | 183.2 | L-Tyrosine-d2; p-Hydroxyphenyl-L-alanine-d2; H-L-Tyr-OH-d2; (2S)-2-amino-3-(2,6-dideuterio-4-hydroxyphenyl)propanoic acid |
L-4-CYANOPHENYLALANINE | 104531-20-6 | C10H10N2O2 | 190.2 | (2S)-2-amino-3-(4-cyanophenyl)propanoicacid; hydrochloride; (S)-2-Amino-3-(4-cyanophenyl)propanoicacidhydrochloride; 104531-20-6; SCHEMBL9710930; MolPort-027-835-018 |
L-3-Pyrazol-1-yl-alanine | 2734-48-7 | C6H9N3O2 | 155.15 | (S)-2-Amino-3-(1-pyrazolyl)propionic acid |
L-3-OH-Norval-OH | 34042-00-7 | C5H11NO3 | 133.15 | L-3-OH-Norval-OH |
L-377202 | 207395-85-5 | C65H89N9O25 | 1396.465 | L-377202; L-377,202; L377202; L377202 |
L-371,257 | 162042-44-6 | C28H33N3O6 | 507.59 | 1-[1-[4-(1-acetylpiperidin-4-yl)oxy-2-methoxybenzoyl]piperidin-4-yl]-4H-3,1-benzoxazin-2-one; 1-[4-[(1-Acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]-4-(2-oxo-2H-3,1-benzoxazin-1(4H)-yl)piperidine |
L-368,899 hydrochloride | 160312-62-9 | C26H43N4O5S2Cl | 591.23 | (2S)-2-Amino-N-[(1S,2S,4R)-7,7-dimethyl-1-[[[4-(2-methylphenyl)-1-piperazinyl]sulfonyl]methyl]bicyclo[2.2.1]hept-2-yl]-4-(methylsulfonyl)butanamide; 1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo[2,2,1]heptan-1(S)-yl)methylsulfonyl |
L-365,260 | 118101-09-0 | C24H22N4O2 | 398.46 | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea |
L-364,373 | 103342-82-1 | C25H20FN3O | 397.44 | 5-(2-Fluorophenyl)-1,3-dihydro-3-(1H-indol-3-ylmethyl)-1-methyl-2H-1,4-benzodiazepin-2-one; (R)-5-(2-Fluorophenyl)-1,3-dihydro-3-(1H-indol-3-ylmethyl)-1-methyl-2H-1,4-benzodiazepin-2-one; (3R)-5-(2-Fluorophenyl)-1,3-dihydro-3-(1H-indol-3-ylmethyl)-1-methy |
L-2-Methylglutamic acid | 6208-95-3 | C6H11NO4 | 161.15584 | L-2-Methylglutamic acid; L-2-Me-Glu-OH; L-Glutamic acid, 2-methyl- |
L-2-Chlorophenylglycine methyl ester | 141109-14-0 | C9H10ClNO2 | 199.63 | methyl(2S)-2-amino-2-(2-chlorophenyl)acetate; 141109-14-0; (S)-(+)-2-Chlorophenylglycinemethylester; (S)-Methyl2-amino-2-(2-chlorophenyl)acetate; L-2-Chlorophenylglycinemethylester; PubChem6252 |
L-2-Aminopentanoic-4,4,5,5,5-d5 Acid | 1202936-50-2 | CD3CD2CH2CH(NH2)COOH | 122.18 | L-Norvaline-d5; (S)-2-Aminovaleric Acid-d5; (2S)-2-amino-4,4,5,5,5-pentadeuteriopentanoic acid |
L-2-Aminohexanoic acid amide · HCl | 94787-97-0 | C6H14N2O · HCl | 166.65 | L-2-Aminohexanoic acid amide hydrochloride; H-Nle-NH2 . HCl |
L-2286 | 684276-17-3 | C15H19N3OS | 289.397 | L-2286; L 2286; L2286. |
L-2,6-difluorophenyl-alanine | 33787-05-2 | C9H9F2NO2 | 201.17 | 2,6-DIFLUOROPHENYLALANINE; 2,6-DIFLUORO-DL-PHENYLALANINE; 2,6-DIFLUORO-L-PHENYLALANINE; 2-AMINO-3-(2,6-DIFLUORO-PHENYL)-PROPIONIC ACID; L-2,6-DIFLUOROPHENYL-ALANINE; DL-2,6-DIFLUOROPHENYLALANINE; H-2,6-DIFLUORO-PHE-OH HCL; (S)-2-AMINO-3-(2,6-DIFLUORO-PHEN |
L-2,3-di-OH-Phe-OH | 28900-64-3 | C9H11 N O4 | 197.18794 | L-2,3-di-OH-Phe-OH |
L-2-(4-Chlorophenyl)glycine | 67336-19-0 | C8H8ClNO2 | 185.61 | (S)-4-CHLOROPHENYL GLYCINE; (S)-AMINO-(4-CHLORO-PHENYL)-ACETIC ACID; PARACHLOROPHENYLGLYCINE; (4-CHLOROPHENYL)GLYCINE; AMINO-(4-CHLORO-PHENYL)-ACETIC ACID; L-4-CHLOROPHENYLGLYCINE; H-PHG(4-CL)-OH; L-4-Cl-Phg-OH |
L-1-Cbz-Nipecotic acid | 88466-74-4 | C14H17NO4 | 263.28 | L-1-CBZ-NIPECOTIC ACID; (S)-1-CBZ-PIPERIDINE-3-CARBOXYLIC ACID; (S)-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-BENZYL ESTER; (S)-Cbz-Nip-OH; (S)-1-CBZ-NIPECOTICACID |
L189 | 64232-83-3 | C11H10N4OS | 246.29 | L189; L 189; L-189. |
Kynurenic acid sodium salt | 2439-02-3 | C10H6NNaO3 | 211.15 | 4-Hydroxyquinoline-2-carboxylic acid sodium salt |
Kynurenic acid | 492-27-3 | C10H7NO3 | 189.17 | 4-Hydroxy-2-quinolinecarboxylic Acid; 4-Hydroxy-quinaldic Acid; 2-Carboxy-4-hydroxyquinoline; 4-Hydroxyquinaldic Acid; Quinurenic Acid; NSC 58973; 4-Hydroxyquinoline-2-carboxylic acid |
KYNURAMINE DIHYDROBROMIDE | 304-47-2 | C9H14Br2N2O | 326.03 | KYNURAMINE DIHYDROBROMIDE; 3-[2-AMINOPHENYL]-3-OXOPROPANAMINE DIHYDROBROMIDE; 3-(2-aminophenyl)-3-oxopropanamine |
KYL | 676657-00-4 | C74H108N14O17 | 1465.75 | L-Lysyl-L-tyrosyl-L-leucyl-L-prolyl-L-tyrosyl-L-tryptophyl-L-prolyl-L-valyl-L-leucyl-L-seryl-L-seryl-L-leucine |
KYA1797K | 1956356-56-1 | C17H11KN2O6S2 | 442.51 | potassium 3-[(5Z)-5-[[5-(4-nitrophenyl)furan-2-yl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoate |
KY1220 | 292168-79-7 | C14H10N4O3S | 314.32 | (5Z)-5-[[1-(4-nitrophenyl)pyrrol-2-yl]methylidene]-2-sulfanylideneimidazolidin-4-one |
KY02111 | 1118807-13-8 | C18H17ClN2O3S | 376.86 | N-(6-chlorobenzo[d]thiazol-2-yl)-3-(3,4-dimethoxyphenyl)propanamide |
KY 05009 | 1228280-29-2 | C18H16N4O2S | 352.41 | 5-(4-methylbenzamido)-2-(phenylamino)thiazole-4-carboxamide; 2-anilino-5-[(4-methylbenzoyl)amino]-1,3-thiazole-4-carboxamide |
KX2-391 dihydrochloride | 1038395-65-1 | C26H31Cl2N3O3 | 504.45 | |
KX2-391 | 897016-82-9 | C26H29N3O3 | 431.53 | KX01; KX2-391. |
KX1-141 | 1000706-00-2 | C24H20F2N2O2 | 406.425 | KX1-141; KX-1-141; KX 1-141 |
KX1-004 | 518058-84-9 | C16H13FN2O2 | 284.29 | KX1-004; KX 1-004; KX1 004 |
KW-3902 | 136199-02-5 | C20H28N4O2 | 356.46 | 1,3-dipropyl-8-(3-noradamantyl)xanthine, 8-(Hexahydro-2,5-methanopentalen-3a(1H)-yl)-3,7-dihydro-1,3-dipropyl-1H-purine-2,6-dione, MK-7418, Rolofylline |
KW-2478 | 819812-04-9 | C30H42N2O9 | 574.66 | |
KW-2450 Tosylate salt | 1360433-93-7 | C35H37N5O6S2 | 687.83 | (E)-N-(2-(2-(1H-indazol-3-yl)vinyl)-5-((4-(2-hydroxyacetyl)piperazin-1-yl)methyl)phenyl)-3-methylthiophene-2-carboxamide 4-methylbenzenesulfonate; 904899-25-8 (free base) |
KW-2449 | 1000669-72-6 | C20H20N4O | 332.407 | KW 2449. |
KT182 | 1402612-62-7 | C27H26N4O2 | 438.5 | [4-[4-[3-(hydroxymethyl)phenyl]phenyl]triazol-1-yl]-(2-phenylpiperidin-1-yl)methanone |
KT109 | 1402612-55-8 | C27H26N4O | 422.5 | (4-([1,1'-Biphenyl]-4-yl)-1H-1,2,3-triazol-1-yl)(2-benzylpiperidin-1-yl)methanone |
KT 5926 | 126643-38-7 | C30H27N3O6 | 525.55 | 9-hydroxy-9-methoxycarbonyl-8-methyl-14-n-propoxy-2,3,9,10-tetrahydro-8,11-epoxy-1H,8H,11H-2,7b,11a-triazadibenzo(a,g)cycloocta[cde]trinden-1-on; KT-5926; KT5926 |
KS176 | 1253452-78-6 | C22H19N3O5 | 405.40 | KS176; KS 176; ZINC86032128; AKOS024458013; CS-5435; HY-19753 |
KRYPTOFIX(R) 221 | 31364-42-8 | C16H32N2O5 | 332.44 | KRYPTOFIX 221; KRYPTOFIX(R) 221; 4,7,13,16,21-PENTAOXA-1,10-DIAZABICYCLO[8.8.5]TRICOSANE; 4,7,16,21-Pentaoxa-1,10-diazabicyclo[8.8.5.]tricosane; 4,7,13,16,21-pentaoxa-1,10-*diazabicyclo(8.8.5)tr; 4,7,13,16,21-pentaoxa-1,10-diazabicylco-(8.8.5)tricosane |
KRYPTOFIX(R) 211 | 31250-06-3 | C14H28N2O4 | 288.38 | 4,7,13,18-TETRAOXA-1,10-DIAZABICYCLO[8.5.5]EICOSANE; KRYPTOFIX 211; KRYPTOFIX(R) 211; 4,7,13,18-tetraoxa-1,10-diazabicyclo[8.5.5]icosane; KRYPTOFIX 211 95+%; cryptating agent 211; [2.1.1]Cryptand; 4,10-(Ethylenebisoxybisethylene)-1,7-dioxa-4,10-diazacyclo |
KRX-0402 | 1000874-21-4 | C12H11N5O | 241.254 | KRX-0402; O6-benzyl guanine,O6-BG |
kobe2602 | 454453-49-7 | C14H9F4N5O4S | 419.31 | |
Kobe0065 | 436133-68-5 | C15H11ClF3N5O4S | 449.79 | |
Koaburaside | 41653-73-0 | C14H20O9 | 332.3 | (-)-3,5-Dimethoxy-4-hydroxyphenyl beta-D-glucopyranoside |
Ko 143 | 461054-93-3 | C26H35N3O5 | 469.57 | |
KNK437 | 218924-25-5 | C13H11NO4 | 245.23 | KNK-437; KNK 437. |
KN-93 Phosphate | 1188890-41-6 | C26H32ClN2O8PS | 599.03 | (E)-N-(2-(((3-(4-chlorophenyl)allyl)(methyl)amino)methyl)phenyl)-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide phosphate; KN93; KN 93; KN-93; KN-93 phosphate |
KN-93 hydrochloride | 1956426-56-4 | C26H29ClN2O4S·HCl | 537.5 | KN-93 HCl; N-[2-[[[(E)-3-(4-chlorophenyl)prop-2-enyl]-methylamino]methyl]phenyl]-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide hydrochloride |
KN-93 | 139298-40-1 | C26H29ClN2O4S | 501.04 | KN 93; KN93 |
KN-92 phosphate | 1135280-28-2 | C24H28ClN2O7PS | 554.98 | |
KN-92 hydrochloride | 1431698-47-3 | C24H26Cl2N2O3S | 493.45 | KN 92 hydrochloride; KN92 hydrochloride |
KN-92 | 176708-42-2 | C24H25ClN2O3S | 456.98 | KN 92; KN92 |
KN-62 | 127191-97-3 | C38H35N5O6S2 | 721.84 | N/A |
KN 93 | 1188890-40-5 | C26H29ClN2O4S | 501.04 | Methoxybenzene-sulfonamide; N-[2-[[[(E)-3-(4-chlorophenyl)prop-2-enyl]-methylamino]methyl]phenyl]-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide |
KML-29 | 1380424-42-9 | C24H21F6NO7 | 549.42 | KML29; SCHEMBL15100615; SXHQLPHDBLTFPM-UHFFFAOYSA-N; BDBM179929; IN2183; ZINC97949367 |
Kmeriol | 54306-10-4 | C12H18O5 | 242.272 | 3-(3,4,5-Trimethoxyphenyl)propane-1,2-diol; 3-(3,4,5-Trimethoxyphenyl)-1,2-propanediol |
KM11060 | 774549-97-2 | C19H17Cl2N3O2S | 422.324 | KM11060; KM-11060; KM 11060. |
KM 233 | 628263-22-9 | C25H30O2 | 362.5 | 6,6,9-Trimethyl-3-(2-phenylpropan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol |
KLS-13019 | 1801243-39-9 | C22H29NO3 | 355.48 | KLS-13019; KLS 13019; KLS13019; 1-(3-(((1'R,2'R)-2,6-dihydroxy-5'-methyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-4-yl)methyl)azetidin-1-yl)ethan-1-one |
KLH 45 | 1632236-44-2 | C24H25F3N4O2 | 458.48 | N-Cyclohexyl-N-(2-phenylethyl)-4-[4-(trifluoromethoxy)phenyl]-2H-1,2,3-triazole-2-carboxamide |
KL001 | 309928-48-1 | C21H22N2O4S | 398.48 | MLS000110334; N-(3-(9H-carbazol-9-yl)-2-hydroxypropyl)-N-(furan-2-ylmethyl)methanesulfonamide; N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(furan-2-ylmethyl)methanesulfonamide; |
KKL-35 | 865285-29-6 | C15H9ClFN3O2 | 317.7 | 4-chloro-N-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]benzamide; F1374-0110; 4-chloro-N-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)benzamide |
KKL-10 | 952849-76-2 | C14H10BrN3O2S | 364.22 | 5-bromo-N-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]thiophene-2-carboxamide; 5-bromo-N-(5-(p-tolyl)-1,3,4-oxadiazol-2-yl)thiophene-2-carboxamide; 5-bromo-N-[5-(p-tolyl)-1,3,4-oxadiazol-2-yl]thiophene-2-carboxamide |
KJ Pyr 9 | 581073-80-5 | C22H15N3O4 | 385.4 | 4-[2-(2-Furanyl)-6-(4-nitrophenyl)-4-pyridinyl]benzamide; |
Kizuta saponin K11 | 97240-03-4 | C61H98O27 | 1263.41 | |
Kitasamycin Tartrate | 37280-56-1 | C40H67NO18 | 936.06 | leucomycin,(r-(r*,r*))-2,3-dihydroxybutanedioate(salt); leucomycintartrate; Tartarickitasamycin; KITASAMYCIN TARTRATE; KITASAMYCINTRTARATE; Leucomycin, (2R,3R)-2,3-dihydroxybutanedioate (salt) (9CI); kitasamycine tartrate; 2-[(2R,4E,6E,8R,9R,11R,12S,13S,1 |
Kisspeptin-10 | 374675-21-5 | C63H83N17O14 | 1302.44 | Metastin (45-54); Kp-10 |
Kisspeptin 234 | 1145998-81-7 | C63H78N18O13 | 1295.42 | |
Kisspeptin 10 (rat) | 478507-53-8 | C63H83N17O15 | 1318.45 | |
KIC-arginine | 72087-40-2 | C12H24N4O5 | 304.34276 | |
Kibdelone C | 934464-79-6 | C29H28ClNO10 | 586.0 | |
Kibdelone B | 934464-78-5 | C29H26ClNO10 | 584.0 | |
Kibdelone A | 934464-77-4 | C29H24ClNO10 | 582.0 | |
Ki8751 | 228559-41-9 | C24H18F3N3O4 | 469.41 | Ki8751; Ki-8751; Ki 8751 |
KI-7 | 1489263-00-4 | C23H18N2O2 | 354.4 | KI-7; alpha-Oxo-N-phenyl-1-(phenylmethyl)-1H-indole-3-acetamide |
KI-328 | 930089-25-1 | C25H25N7O3 | 471.511 | KI-328; KI 328; KI328. |
Ki23057 | 516523-31-2 | C30H35N3O4 | 501.627 | Ki23057; Ki-23057; Ki 23057. |
Ki20227 | 623142-96-1 | C24H24N4O5S | 480.54 | |
Khellactone | 24144-61-4 | C14H14O5 | 262.26 | |
KH-CB19 | 1354037-26-5 | C15H13Cl2N3O2 | 338.19 | KH-CB19; KH CB19; Ethyl 3-[(E)-2-Amino-1-Cyanoethenyl]-6,7-Dichloro-1-Methyl-1h-Indole-2-Carboxylate; 2wu7; GTPL8055; 3761AH |
Khayalenoid E | 1220508-29-1 | C29H34O9 | 526.6 | Methyl (2S)-acetoxy[(1R,2S,5R,6R,10S,13S,16S)-6-(3-furyl)-1,5,15,15-tetramethyl-8,14,17-trioxo-7-oxatetracyclo[11.3.1.02,11.05,10]heptadec-11-en-16-yl]acetate |
KGA2727 | 666842-36-0 | C26H40N4O8 | 536.63 | KGA-2727;3-(3-{4-[3-(beta-D-glucopyranosyloxy)-5-isopropyl-1Hpyrazol-4-ylmethyl]-3-methylphenoxy}propylamino)propionamide |
KG 5 | 877874-85-6 | C20H16F3N7OS | 459.45 | 2-(Methylthio)-6-[4-[5-[[3-(trifluoromethyl)phenyl]amino]-1H-1,2,4-triazol-3-yl]phenoxy]-4-pyrimidinamine; 2-Methylsulfanyl-6-[4-[3-[3-(trifluoromethyl)anilino]-1H-1,2,4-triazol-5-yl]phenoxy]pyrimidin-4-amine |
KFM19 | 133058-72-7 | C16H22N4O3 | 318.37 | 8-(3-oxocyclopentyl)-1,3-dipropyl-7H-purine-2,6-dione; ((S)-(-)-8-(3-oxocyclopentyl)-1,3-dipropyl-7H-purine-2,6-dione) 1H-Purine-2,6-dione, 3,7-dihydro-8-(3-oxocyclopentyl)-1,3-dipropyl-; BIIP 20; BIIP-20; KFM 19; KFM-19 |
KF-58333 | 308244-21-5 | C24H27ClN2O7 | 490.93 | |
KF-55823 | 452083-20-4 | C24H27ClN2O7 | 490.94 | |
KF-25706 | 184537-25-5 | C18H18ClNO6 | 379.79 | |
KF21213 | 155271-17-3 | C19H22N4O3 | 354.4 | 8-[2-(4-methoxy-2,3-dimethylphenyl)ethenyl]-1,3,7-trimethylpurine-2,6-dione; 8-(2,3-dimethyl-4-methoxystyryl)-1,3,7-trimethylxanthine; KF 21213; KF-21213; KF21213 |
KF 38789 | 257292-29-8 | C19H21NO5S | 375.44 | 3-[7-(2,4-Dimethoxyphenyl)-2,3,6,7-tetrahydro-1,4-thiazepin-5-yl]-4-hydroxy-6-methyl-2H-pyran-2-one |
KF 13218 | 127654-03-9 | C20H20N2O3 | 336.38 | (6Z)-6-(6-methyl-5-oxopyrido[4,3-c][1]benzazepin-11-ylidene)hexanoic acid; 11-(5-carboxypentylidene)-6-methyl-5,11-dihydropyrido(4,3-c)(1)benzazepin-5(6H)-one; KF 13218; KF-13218; KF13218 |
Keycure 8179 | 119344-86-4 | C24H32N2O2 | 380.52 | |
Kevetrin hydrochloride | 66592-89-0 | C5H10ClN3S | 179.66 | UNII-NL6L2371DP; thioureidobutyronitrile; 3-cyanopropyl carbamimidothioate;hydrochloride; Carbamimidothioic acid, 3-cyanopropyl ester, monohydrochloride |
Kevetrin | 500863-50-3 | C5H12N2S | 132.227 | Kevetrin; thioureidobutyronitrile; thioureido butyronitrile |
Ketotriclabendazole | 1201920-88-8 | 5-Chloro-6-(2,3-dichloro- phenoxy)-1,3-dihydro- benzoimidazol-2-one | ||
Ketotifen Impurity G | 43076-16-0 | C19H17NO2S | 323.42 | 9,10-Dioxo Ketotifen; 4-(1-Methyl-4-piperidinylidene)-4H-benzo[4,5]cyclohepta[1,2-b]thiophene-9,10-dione; |
Ketotifen Impurity E | 34580-09-1 | C19H19NOS | 309.43 | 9-Oxo Ketotifen; 4,10-Dihydro-4-(1-methyl-4-piperidinylidene)-9H-benzo[4,5]cyclohepta[1,2-b]thiophen-9-one; |
Ketotifen Impurity D | 88456-70-6 | C19H19NO2S | 325.43 | Ketotifen N-Oxide; 4,9-Dihydro-4-(1-methyl-1-oxido-4-piperidinylidene)-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one; 4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo [4,5]cyclohepta[1,2-b]thiophen-10-one N-Oxide; |
Ketotifen Impurity C | 126939-27-3 | C19H21NO2S | 327.45 | 4-Hydroxy Ketotifen; 4,9-Dihydro-4-hydroxy-4-(1-methyl-4-piperidinyl)-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one; |
Ketotifen Impurity B | 59743-88-3 | C20H23NO2S | 341.48 | 4-Hydroxy-9,10-dehydro-10-methoxy Ketotifen; 10-Methoxy-4-(1-methyl-4-piperidinyl)-4H-benzo[4,5]cyclohepta[1,2-b]thiophene-4-ol; |
Ketotifen Fumarate | 34580-14-8 | C19H19NOS.C4H4O4 | 425.5 | Zaditen; Zaditor |
Ketotifen | 34580-13-7 | C19H19NOS | 309.426 | 10h-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one,4,9-dihydro-4-(1-methyl-4-piper; 4-(1-Methyl-4-piperidinylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one; |
Ketorolaco | 66635-83-4 | C15H13NO3 | 255.27 | 1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro-;5-Benzoyl-1,2-dihydro-3H-pyrrolo(1,2A)pyrrole-1-carboxylic acid;Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid;Ketorolacum;5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid;Toradol;Acular |
Ketorolac-d5 | 1215767-66-0 | C15H8NO3D5 | 260.31 | (±)-5-Benzoyl-d5-2,3-dihydro-1H-pyrrolizine-1-carboxylic Acid; (±)-Ketorolac-d5 |
Ketorolac Impurity I | 113502-55-9 | C14H13NO | 211.27 | 1-Descarboxy Ketorolac; 2,3-Dihydro-1H-pyrrolizin-5-yl)phenylmethanone; USP Ketorolac Related Compound D; |
Ketorolac Impurity G | 1391051-90-3 | C16H15NO4 | 285.30 | rac 1-Hydroxy Ketorolac Methyl Ester; 5-Benzoyl-1-hydroxy-2,3-dihydro-1H-pyrrolizine-1-carboxylic Acid Methyl Ester; |
Ketorolac Impurity F | 1391052-68-8 | C15H13NO3 | 255.28 | rac Ketorolac 7-Benzoyl Isomer; 7-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic Acid; |
Ketorolac Impurity E | 167105-80-8 | C19H22N2O5 | 358.40 | rac Ketoroloc Tris Amide Impurity; (±)-5-Benzoyl-2,3-dihydro-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]-1H-pyrrolizine-1-carboxamide; |
Ketorolac Impurity D | 1391053-45-4 | C16H15NO4 | 285.30 | rac 1-Methoxy Ketorolac; 5-Benzoyl-1-methoxy-2,3-dihydro-1H-pyrrolizine-1-carboxylic Acid |
Ketorolac Impurity C | 1026936-07-1 | C15H13NO3 | 255.28 | rac Ketorolac 6-Benzoyl Isomer; 6-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic Acid; (1RS)-6-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid |
Ketorolac Impurity A | 154476-25-2 | C14H13NO2 | 227.27 | Descarboxy 1-Hydroxy Ketorolac; (2,3-Dihydro-1-hydroxy-1H-pyrrolizin-5-yl)phenylmethanone; USP Ketorolac Related Compound B; |
Ketorolac | 74103-06-3 | C15H13NO3 | 255.27 | Acular LS; RS37619; RS 37619; RS-37619; Sprix; Toradol |
Ketorolac | 74103-07-4 | C15H13N1O3 | 255.27 | |
Ketorfanol | 79798-39-3 | C20H25NO2 | 311.422 | |
Ketoprofen-d3 | 159490-55-8 | 2-(3-Benzoyl-phenyl)- propionic acid-D3 | ||
Ketoprofen Sodium Salt | 57495-14-4 | C16H13NaO3 | 276.26 | sodium 2-(3-benzoylphenyl)propionate |
Ketoprofen Related Compound D | 66067-44-5 | C15H12O2 | 224.26 | 3-Acetylbenzophenone 1-(3-Benzoylphenyl)ethanone 3-Benzoylacetophenone m-Benzoylacetophenone |
Ketoprofen Lysinate | 57469-78-0 | C22H28N2O5 | 400.47 | 2-(3-Benzoylphenyl)propanoic acid lysine salt |
Ketoprofen Impurity I | 21288-34-6 | C15H11NO | 221.26 | 3-Benzoylbenzeneacetonitrile; m-Benzoylphenylacetonitrile; 3-(Cyanomethyl)benzophenone; |
Ketoprofen Impurity B | 22071-22-3 | C15H12O3 | 240.26 | 3-Benzoylphenylacetic Acid; Desmethyl Ketoprofen; 2-(3-Benzoylphenyl)acetic Acid; |
Ketoprofen | 22071-15-4 | C16H14O3 | 254.28 | RP-19583; RP 19583; RP19583 |
Ketopinic acid | 464-78-8 | C10H14O3 | 182.22 | Bicyclo[2.2.1]heptane-1-carboxylic acid, 7,7-dimethyl-2-oxo-; 2-Oxo-7,7-dimethylbicyclo[2.2.1]heptane-1-carboxylic acid; 2-Oxobornane-10-oic acid; 7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxylic acid; Ketopinic acid |
Ketone Ester | 1208313-97-6 | C8H16O4 | 176.21 | Ketone Ester |
Ketomalonic acid | 473-90-5 | C3H2O5 | 118.04 | |
Ketohakonanol | 18004-20-1 | C29H48O2 | 428.701 | |
Keto-D-fructose phthalazin-1-ylhydrazone | 1082040-10-5 | C14H18N4O5 | 322.32 | |
Kemptide | 65189-71-1 | C32H61N13O9 | 771.91 | H-Leu-Arg-Arg-Ala-Ser-Leu-Gly-OH; L-leucyl-L-arginyl-L-arginyl-L-alanyl-L-seryl-L-leucyl-glycine; 2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino |
KEMP'S TRIACID | 79410-20-1 | C12H18O6 | 258.27 | CIS,CIS-1,3,5-TRIMETHYLCYCLOHEXANE-1,3,5-TRICARBOXYLIC ACID; KEMP'S TRIACID; cis,cis-1,3,5-trime.cyclohexane-1,3,5-tricarboxylic acid; 1,3,5-Trimethyl-1,3,5-cyclohexanetricarboxylicacid(Kemp'striacid); Aluminum oxide, fused, #200+325 mesh, 99+% metals bas |
Kelampayoside A | 87562-76-3 | C20H30O13 | 478.5 | 3,4,5-Trimethoxyphenyl 6-O-D-apio-beta-D-furanosyl-beta-D-glucopyranoside |
Kebuzone | 853-34-9 | C19H18N2O3 | 322.36 | 4-(3-Oxobutyl)-1,2-diphenyl-3,5-pyrazolidinedione; 1,2-Diphenyl-4-(2-acetylethyl) pyrazolidine-3,5-dione; Chebutan; Chepirol; Chetazol; Chetazolidin; Chetil; Chetopir; Copirene; Ejor; Gammachetone; KPB; Ketanol; Ketason; Ketazon; Ketazone; Ketophenylbutaz |
KDU691 | 1513879-19-0 | C22H18ClN5O2 | 419.86 | HY-12912; N-(4-chlorophenyl)-N-methyl-3-[4-(methylcarbamoyl)phenyl]imidazo[1,2-a]pyrazine-6-carboxamide |
KDR-in-4 | 408502-06-7 | C23H25N3O3 | 391.46 | 3-[5-[2-[2-methoxyethyl(methyl)amino]ethoxy]-1H-indol-2-yl]-1H-quinolin-2-one |
KB-R7943 mesylate | 182004-65-5 | C17H21N3O6S2 | 427.49 | KB-R7943; KB R7943; KB-R 7943; KB-R7943 mesylate |
kb-NB77-78 | 1350622-33-1 | C18H25NO3Si | 331.48 | 9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1,2,3,4-tetrahydro-5H-[1]benzopyrano[3,4-b]pyridin-5-one; kb-NB77-78; kb-NB-77-78; kb-NB 77-78; kb-NB7778; kb-NB-7778; kb-NB 7778; |
KBC-007 | 1037297-61-2 | C46H92N2O9 | 817.23 | 8-(Diheptylamino)-N-[(2S,3S,4R)-3,4-dihydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]octanamide |
KB3022 | 101001-34-7 | C25H24N2O4S | 448.53 | ethyl 2-[2-[4,5-bis(4-methoxyphenyl)-1,3-thiazol-2-yl]pyrrol-1-yl]acetate; 1H-Pyrrole-1-acetic acid, 2-(4,5-bis(4-methoxyphenyl)-2-thiazolyl)-, ethyl ester; ethyl 2-(4,5-bis(4-methoxyphenyl)thiazol-2-yl)pyrrol-1-ylacetate; KB 3022; KB-3022; KBT-3022 |
KB SRC 4 | 1380088-03-8 | C32H23ClN8 | 555.03 | 1-[3-[1-([1,1'-Biphenyl]-3-ylmethyl)-1H-1,2,3-triazol-5-yl]phenyl]-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
kb NB 142-70 | 1233533-04-4 | C11H9NO2S2 | 251.32 | kb-NB142-70 |
Kazusamycin B | 107140-30-7 | C32H46O7 | 542.7 | Hydroxyleptomycin A, CL 1957E, PD 124895, PD 124,895 |
Kazusamycin A | 92090-94-3 | C33H48O7 | 556.7 | Kazusamycin, Hydroxyleptomycin B, Hydroxyelactocin, CL 1957B, PD 114721 |
Kazinol U | 1238116-48-7 | C20H22O4 | 326.39 | 4-[(2R)-3,4-Dihydro-7-hydroxy-2H-1-benzopyran-2-yl]-3-(3-methyl-2-buten-1-yl)-1,2-benzenediol |
Kazinol B | 99624-27-8 | C25H28O4 | 392.5 | (2S)-2',2'-dimethyl-7'-(3-methylbut-2-en-1-yl)-3,4-dihydro-2H,2'H-2,6'-bichrom ene-7,8'-diol |
Kavain | 3155-48-4 | C14H14O3 | TRANS-5,6-DIHYDRO-4-METHOXY-6-(2-PHENYLETHENYL)-2H-PYRAN-2-ONE; DL-KAVAIN; DL-KAWAIN; KAWAIN; KAVAIN, DL-; KAVAIN, D/L-(P); METHYSTICIN SNAP-N-SHOOT 0.1mg/mL(P); METHYSTICIN(P) | |
Kavain | 500-64-1 | C14H14O3 | 230.26 | Kawain; (+)-Kavain; (2R)-4-methoxy-2-[(E)-2-phenylethenyl]-2,3-dihydropyran-6-one |
Kauri Gum Solution | 77465-88-4 | |||
Kaurenoic acid | 6730-83-2 | C20H30O2 | 302.46 | (-)-Kaur-16-en-18-oic acid;Cunabic acid;Kaurane-16-ene-18-oic acid;ent-Kaur-16(17)-en-19-oic acid;ent-Kaur-16-en-19-oic acid;NSC 339145;Kaur-16-en-18-oic acid,(4a)- |
Kaurene | 34424-57-2 | C20H32 | 272.46808;g/mol | 34424-57-2 |
Kauran-18-olc acid,16,1719-tnhydroxy-,(4a) | 308821-59-2 | |||
Kauran-16,17-diol | 16836-31-0 | C20H34O2 | 306.5 | Kaurane-16,17-diol; Ent-kauran-16,17-diol |
Kaura-2,16-dien-1-one,15-(acetyloxy)-7,20-epoxy-6,7-dihydroxy-, (6b,7a,15b)- | 96850-29-2 | C22H28O6 | 388.5 | |
Kaur-16-en-15-one,18-(acetyloxy)-7,20-epoxy-1,6,7,14-tetrahydroxy-, (1b,4a,6b,7a,14R)- | 304642-94-2 | C22H30O8 | 422.5 | |
Kauniolide | 81066-45-7 | C15H18O2 | 230.3 | |
Karenitecin | 203923-89-1 | C25H28N2O4Si | 448.594 | BNP 1350; Cositecan, 7-Trimethylsilylethylcamptothecin; BNP-1350; |
KARBUTILATE | 4849-32-5 | C14H21N3O3 | 279.33 | 3-(3,3-DIMETHYLUREIDO)PHENYL-TERT-BUTYLCARBAMATE; KARBUTILATE; KARBUTYLAT; KARBUTYLATE; 1,1-dimethyl-3-(3-(n-tert-butylcarbamyloxy)phenyl)urea; 3-(((dimethylamino)carbonyl)amino)phenyl1,1-dimethylethylcarbamate |
Karavilagenin D | 934739-29-4 | C30H46O4 | 470.694 | |
Karavilagenin A | 912329-03-4 | C32H54O3 | 486.781 | 3-Hydroxy-7,25-dimethoxycucurbita-5,23-diene |
Karanjin | 521-88-0 | C18H12O4 | 292.29 | 3-METHOXY-2-PHENYL-4H-FURO[2,3-H]-1-BENZOPYRAN-4-ONE; KARANJIN; karanjin from pongamia glabra oil; 2-Phenyl-3-methoxy-4H-furo[2,3-h]-1-benzopyran-4-one; Kranjin; 3-methoxy-2-phenyl-furo[2,3-h]chromen-4-one; 3-methoxy-2-phenylfuro[2,3-h]chromen-4-one; NSC |
kappa-Cyclodextrin | 156510-99-5 | Cyclomaltopentadecaose; CD15 | ||
KAI-407 | 1513879-18-9 | C22H14F3N5O | 421.38 | KAI-407; KAI 407; KAI407; N-(4-cyanophenyl)-N-methyl-3-(4-(trifluoromethyl)phenyl)imidazo[1,2-a]pyrazine-6-carboxamide |
Kahweofuran | 26693-24-3 | C7H8OS | 140.20 | kahweofuran; TomatoLycopene; Spicery; 2,3-Dihydro-6-methylthieno[2,3-c]furan; 6-Methyl-2,3-dihydrothieno[2,3-c]furan |
Kahalalide F | 149204-42-2 | C75H124N14O16 | 1477.899 | Kahalalide F; PM-92102. |
Kaerophyllin | 75590-33-9 | C21H20O6 | 368.4 | (3E,4R)-4-(1,3-benzodioxol-5-ylmethyl)-3-[(3,4-dimethoxyphenyl)methylidene]oxolan-2-one |
KaempferoL-4-glucoside | 52222-74-9 | |||
Kaempferol-3-O-glucosyl(1-2)rhamnoside | 142451-65-8 | C27H30O15 | 594.52 | Kemp-glu-rham |
Kaempferol-3-O-(6''-O-cis-coumaryl)glucoside | 163956-16-9 | C30H26O13 | 594.52 | cis-Tiliroside |
Kaempferol-3-O-(6-Malonyl-Glucoside) | 81149-02-2 | C24H22O14 | 534.43 | 3-[[(2R,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-3-oxopropanoic acid |
Kaempferol-3-O-(2',6'-di-O-trans-p-coumaroyl)-beta-D-glucopyranoside | 121651-61-4 | C39H32O15 | 740.66 | |
Kaempferol-3-Glucuronide | 22688-78-4 | C21H18O12 | 462.36 | 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-3-yl-beta-D-glucopyranosiduronic acid |
Kaempferide | 491-54-3 | C16H12O6 | 300.26 | Kaempferol 4'-O-methyl ether |
Kaempeerol-3-O-glucorhamnoside | 40437-72-7 | C27H30O15 | ||
Kadsurin A | 99340-07-5 | C21H24O6 | 372.4 | (2S,3R,3aS,7aR)-2-(1,3-Benzodioxol-5-yl)-3,3a,7,7a-tetrahydro-3a,7a-dimethoxy-3-methyl-5-(2-propenyl)-6(2H)-benzofuranone |
Kadsuric acid | 62393-88-8 | C30H46O4 | 470.7 | 3,4-secolanosta-4(28),9(11),24Z-triene-3,26-dioic acid; (Z,6R)-6-[(3aR,6S,7S,9aS,9bS)-6-(2-carboxyethyl)-3a,6,9b-trimethyl-7-prop-1-en-2-yl-1,2,3,4,7,8,9,9a-octahydrocyclopenta[a]naphthalen-3-yl]-2-methylhept-2-enoic acid |
Kadsurenin D | 140669-89-2 | C21H24O5 | 356.412 | (1S,5S,6R,7R)-5-allyl-7-(3,4-dimethoxyphenyl)-3-methoxy-6-methylbicyclo[3.2.1]oct-3-ene-2,8-dione |
Kadsuracoccinic acid A | 1016260-22-2 | C30H44O4 | 468.678 | |
KAAD-Cyclopamine | 306387-90-6 | C44H63N3O4 | 697.99 | |
K-858 | 72926-24-0 | C13H15N3O2S | 277.34 | K-858; K 858; K858. |
K-7174 dihydrochloride | 191089-60-8 | C33H50Cl2N2O6 | 641.67 | 1,4-bis((E)-5-(3,4,5-trimethoxyphenyl)pent-4-en-1-yl)-1,4-diazepane dihydrochloride; K7174; K 7174; K-7174; K-7174-2HCl; K-7174 dihydrochloride |
K-7174 | 191089-59-5 | C33H48N2O6 | 568.74 | K-7174; K 7174; K7174 |
K6PC-5 | 756875-51-1 | C19H37NO4 | 343.5 | Dihydroxyisopropyl capryloylcaprylamide; Decanamide, 2-hexyl-N-(2-hydroxy-1-(hydroxymethyl)ethyl)-3-oxo |
K252C | 85753-43-1 | C20H13N3O | 311.40 | Staurosporine aglycone;Staurosporinone |
K252A | 99533-80-9 | C27H21N3O5 | 467.50 | NZ0550000 |
K252A | 99570-78-2 | C26H19N3O5 | 453.5 | SF 2370 |
K145 hydrochloride | 1449240-68-9 | C18H25ClN2O3S | 384.92 | SphK2 inhibitor; K 145 hydrochloride; K-145 hydrochloride |
K145 | 1309444-75-4 | C18H24N2O3S | 348.46 | SphK2 inhibitor; K 145; K-145 |
K134 | 189362-06-9 | C22H29N3O4 | 399.48 | 1-cyclopropyl-1-[(1R,2R)-2-hydroxycyclohexyl]-3-[3-[(2-oxo-1H-quinolin-6-yl)oxy]propyl]urea; 6-(3-(3-cyclopropyl-3-(2-hydroxycyclohexyl)ureido)propoxy)-2(1H)-quinolinone; K 134 compound; K-134 compound; K134 compound; OPC 33509; OPC-33509; K-134 |
K-11777 | 233277-99-1 | C32H38N4O4S | 574.74 | 4-methyl-N-((S)-1-oxo-3-phenyl-1-(((S,E)-5-phenyl-1-(phenylsulfonyl)pent-1-en-3-yl)amino)propan-2-yl)piperazine-1-carboxamide; APC-3316; APC3316; APC 3316; K-11777; K 11777; K11777; K 777; K-777; K777; CRA-3316; CRA3316; CRA 3316 |
K-115 | 223645-67-8 | C15H18FN3O2S | 323.39 | 4-fluoro-5-[[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl]isoquinoline Glanatec K-115 K115 compound ripasudil |
K03861 | 853299-07-7 | C24H26F3N7O2 | 501.5 | |
K02288 | 1431985-92-0 | C20H20N2O4 | 352.38 | K-02288; 3-(6-amino-5-(3,4,5-trimethoxyphenyl)pyridin-3-yl)phenol |
K-(D-1-Nal)-FwLL-NH2 | 1394288-22-2 | C51H67N9O6 | 902.13 | L-Lysyl-3-(1-naphthalenyl)-D-alanyl-L-phenylalanyl-D-tryptophyl-L-leucyl-L-leucinamide |
K 579 | 440100-64-1 | C17H24N6O | 328.41 | (2S)-1-[[[4-Methyl-1-(2-pyrimidinyl)-4-piperidinyl]amino]acetyl]-2-pyrrolidinecarbonitrile; (S)-1-(4-Methyl-1-(2-pyrimidinyl)-4-piperidylamino)acetyl-2-pyrrolidinecarbonitrile; DPP IV Inhibitor IV |
K 114 | 872201-12-2 | C22H17BrO2 | 393.27 | 4,4'-[(2-Bromo-1,4-phenylene)di-(1E)-2,1-ethenediyl]bisphenol; (trans,trans)-1-Bromo-2,5-bis-(4-hydroxy)styrylbenzene |
K 01-162 | 677746-25-7 | C15H14BrN | 288.19 | 7-bromo-N,N-dimethyl-9H-fluoren-2-amine; 9H-Fluoren-2-aMine, 7-broMo-N,N-diMethyl-; |
JZP-430 | 1672691-74-5 | C16H26N4O3S | 354.47 | JZP-430; JZP 430; JZP430; 4-morpholino-1,2,5-thiadiazol-3-yl cyclooctyl(methyl)carbamate |
JZP 361 | 1680193-80-9 | C22H20ClN5O | 405.88 | [4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinyl](1H-1,2,4-triazol-1-yl)methanone |
JZL195 | 1210004-12-8 | C24H23N3O5 | 433.46 | JZL 195; JZL-195 |
JZL184 | 1101854-58-3 | C27H24N2O9 | 520.49 | N/A |
JYL1421 | 401907-26-4 | C20H26FN3O2S2 | 423.6 | 3-[(4-Tert-butylphenyl)methyl]-1-[(3-fluoro-4-methanesulfonamidophenyl)methyl]thiourea |
JX 401 | 349087-34-9 | C21H25NO2S | 355.49 | 1-[2-Methoxy-4-(methylthio)benzoyl]-4-(phenylmethyl)piperidine; [2-Methoxy-4-(methylthio)phenyl][4-(phenylmethyl)-1-piperidinyl]-methanone; N-(2-Methoxy-4-thiomethyl)benzoyl-4-benzylpiperidine |
JX 06 | 729-46-4 | C10H16N2O2S4 | 324.51 | Bis(morpholinothiocarbonyl) Disulfide; 4,4'-(Dithiodicarbonothioyl)bis[morpholine]; 4-Morpholinethiocarbonyl Disulfide; Dimorpholinethiuram Disulfide; Disulfide, bis(4-Morpholinylthioxomethyl); NSC 402538; bis(Oxydi-2,1-ethanediyl)-thiuram Disulfide |
Junipediol B | 144881-19-6 | C10H12O4 | 196.2 | 2-(3,4-Methylenedioxyphenyl)propane-1,3-diol |
Junipediol A | 86548-91-6 | C10H14O4 | 198.22 | 2-Guaiacyl-1,3-propanediol |
Junicedric acid | 41787-69-3 | C20H32O4 | 336.47 | Mercusic acid; 13S-Dihydroagathic acid; (1S,4aR,5S,8aR)-5-[(3S)-4-carboxy-3-methylbutyl]-1,4a-dimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalene-1-carboxylic acid |
Juncutol | 1021950-14-0 | C18H18O2 | 266.34 | |
Juncusol | 62023-90-9 | C18H18O2 | 266.34 | 1,6-dimethyl-5-vinyl-9,10-dihydrophenanthrene-2,7-diol; 5-ethenyl-1,6-dimethyl-9,10-dihydrophenanthrene-2,7-diol |
Juncuenin D | 1161681-24-8 | C18H18O3 | 282.339 | |
Juncuenin B | 1161681-20-4 | C18H18O2 | 266.34 | |
Juncuenin A | 1161681-18-0 | C18H18O | 250.34 | |
Julolidine | 479-59-4 | C12H15N | 173.26 | JULOLIDINE; 2,3,6,7-TETRAHYDRO-1H,5H-BENZO[IJ]QUINOLIZINE; 2,3,6,7-TETRAHYDRO-1H,5H-PYRIDO[3.2.1-IJ]QUINOLINE; 1H,5H-BENZO[IJ]QUINOLIZINE, 2,3,6,7-TETRAHYDRO-; 5h-benzo[ij]quinolizine,2,3,6,7-tetrahydro-1; Julolidine,98%; 2,3,6,7-Tetrahydro-1H,5H-benzop[i |
Jujuboside D | 194851-84-8 | C58H94O26 | 1207.35 | Jujuboside A1 |
JTP 103237 | 1883864-16-1 | C24H29F3N6O | 474.52 | 7-[4,6-Bis(1,1-dimethylethyl)-2-pyrimidinyl]-5,6,7,8-tetrahydro-3-[4-(trifluoromethoxy)phenyl]-1,2,4-triazolo[4,3-a]pyrazine |
JSH-23 | 749886-87-1 | C16H20N2 | 240.35 | JSH-23; JSH 23; JSH23. |
JQEZ5 | 1913252-04-6 | C30H38N8O2 | 542.68 | N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-6-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide |
JQ-1 | 1268524-70-4 | C23H25ClN4O2S | 457 | (6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 1,1-dimethylethyl ester; (+)-JQ1; (+)-JQ-1; (+)-JQ 1; Bromodomain Inhibitor |
JPM-OEt | 262381-84-0 | C20H28N2O6 | 392.45 | |
JPH203 dihydrochloride | 1597402-27-1 | C23H19Cl2N3O4·2HCl | 545.24 | KYT 0353; O-[(5-Amino-2-phenyl-7-benzoxazolyl)methyl]-3,5-dichloro-L-tyrosine dihydrochloride; (2S)-2-amino-3-[4-[(5-amino-2-phenyl-1,3-benzoxazol-7-yl)methoxy]-3,5-dichlorophenyl]propanoic acid dihydrochloride |
JPH203 | 1037592-40-7 | C23H19Cl2N3O | 472.32 | KYT-0353;KYT0353;JPH-203;(S)-2-amino-3-(4-((5-amino-2-phenylbenzo[d]oxazol-7-yl)methoxy)-3,5-dichlorophenyl)propanoic acid |
JPC-211 | 82668-33-5 | C17H27NO2 | 277.41 | 234757-41-6(maleate); PNU-99194A free base;2,3-dihydro-5,6-dimethoxy-N,N-dipropyl- 1H-Inden-2-amine |
JP83 | 887264-44-0 | C26H28N2O3 | 416.5 | 3'-Carbamoyl-biphenyl-3-yl-hexylphenylcarbamate |
JP-4 (Jet Fuel) | 50815-00-4 | 0 | PETROLEUM-DERIVEDJP-4JETFUEL; PETROLEUMJP-4; SHALE-DERIVEDJP-4JETFUEL; JETFUELJP-4; SHALEJP-4 | |
JP104 | 887264-45-1 | C25H30N2O3 | 406.5 | 3'-Carbamoyl-biphenyl-3-yl-undecynecarbamate |
JP 1302 dihydrochloride | 1259314-65-2 | C24H24N4.2HCl | 441.40 | N-[4-(4-Methyl-1-piperazinyl)phenyl]-9-acridinamine dihydrochloride; N-[4-(4-Methyl-1-piperazinyl)phenyl]-9-acridinamine Hydrochloride (1:2) |
Jolkinolide E | 54494-34-7 | C20H28O2 | 300.44 | Helioscopinolide G; (4aR,10aR,11aR,11bR)-2,3,4,4a,5,6,10a,11,11a,11b-Decahydro-4,4,8,11b-tetramethyl-phenanthro[3,2-b]furan-9(1H)-one; (4aR)-2,3,4,4aalpha,5,6,10abeta,11,11aalpha,11b-Decahydro-4,4,8,11bbeta-tetramethylphenanthro[3,2-b]furan-9(1H)-one; (4a |
Jolkinol A | 62820-11-5 | C29H36O6 | 480.6 | 1a,1b,2,3,4,5,7a,8,8a,9,10,10a-Dodecahydro-2-hydroxy-6-(hydroxymethyl) -3,8,8,10a-tetramethyl-5-oxo-4aH-cyclopenta(3,4)cyclopropa(8,9)cycloun dec(1,2-b)oxiren-4a-yl ester |
jojoba oil from simmondsia chinensis | 61789-91-1 | jojobaoilfromsimmondsiachinensis; Jojobawax; WaxesandWaxysubstances,jojoba; OIL OF JOJOBA; OIL, JOJBA; EMALEX J J O-V; JOJOBA BEAN OIL; JOJOBAE OELUM | ||
JNK-IN-8 | 1410880-22-6 | C29H29N7O2 | 507.59 | |
JNK-IN-7 | 1408064-71-0 | C28H27N7O2 | 493.56 | JNK inhibitor |
JNK Inhibitor IX | 312917-14-9 | C20H16N2OS | 332.42 | TCS JNK 5a |
JNJ7925476 HCl | 109085-56-5 | C20H20ClN | 309.84 | Pyrrolo(2,1-a)isoquinoline, 6-(4-ethynylphenyl)-1,2,3,5,6,10b-hexahydro-, hydrochloride (1:1), (6R,10bS)-rel-;Pyrrolo(2,1-a)isoquinoline, 6-(4-ethynylphenyl)-1,2,3,5,6,10b-hexahydro-, hydrochloride, trans-;JNJ-7925476 HCl;(6S,10bR)-6-(4-ethynylphenyl)-1,2 |
JNJ-7777120 | 459168-41-3 | C14H16ClN3O | 277.75 | |
JNJ-7706621 | 443797-96-4 | C15H12F2N6O3S | 394.36 | JNJ-7706621; JNJ-7706621; JNJ-7706621 |
JNJ-64619178 | 2086772-26-9 | C22H23BrN6O2 | 483.36 | (1S,2R,3S,5R)-3-[2-(2-Amino-3-bromoquinolin-7-yl)ethyl]-5-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol |
JNJ-632 | 1572510-42-9 | C18H19FN2O4S | 378.42 | N-(4-fluoro-3-methylphenyl)-3-[[(3S)-oxolan-3-yl]sulfamoyl]benzamide |
JNJ-42259152 | 1301167-87-2 | C24H23FN4O | 402.46 | UNII-B1QHA9M0I6;2-((4-(1-(2-fluoroethyl)-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)-3,5-dimethylpyridine |
JNJ-42165279 hydrochloride | 1346528-52-6 | C18H17ClF2N4O3. HCl | ||
JNJ-42165279 | 1346528-50-4 | C18H17ClF2N4O3 | 410.81 | N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)methyl)piperazine-1-carboxamide; JNJ-42165279; JNJ 42165279; JNJ42165279 |
JNJ-42153605 | 1254977-87-1 | C22H23F3N4 | 400.44 | 3-(cyclopropylmethyl)-7-(4-phenylpiperidin-1-yl)-8-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine; 3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl(1,2,4)triazolo(4,3-a)pyridine; JNJ-42153605 |
JNJ-42041935 | 1193383-09-3 | C12H6ClF3N4O3 | 346.65 | JNJ-42041935; JNJ 42041935; JNJ42041935. |
JNJ-41443532 | 1228650-83-6 | C22H25F3N4O3S | 482.52 | N-(2-((1-(trans-4-hydroxy-4-(5-thiazolyl)cyclohexyl)-3-azetidinyl)amino)-2-oxoethyl)-3-(trifluoromethyl)Benzamide |
JNJ-40411813 | 1127498-03-6 | C20H25ClN2O | 344.88 | |
JNJ-40355003 | 1394894-41-7 | C23H23ClN4O2 | 422.91 | 4-((3-(4-chlorophenoxy)phenyl)methyl)-N-3-pyridinyl-1-Piperazinecarboxamide |
JNJ-39933673 hemihydrate | 1404307-42-1 | 2(C24H26FNO5).H2O | 872.95 | TA-1887 hemihydrate; (2R,3R,4S,5S,6R)-2-(3-(4-cyclopropylbenzyl)-4-fluoro-1H-indol-1-yl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol hemihydrate;1003005-29-5(Free); |
JNJ-39758979 dihydrochloride | 1620648-30-7 | C11H19N5·2HCl | 294.22 | 4-[(3R)-3-Amino-1-pyrrolidinyl]-6-(1-methylethyl)-2-pyridinamine dihydrochloride |
JNJ-39327041 | 1093069-32-9 | C31H42N6O5S | 610.77 | N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[7-(4-ethylpiperazin-1-yl)-3-oxo-1H-isoindol-2-yl]butyl]-1,2-dimethylimidazole-4-sulfonamide;JNJ39327041;1H-Imidazole-4-sulfonamide, N-((4R)-4-(3,4-dimethoxyphenyl)-4-(4-(4-ethyl-1-piperazinyl)-1,3-dihydro-1-oxo-2H-isoind |
JNJ-38877618 | 943540-74-7 | C20H12F2N6 | 374.35 | OMO-1; HY-111050; 6-[Difluoro-(6-pyridin-4-yl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinoline |
JNJ-38877605 | 943540-75-8 | C19H13F2N7 | 377.36 | |
JNJ-38877605 | 1072116-03-0 | C19H13F2N7 | 377.359 | JNJ-38877605 |
JNJ-31020028 | 1094873-14-9 | C34H36FN5O2 | 565.6 | JNJ31020028; JNJ 31020028; JNJ-31020028. |
JNJ-28312141 | 885692-52-4 | C26H32N6O2 | 460.582 | JNJ-28312141; JNJ28312141; JNJ 28312141. |
JNJ-26483327 | 807640-87-5 | C22H25BrN4O2 | 457.372 | JNJ-26483327; JNJ 26483327; JNJ26483327. |
JNJ26483327 | 1021686-80-5 | C22H27Br3N4O2 | 619.19 | (Z)-35-bromo-17-methoxy-5-methyl-13,14-dihydro-11-oxa-2,5-diaza-1(4,6)-quinazolina-3(1,2)-benzenacycloundecaphane;JNJ-26483327 |
JNJ-26146900 | 868691-50-3 | C15H15F3N2O3S | 360.35 | (-)(R)-2-(2-Ethylsulfonyl-1-hydroxy-1-methylethyl)-6-trifluoromethyl-1H-indole-5-carbonitrile |
JNJ26076713 | 669076-03-3 | C29H38N4O3 | 490.65 | JNJ-26076713;3-Quinolinepropanoic acid, 1,2,3,4-tetrahydro-beta-((1-(1-oxo-3-(1,5,6,7-tetrahydro-1,8-naphthyridin-2-yl)propyl)-4-piperidinyl)methyl)-, (betaS,3S)-;(3S)-4-[1-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propanoyl]piperidin-4-yl]-3-[(3S)-1,2 |
JNJ-2408068 | 317846-22-3 | C22H30N6O | 394.52 | 2-[[2-[[1-(2-aminoethyl)piperidin-4-yl]amino]-4-methylbenzimidazol-1-yl]methyl]-6-methylpyridin-3-ol; |
JNJ-19567470 | 724471-26-5 | C22H27BrN4O | 443.38 | TAI-041;R-317573;1-(7-(4-bromo-2,6-dimethylphenyl)-2,5-dimethyl-7H-pyrrolo(2,3-d)pyrimidin-4-yl)-4-Piperidinemethanol |
JNJ-17203212 | 821768-06-3 | C17H15F6N5O | 419.32 | 4-[3-(Trifluoromethyl)-2-pyridinyl]-N-[5-(trifluoromethyl)-2-pyridinyl]-1-piperazinecarboxamide;1-PiperazinecarboxaMide, 4-[3-(trifluoroMethyl)-2-pyridinyl]-N-[5-(trifluoroMethyl)-2-pyridinyl]-;N1-(3-Trifluoromethylpyrid-2-yl)-N4-(4-trifluoromethylpyrid-2 |
JNJ17156516 sodium | 648861-58-9 | C26H21Cl2N2NaO3 | 503.35 | JNJ-17156516 sodium;1H-Pyrazole-3-propanoic acid, 5-(3,4-dichlorophenyl)-1-(4-methoxyphenyl)-alpha-(3-methylphenyl)-, sodium salt (1:1), (alphaS)-;(S)-3-(5-(3,4-Dichlorophenyl)-1-(4-methoxyphenyl)-1H-pyrazol-3-yl)-2-(3-methylphenyl)propionic acid sodium s |
JNJ17156516 | 649551-06-4 | C26H22Cl2N2O3 | 481.37 | JNJ-17156516;(S)-3-(5-(3,4-Dichlorophenyl)-1-(4-methoxyphenyl)-1H-pyrazol-3-yl)-2-(3-methylphenyl)propionic acid |
JNJ-1661010 | 681136-29-8 | C19H19N5OS | 365.45 | Cobalamin, Cyanocobalamin |
JNJ-1250132 | 240805-96-3 | C33H41NO4 | 515.68 | [(8S,11R,13S,14S,17R)-17-acetyl-13-methyl-3-oxo-11-(4-piperidin-1-ylphenyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate; JNJ-1250132; JNJ 1250132; JNJ1250132 |
JNJ-10397049 | 708275-58-5 | C19H20Br2N2O3 | 484.19 | 1-(2,4-Dibromophenyl)-3-((4S,5S)-2,2-dimethyl-4-phenyl-(1,3)dioxan-5-yl)urea |
JNJ-10329670 | 400797-24-2 | C30H34ClF3N6O3S | 651.14 | 1-(3-(4-(6-chloro-2,3-dihydro-3-methyl-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl)propyl)-4,5,6,7-tetrahydro-5-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-1H-Pyrazolo(4,3-C)pyridine |
JNJ10311795 | 518062-14-1 | C40H35N2O6P | 670.70 | JNJ-10311795;[2-[3-[Methyl-[1-(naphthalene-2-carbonyl)piperidin-4-yl]carbamoyl]naphthalen-2-yl]-1-naphthalen-1-yl-2-oxoethyl]phosphonic acid;Phosphonic acid, (2-(3-((methyl(1-(2-naphthalenylcarbonyl)-4-piperidinyl)amino)carbonyl)-2-naphthalenyl)-1-(1-naph |
JNJ-10258859 | 374927-03-4 | C30H24N4O3 | 488.54 | (3R)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-[5-(4-methoxyphenyl)pyrimidin-2-yl]-3,4-dihydro-1H-pyrrolo[3,4-b]quinolin-9-one; |
JNJ10229570 | 524923-88-4 | C22H19N3O2S | 389.47 | JNJ-10229570;2,3-Bis(2-methoxyphenyl)-N-phenyl-1,2,4-thiadiazol-5-imine;Benzenamine, N-(2,3-bis(2-methoxyphenyl)-1,2,4-thiadiazol-5(2H)-ylidene)- |
JNJ10198409 | 627518-40-5 | C18H16FN3O2 | 325.343 | PDGFR Tyrosine Kinase Inhibitor IV; PDGF Receptor Tyrosine Kinase Inhibitor IV; N-(3-fluorophenyl)-6,7-dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-amine |
JNJ-10191584 | 73903-17-0 | C13H15ClN4O | 278.74 | VUF-6002;(5-Chloro-1H-benzimidazol-2-yl)(4-methylpiperazin-1-yl)methanone;869497-75-6(maleate) |
JNJ10181457 dihydrochloride | 544707-19-9 | C20H30Cl2N2O | 385.37 | JNJ-10181457 dihydrochloride;4-[[3-(4-piperidin-1-ylbut-1-ynyl)phenyl]methyl]morpholine dihydrochloride |
JNJ DGAT2-A | 1962931-71-0 | C24H16BrFN4O2S | 523.38 | 3-Bromo-4-[2-fluoro-4-[[4-oxo-2-[[2-(pyridin-2-yl)ethyl]amino]-1,3-thiazol-5-(4H)ylidene]methyl]phenoxy]benzonitrile |
JNJ 63533054 | 1802326-66-4 | C17H17ClN2O2 | 316.785 | 3-chloro-N-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]benzamide; GTPL8766; JNJ-63533054 |
JNJ 55511118 | 2036081-86-2 | C14H8ClF3N2O2 | 328.67 | 5-[2-Chloro-6-(trifluoromethoxy)phenyl]-1,3-dihydro-2H-benzimidazol-2-one |
JNJ 5207852 dihydrochloride | 398473-34-2 | C20H32N2O.2HCl | 389.40 | 1-[3-[4-(1-Piperidinylmethyl)phenoxy]propyl]piperidine hydrochloride |
Jasmine oil | 8022-96-6 | C10H16 | 136.23404 | ConcreteJasminItalian; Concretejasminturc; HyperabsoluteJasmine; Jasmin; Jasminabsolute; Jasmincomores; Jasmineconcrete; Jasmineoil,French |
Jaslanceoside B | 188300-82-5 | C26H30O14 | 566.51 | (4S,5Z,6S)-5-[2-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyethylidene]-4-(2-methoxy-2-oxoethyl)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid |
Jasamplexoside C | 147742-02-7 | C42H54O25 | 958.87 | |
Jasamplexoside A | 147764-93-0 | C42H54O24 | 942.87 | Methyl (4S,5Z,6S)-5-(2-hydroxyethylidene)-4-[2-[(2E)-2-[(2S,4S)-4-[2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl]-5-methoxycarbonyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-ylidene]ethoxy]-2-oxoethyl]-6-[(2S,3R,4S,5S,6R)-3 |
Jaboticabin | 911315-93-0 | C16H14O8 | 334.29 | 2-[(3,4-Dihydroxybenzoyl)oxy]-4,6-dihydroxy-benzeneacetic Acid Methyl Ester |
Ixazomib Impurity 1 | 1201903-02-7 | C24H33BCl2N2O4 | 495.26 | |
Ixazomib Citrate | 1239908-20-3 | C20H23BCl2N2O9 | 517.12 | 4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid; MLN9708; MLN-9708; MLN 9708; Ninlaro |
Ixazomib | 1072833-77-2 | C14H19BCl2N2O4 | 361.026 | MLN2238; MLN-2238; MLN 2238; Ixazomib. Trade name: Ninlaro. (R)-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)boronic acid |
Ixazomib | 1201902-80-8 | C20H23BCl2N2O9 | 517.119 | Ixazomib; MLN-9708. |
Ixabepilone Impurity 6 | 1220999-09-6 | C27H44N2O6S | 524.73 | (4S,7R,8S,9S,13R,14R)-14-((S,E)-2-Amino-3-methyl-4-(2-methylthiazol-4-yl)but-3-en-1-yl)-4,8,13-trihydroxy-5,5,7,9,13-pentamethyloxacyclotetradecane-2,6-dione |
Ixabepilone Impurity 2 | 1220999-07-4 | C27H42N2O5S | 506.71 | (Z)-Ixabepilone; (1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-((Z)-1-(2-methylthiazol-4-yl)prop-1-en-2-yl)-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione; |
Ixabepilone | 219989-84-1 | C27H42N2O5S | 506.7 | Azaepothilone B; BMS247550; BMS-247550; BMS 247550; Ixempra |
IWR-1-endo | 1127442-82-3 | C25H19N3O3 | 409.44 | 4-[(1R,2S,6R,7S)-3,5-dioxo-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl]-N-quinolin-8-ylbenzamide |
IWP-O1 | 2074607-48-8 | C26H20N6O | 432.487 | N-(5-phenylpyridin-2-yl)-2-(5-phenyl-4-pyridin-4-yltriazol-1-yl)acetamide |
IWP-L6 | 1427782-89-5 | C25H20N4O2S2 | 472.58 | IWP L6; Porcn Inhibitor III; 2-[(4-oxo-3-phenyl-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)sulfanyl]-N-(5-phenylpyridin-2-yl)acetamide |
IWP-3 | 687561-60-0 | C22H17FN4O2S3 | 484.58 | 2-[[3-(4-fluorophenyl)-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]sulfanyl]-N-(6-methyl-1,3-benzothiazol-2-yl)acetamide |
IWP-2-V2 | 877618-79-6 | C23H20N4O2S3 | 480.6 | 2-((3-benzyl-4-oxo-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)-N-(6-methylbenzo[d]thiazol-2-yl)acetamide |
IWP-051 | 1354041-91-0 | C17H11F2N5O2 | 355.30 | 5-fluoro-2-(1-(2-fluorobenzyl)-5-(isoxazol-3-yl)-1H-pyrazol-3-yl)pyrimidin-4(3H)-one |